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Abstract
Production of pharmaceuticals is a complex process which goes beyond the synthetic
reactions undertaken to produce the final drug product. In multi purpose
manufacturing facilities the equipment used in the processes must be proven to be
sufficiently free of residue from the previous compound so that safe manufacture of
the next compound can commence. Cross contamination can pose serious health risks
so cleaning verification is a process of extreme importance.
Pharmaceutical products may contain impurities that originate from the synthetic
stages of production, the starting materials or from in situ reactions taking place in the
final drug. Some of these impurities may be genotoxic. Genotoxic impurities are a
class of impurities for which awareness is currently growing in the pharmaceutical
industry.
Traditional analytical chemistry methods such as HPLC are currently employed for
the detection and quantification of cleaning residues and genotoxic impurities. These
methods can be extremely time consuming. The aims of this project are to investigate
swab sampling in cleaning verification, to develop alternative analytical methods
which speed up and enhance knowledge of the cleaning verification process and to
begin the development of an assay system for commonly occurring genotoxic
impurities.
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1 Introduction
21.1 Pharmaceutical production: cleaning verification and genotoxic
impurities.
Pharmaceuticals are produced in specialist manufacturing facilities. Some facilities
are dedicated to the production of a particular drug but some facilities may be multi
purpose. In multi purpose plants the equipment must be proven to be sufficiently free
of the previous drug in order for production of the next drug to commence. This
means the machinery must be appropriately clean with residue from the previous drug
proven to be at a predetermined target level. The process by which the plant is
determined as clean is known as cleaning verification and the process involves
sampling from equipment surfaces and subsequent analysis of those samples.
The quality of pharmaceutical product is critically affected by a production step which
is neither productive, nor in a sense pharmaceutical. This production step is the
cleaning of pipes, equipment and containers bearing pharmaceutical products (Zeller,
1993). Its planning, performance and validation are important in the production of
pharmaceuticals.
3Figure 1.1. Photographic example of a pharmaceutical pilot plant. The presence of
large surface area, plus pipes, valves etc means that cleaning is an arduous process
and it must be done rigorously to ensure that residues are eliminated.
Source:http://www.ittallaght.ie/science/nationalpharmaceuticaleducationcentre/pharm
aceuticalpilotplant/
The development of rigorous cleaning verification systems is critical to companies
involved in the manufacture of pharmaceuticals. Responsibility lies with the
manufacturer to develop robust cleaning procedures and to demonstrate that the
execution of the cleaning procedure was successful. Success of cleaning is shown by
analytical testing of the equipment involved in manufacture for both residual drug
ingredients and cleaning agents introduced during the cleaning process itself (Shifflet
and Shapiro, 2002).
Impurities can accumulate in drug products as by products from either the synthetic
reactions/intermediates involved in the manufacturing process, impurities from the
starting materials or from in situ reactions taking place in the drug product involving
classes of compounds such as residual solvents. Some of these impurities may have
4unwanted toxicities such as genotoxicity or carcinogenicity and therefore have an
effect on a product’s risk assessment (Muller et al., 2006).
Pharmaceutical companies are under pressure to limit impurities and therefore
cleaning verification and measuring genotoxic impurities are two areas of interest.
Both represent emerging areas of research; the reason being analytical technology
improving to a point where residuals on manufacturing equipment are much more
apparent and awareness of impurities and their potential toxicological effect is greater
than in the past. Cleaning verification also represents a significant cost factor to the
pharmaceutical industry and this is because the process currently relies on
chromatographic methods such as HPLC for sample analysis. Sampling must be
representative of the equipment train used to produce a particular drug and this can
lead to the generation of a significant number of samples for analysis. Manufacturing
downtime can be significant because HPLC analysis is a lengthy process particularly
when the number of samples is so high. The failure of one sample can trigger a
recleaning of the equipment and so change over or release of the plant as it sometimes
known can take weeks. This period of downtime represents a significant incursion of
costs because the plant is effectively standing idle.
Genotoxic impurities represent an unwanted class of impurities which the
pharmaceutical industry is becoming increasingly aware of. Genotoxic impurities can
be reduced or eliminated by selecting appropriate synthetic routes, solvents and
intermediates but it is acknowledged by the regulatory bodies of the pharmaceutical
industry that the presence of impurities and therefore potentially genotoxic impurities
5in pharmaceutical products is almost inevitable. The industry’s aim is to control the
types and quantities of impurities in their drugs.
1.1.1 Aims and objectives
The aims and objectives of this project are: to enhance the understanding of aspects of
the cleaning verification process, to investigate potential analytical technologies that
could be implemented to speed up the process of cleaning verification and to develop
an analytical technique to detect the presence of genotoxic impurities in drug samples.
The characteristics of different commercially available swabs were tested in order to
identify the best swabs for swab sampling. The investigation shed light on aspects of
the sampling process that are important within the field of cleaning verification. The
work is presented in chapter 3 and the outcome was an increased understanding of the
issues associated with swab sampling.
Alternative cleaning verification technologies were introduced and tested. The
introductory section of the thesis contains information on optical spectroscopies and
chapter 4 will present results on the investigations of the chosen techniques and their
potential use within cleaning verification.
Optically active dyes were investigated with the aim of developing an assay or sensor
for the presence of genotoxic impurities in drug products. The results of these
investigations are presented in chapter 5. Chapter 6 contains an overall discussion of
the work undertaken during this programme of research.
62 Literature Review
72.1.1 Cleaning – definitions and outline
Cleaning validation and cleaning verification are two terms used in the area of
cleaning pharmaceutical equipment. A cleaning process must be validated before it
can be implemented on the industrial scale. The strategy of validation should be
defined, often validating from the worst case of cleaning so subsequent reductions can
be made. Personnel should be trained in terms of plant operations, processes and
cleaning methods for the drug of interest and standard operating procedures are
written for, plant operations, plant processes, method of cleaning and sampling and
testing methods. The cleaning method should be optimised where necessary during
the development of the cleaning procedure. The work should highlight potential
problems such as poor solubility, scale build up, critical parts of the plant which may
require testing and any affinities of the products to stick to manufacturing equipment.
The analytical method should be chosen appropriately and validated so that accuracy
and sensitivity are known. The sampling plan should be designed so that it is
representative of the manufacturing equipment train, particularly any curved pipes or
valves where material can accumulate and then documented in the validation protocol.
Toxicological and medical data should be documented so that cleaning limits can be
agreed (Pharmaceutical Quality Group, 1999).
Sampling, analysis and limits are vital aspects of both cleaning validation and
verification. Verification and validation mean slightly different things but sometimes
their use in the literature isn’t always clear. Cleaning validation refers to the
validation of the cleaning processes to be used in a plant and covers the aspects of
8setting up a validated cleaning programme. All aspects of the validated cleaning
programme should be documented as this is subject to regulatory scrutiny. The
overall aim of cleaning validation is to design a valid cleaning protocol. Cleaning
verification refers primarily to the process of cleaning and checking the plant for
contamination once production has begun and the appropriate cleaning protocol is in
place. The two definitions are loose and used interchangeably in the literature but
from henceforward the term cleaning verification will be used in this thesis unless
specifically referring to the process of validating a cleaning regime.
2.1.2 Cleaning Verification – background and regulatory expectations
The US Food and Drug Administration (FDA) has noted that US drug products are of
a generally high quality, however there is an increasing trend towards manufacturing
related problems leading to recalls and disruption of manufacture (Urbas & Lodder,
2003). Jenkins & Vanderwielen, 1993 presented evidence that the number and
severity of FDA citations over cleanliness was increasing and this showed that
regulatory authorities were placing greater emphasis on cleaning. Low manufacturing
process efficiency has also led to an increased cost of drugs and emphasis on good
manufacturing practices (GMP) as the means of controlling drug quality has led to a
widespread reluctance amongst companies to innovate within the manufacturing
sector of their business. Such problems have led the FDA to conclude that a new
scientific understanding of the drug production process achieved through the use of
new technologies should be used to provide science-based approaches to improving
the quality of the manufacturing process (FDA, 1993).
9Attention to cleaning procedures from the regulatory bodies of the pharmaceutical
industry is increasing. Increased levels of scrutiny from the authorities make it
necessary for companies to better understand their cleaning verification processes.
The mandate of cleaning verification is very simple, the idea is to reduce the levels of
contaminants to below those deemed acceptable before commencing the manufacture
of another drug. The greatest concerns are associated with instances where equipment
is used to manufacture multiple active pharmaceutical ingredients (APIs) and where
cross contamination can have potentially deleterious effects.
Regulation of cleaning verification is not a rigid process and the individual cleaning
programmes need to be tailored to suit the pharmaceutical product manufactured. In
it’s 1993 document, entitled Guide to Inspections Validation of Cleaning Processes
the FDA lists its expectations.
FDA expects firms to have written procedures (SOP's) detailing the cleaning
processes used for various pieces of equipment. FDA expects firms to have written
general procedures on how cleaning processes will be validated. FDA expects the
general validation procedures to address who is responsible for performing and
approving the validation study, the acceptance criteria, and when revalidation will be
required. FDA expects firms to prepare specific written validation protocols in
advance for the studies to be performed on each manufacturing system or piece of
equipment which should address such issues as sampling procedures, and analytical
methods to be used including the sensitivity of those methods. FDA expects firms to
conduct the validation studies in accordance with the protocols and to document the
results of studies. FDA expects a final validation report which is approved by
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management and which states whether or not the cleaning process is valid. The data
should support a conclusion that residues have been reduced to an "acceptable level."
(FDA 1993).
2.1.3 Cleaning
Cleaning personnel should have clean room garments including: boots, cover alls
(normally woven polyester), masks, hoods and gloves for cleanliness and safety
(Cooper, 1997). The recommended steps for wiping are:
Fold the wiper into quarters, obtaining several clean wiper surfaces (figure 2.1).
Folding helps to better distribute the pressure of the fingers and the hand. Wipe on a
pattern of parallel strokes with some overlap, changing the surface of the wiper on
every stroke. Start each stroke at the cleaner end of the path to be cleaned. Change
the wiper after approximately every ten wiper lengths of surface. This should be done
more frequently if the surface is visibly dirty (figure 2.2). To disinfect, use a
saturated wiper and leave a visible film of disinfectant. (Cooper, 1997)
11
Figure 2.1. Showing how the wiper should be folded prior to cleaning. Folding into
quarters helps the worker to better distribute pressure from their hand. Source:
Cooper, 1997.
Figure 2.2. Showing the recommended method for cleaning surfaces by hand. It is
recommended that the worker start from the cleaner end of the path and wipe in
overlapping strokes. Source: Cooper 1997.
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The success of cleaning has been evaluated by adding dye to product surrogates and
then swabbing the surfaces and analysing the swabs for traces of the dye (Gavlick et
al., 1995). A similar procedure can be carried out where the drug itself or cleaning
residues are tested for rather than the dye (Zeller, 1993). Cleaning validation needs to
take into account the nature of the surfaces being tested. Flat surfaces are relatively
easy to analyse and it is also easy to calculate the area of surface being analysed.
There can be a tendency to avoid corners and depressions with some people
recommending the use of pointed swabs to recover residues from hard to reach areas
(Zeller, 1993). Others recommend using rinse analysis for sampling in hard to reach
areas such as corners, depressions and around valves (Gavlick et al., 1995). However,
as will be stated there are problems associated with rinse analysis.
Understanding the removal of sample from the swab for analysis is another important
part of the cleaning validation and verification processes (see figure 2.3). Usually
swabs are employed to remove materials from the surface of interest. The swabs are
immersed in liquid and then agitated or sonicated in order to liberate as much material
as possible. Three of the most important criteria when choosing the correct swabbing
material for cleaning verification are:
1) Minimal background - background is the amount of contamination on the
swab. The procedure must be validated to take this into account. Blank
contribution from the swab must be minimal.
2) High recovery rate - this is essentially the percentage of contaminant actually
measured by the analytical technique when the swab is spiked with a known
13
quantity of the species of interest. Sixty per cent recovery rates are acceptable,
however, higher recovery rates are desirable.
3) Low particle generation - it is critical that as little material as possible from the
swab be left behind on the surface of interest. These particles would further
contaminate the surface (Miscoscio, 1997)
Figure 2.3. Showing the removal of samples from surfaces with a swab for
subsequent analysis. Source: Miscoscio, 1997.
Nozal et al., (2000) described a method where the removal of acetylsalicylic acid
from glass, vinyl and steel surfaces was validated. They were able to achieve
recovery rates of 86 per cent, 90 per cent and 94 per cent from glass, vinyl and steel
by using moistened cotton swabs to recover the compound from the surface. Mirza et
al., (1999) carried out a study where they were able to use cotton swabs to achieve
87.5 per cent and 89.0 per cent recoveries of meclizine hydrochloride from stainless
steel plates. Nozal et al., (2002) again used their procedure of swabbing to achieve
recovery rates of 88.5 per cent, 94.2 per cent and 95.2 per cent for vinyl, glass and
steel for the drug sumatriptan succinate. Klinkenberg et al., (2003) used cotton swabs
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moistened with methanol to achieve a recovery rate of 90 per cent for amlodipine
from stainless steel. All of these methods outlined used HPLC as the analytical
technique. As is often stated in the literature, HPLC is the most widely used
analytical technique for cleaning verification sample analysis within the
pharmaceutical industry.
Equipment and facility design is a vitally important aspect of the cleaning process.
Material selection depends upon the characteristics of the product to be handled.
Materials should be smooth surfaces for which the product does not have any affinity
such as glass, inert plastic and stainless steel. Tests to determine the absorption of
chemicals by the surfaces of materials and desorption of chemicals from the materials
into the drug formulation should be done at the development stage. This problem is
of relevance to rubber and plastic. For example, preservatives from the drug can
absorb into silicone rubber and mould release lubricants from plastic can enter the
drug formulation (Pharmaceutical Quality Group, 1999).
Parts for cleaning should be easily dismantled, connections should be easily
dismantled, dead legs should be avoided and in no case should extend beyond a length
equivalent to six diameters of the pipe, tight bends in pipe work should be avoided,
pumps should be easily dismantled, valves with easy clean designs should be selected
and adequate drainage should be ensured (Pharmaceutical Quality Group, 1999).
Considerations such as those just outlined from the Pharmaceutical Quality Group
1999 are elements of understanding for the sampling process and must be considered
when devising a sampling regime that is representative of the equipment train.
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2.1.4 How clean is clean?
No standards for selecting safety margins or establishing cleanliness criteria exist
within the industry. As a result, each company develops its own guidelines on
cleaning requirements for the various compounds they manufacture. For example,
one such approach uses daily intake as the basis for such determinations (Jenkins et
al., 1995). Acceptable daily intake for humans is normally calculated by applying a
hazard risk factor to toxicological and pharmacological data which establishes a “no
effect level” for humans. Typical hazard risk factors range between 1/100 and
1/10000 and usually vary in an inversely proportional manner relative to the potency
of a substance and completeness of available toxicology/pharmacology data. A
common practice observed in most companies today involves the use of three basic
formulae:
1) The 10 ppm formula. This formula allows the presence of no more than 10
ppm of product A into the next products (B) maximum potential daily dose.
Given the production scale of product B, the acceptance level is calculated as
milligrams of product A per litre of cleaning solution.
2) The acceptable daily intake formula. This formula allows no more of product
A into product B than what the acceptable daily intake dictates. The
acceptable daily intake can be based on the eight hour acceptable worker
exposure limit (AWEL).
3) The 1/1000 of therapeutic level formula. This formula allows no more than
1/1000 of product A’s minimum therapeutic daily dose into product B’s daily
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maximum dose. Calculation requires knowledge of product B’s production
scale. (Jenkins et al., 1995)
Depending on data availability, cleaning criteria are frequently based on the formula
that results in the lowest number – most typically the 1/1000 of therapeutic level
formula. It is apparent that the more active a particular drug is the lower the cleaning
criteria would be and therefore the cost of maintaining product quality and personnel
safety would be higher. This results in cleaning and decontamination being a serious
concern and a major cost contributor to the manufacturing process (Valvis &
Champion, 1999).
The first step when initiating a cleaning validation program is to define the strategy
and make sure that the cleaning methods to be employed have themselves been
validated (Gavlick et al., 1995). The strategy must account for the range of products
and types of equipment employed in the manufacturing process. The procedure must
have minimum acceptance levels determined by acceptable numbers of trials and
appropriate levels of sampling. The continuous improvement of analytical techniques
means that the limit of quantification no longer represents the standard of cleanliness.
Instead acceptable levels of impurities have to be set (Zeller, 1993). A number of
publications have proposed acceptance levels for tolerable concentrations of
contaminating substances. Nearly all of the proposed acceptance levels have one
disadvantage in common; their definition is very rigid. Either a theoretical
concentration is increased by a set value or an existing concentration such as the daily
therapeutic dose gets reduced by a set percentage or a logarithmic value. Both of
these methods create problems (Zeller, 1993).
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The method of cleaning employed is related to the types of residue/material that must
be removed from the manufacturing surface. This means that acceptable residue
limits should be based on information related to the drug toxicological profile and its
relative potency. The biggest problems are caused by highly potent drugs, or drugs
with relatively high toxicities. Cleaning verification needs to be sufficiently sensitive
in order to confirm that acceptable levels of cleanliness have been attained. In
addition, more frequent validations and follow up monitorings may be necessary in
the case of more potent drugs (Zeller, 1993). Other areas of difficulty for cleaning
verification and therefore potentially in need of special attention are filling needles
and tablet punches. Residue left behind on these devices can lead to significant
contamination because of the critical role the equipment plays in the manufacturing
process (Jenkins & Vanderweilen, 1994).
2.1.5 Sample collection
There are two major methods employed for collecting samples for analysis, these are
residue collection by swabbing surfaces and residue collection by rinse analysis
(Kaiser et al., 1999).
Surface swabbing and rinse analysis have been fairly successful, but there are
disadvantages associated with both methods. Swabbing is the more prevalent of the
two procedures and some of the problems associated with it include: the requirement
to physically collect samples from the surface, partial recovery of residues, problems
associated with the recovery of residues from the swab itself and it is a lengthy
procedure resulting in significant amounts of downtime. Rinse analysis can be used
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in its own right or as a complementary procedure to swab analysis. Limitations with
this approach include difficult method validation and residue solubility/detachment
issues. Both methods present the additional difficulty of still having to ascertain the
amount of residue remaining on the surface of interest (Gavlick et al., 1995). In swab
analysis, water is the most commonly used agent when dislodging material from the
swab itself, although organic solvents such a methanol or hexane can be employed. In
rinse analysis, the solvent could be organic, e.g. methanol or it could be the final
water rinse that commonly marks the terminal step of the cleaning process.
The sampling technique plays an important role in determining which analytical
method is to be employed. Some techniques are more compatible with swabbing and
others more compatible with rinse analysis. An important factor to be taken into
account when trying to select an analytical method is the nature of the sample itself.
Residues can be: drug actives, formulation components, cleaning agents, organic,
inorganic, water soluble, particulate, microbial and/or endotoxins (Zeller, 1993). In
addition, it must be recognised that the chemical structure of the active ingredient can
be altered by cleaning agents. If the cleaning agent is going to have an effect upon the
chemical structure of the active ingredient, the worker needs to be aware of this so
that the correct chemical structure is actually investigated (Gavlick et al., 1995).
2.1.6 Sample analysis – requirements, options and constraints
In advance of selecting an analytical method, some definitions need to be considered.
The limit of detection (LOD) is the lowest amount of a particular compound that can
be detected. The limit of quantitation (LOQ) is defined as the lowest amount of a
particular compound that can be quantified. The residue acceptance limit should be
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above the LOQ so that it can be accurately quantified. (Kaiser et al., 2001). The
analytical methods involved in cleaning verification can be divided into two broad
groups. Some are specific and some are non specific. Specific methods include: High
Performance Liquid Chromatography (HPLC), ion chromatography, infrared
spectroscopy, inductively coupled plasma, capillary electrophoresis and the other
chromatographic methods. It must however be noted that not all of these methods are
specific in that they will identify the potential contaminant without additional
information. For example, HPLC can be used to separate out potential contaminants
by manipulating the conditions within the HPLC instrument. Non specific methods
will highlight the presence of particular types of compounds that produce a defined
response. Some examples include total organic carbon (TOC), pH, titrations and
conductivity (Kaiser et al.,1999). Titrations can be for acids or bases but not particular
acids or bases. There are however specific titrations for classes of surfactants
(Jenkins & Vanderweilen, 1994).
Deciding upon which analytical technique to use is obviously a multifaceted decision.
Many of the articles within the literature describe HPLC and TOC as favourable
approaches (Kaiser et al., 1999). Other groups have looked at column liquid
chromatography coupled to Fourier transform-infrared spectroscopy (Somsen et al.,
1998). Gas chromatography and Fourier transform-infrared spectroscopy is a well
established system and commercially available units are in existence (Somsen et al.,
1998).
The analytical methods chosen should also reflect an optimisation between
practicality and reliability (Zeller, 1993). To achieve this optimisation, it is useful to
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denote one ingredient in the formulation as a “guiding substance”. The criteria upon
which the analytical technique is selected are: concentration of the concerned
substance within the product, its UV absorption, its pharmacological potency, the
existence of an analytical assay method and its solubility.
Another important element of cleaning verification is making sure that there are no
residuals left from the cleaning agents employed. If a cleaning agent effectively
removes the drug/product residues but leaves behind its own residue, then one type of
contamination has been exchanged for another and the equipment has not been
cleaned effectively. Thus, the analytical strategy must consist not only of assays for
the determination of pharmaceutical product and cleaning agent residues, but also a
clear rationale for choosing a particular assay (Gavlick et al., 1995).
2.1.7 Analytical techniques associated with cleaning verification
Almost every pharmaceutical company has an HPLC instrument. HPLCs utilise a
variety of detectors and these include: ultraviolet (UV), fluorescence, electrochemical,
refractive index, conductivity and evaporative light scattering. The ultraviolet
detector is by far the most common, however evaporative light scattering may well be
the most appropriate detector for cleaning agents (Kaiser & Minowitz, 2001).
There are a number of advantages to using UV detectors and these include: the fact
that many compounds contain chromophore groups, usually no additional reagents or
pre-column or post column reactions are necessary, the technique is generally
inexpensive and molar absorptions are generally not affected by temperature and
therefore there is no need for heating or cooling the detector. Many instruments are
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equipped with diode array spectral capabilities allowing for easy identification of
impurities or potential contaminants. A disadvantage with UV detection is the fact
that not all compounds have chromophores and this is particularly true of some
surfactants used in the pharmaceutical industry (Kaiser & Minowitz, 2001).
Under the technique of evaporative light scattering detection the compound is
separated on an HPLC column as usual, moved to a nebulizer that is combined with a
gas stream and then passed through a heated column. The heated column incorporates
the mobile phase leaving the solid analyte in the column. The solid phase then passes
through a detector that consists of a laser or light source. The laser or light source is
scattered when it hits the solid analyte. The detector then picks up this scattering.
There are many advantages associated with evaporative light scattering detectors.
The technique is described as universal because it can detect any sort of compound.
Evaporative light scattering is simple, versatile, rugged in use and since it is a mass
detector all compounds produce similar responses. The two main disadvantages are
that there is a very limited choice of buffer salts (buffers that evaporate are necessary
so that they do not remain behind and interfere with the solid phase). The second
disadvantage is that the nebulizer and detector must produce a consistent particle size,
careful cleaning and monitoring of the nebulizer is required (Kaiser & Minowitz,
2001).
Many different residues can be detected by HPLC techniques, including drugs and
detergents. When dealing with detergent residues it is important to clearly identify
what is being analysed because the separation and quantitation of these particular
compounds is especially difficult (Kaiser & Minowitz, 2001).
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Total organic carbon (TOC) analysis is determined by the oxidation of an organic
compound into carbon dioxide. This oxidation can occur through a number of
mechanisms depending on the instrument being used. Some typical methods are
persulfate, persulfate/UV detectors and direct combustion. The carbon dioxide
produced from these reactions is either measured by conductivity or infrared
spectroscopy. Instruments generally measure the inorganic carbon content of a
sample. The total carbon content of a sample is then determined and the inorganic
portion deducted to yield the levels of total organic carbon. There are two primary
advantages associated with total organic carbon analysis. Firstly, it does not take long
to develop a method as there are not a lot of variables in the actual analysis. Secondly,
the method is a very quick one (Jenkins et al., 1996).
A significant disadvantage with total organic carbon analysis is the fact that the
compound must be water soluble. Organic solvents cannot be used because they
contribute to the final measurement. Another potential problem is that contamination
can be an issue, the atmosphere, the swab itself, personnel and other sources can
cause contamination. When a total organic carbon method is developed appropriate
blanks and controls should be elucidated in order to ensure the correct levels of
organic carbon are measured (Kaiser & Minowitz, 2001).
Jenkins et al., 1996 showed ppm and ppb detection of pharmaceuticals and
biopharmaceuticals and also discussed the potential for significant time savings with
total organic carbon analysis but as discussed above there are widely known
disadvantages with total organic carbon analysis. At this point it is pertinent to say
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that HPLC remains the dominant analytical technique employed by the
pharmaceutical industry for analysis of cleaning verification. Much of this is because
of regulatory viewpoints and because companies for sound commercial reasons will
follow the regulatory view point in terms of pharmaceutical production whilst
maintaining an interest in cleaning verification research and analysis methods. Total
organic carbon analysis will be discussed again further in the section on commercially
available cleaning verification systems.
2.1.8 Helpful strategies
In many ways it is easier to dedicate a facility to the manufacture of one drug rather
than having to clean to such stringent levels. Already there are certain drugs that must
be manufactured in dedicated facilities. Penicillin and beta-lactam antibiotics are
examples of drugs where an isolated facility is required for production. Another
approach that can be taken by pharmaceutical companies is to try and group the
manufacture of certain drugs to certain facilities in order to aid the cleaning process.
When this occurs, the groupings are based on scientific data such as product type,
product family and equipment type (Gavlick et al., 1995). A potential mistake is to
focus attention on the high volume or higher money making drugs when the lower
volume drugs may be more potent and thus place the higher volumes at risk.
Therefore, when looking at cleaning verification strategies the nature of all the
products being manufactured in a particular facility must be taken into account
(Gavlick et al., 1995).
Clean in place (CIP) operations are becoming increasingly important within the
pharmaceutical industry. The technologies were initially implemented within the
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food and dairy industries. CIP systems offer significant benefits including automation
and the ability to consistently produce uniform levels of cleanliness. Manually based
systems are subject to operator based error and sometimes result in equipment not
reaching the desired level of cleanliness. CIP systems are used mainly for cleaning
tanks and transfer lines and they have a variety of designs ranging from a simple high
pressure flush to a multiprocessor controlled multi task batch-type system (Myers et
al., 1997). Another method of obtaining a final sample for establishing cleanliness is
that of conducting a boil out (Valvis & Champion, 1999). A boil out involves the
refluxing of a solvent inside a closed vessel system in order to clean its interior
surfaces and produce a representative sample. The cleaning effectiveness of a boil out
relies on the combined actions of the dissolution, mixing shear and vapour extraction
all resulting in an exponential dilution cleaning profile (Valvis & Champion, 1999).
Clean in place systems can be used to facilitate the cleaning of hard to reach areas in a
boil out procedure.
The potency and toxicological profile of a drug are extremely important factors when
considering cleaning verification. Understandably, the pharmaceutical industry is the
most heavily regulated of the industries of this type (paints, foods etc). The narrow
concentration range over which compounds are therapeutically active dictates that the
final concentration must be as accurate as possible. Also, people taking these drugs
are often in a weakened state because of illness and are therefore less likely to tolerate
excessive amounts of impurities. A result of this strict regulation is that the
pharmaceutical industry is at the cutting edge of cleaning verification technology
(Ciurczack, 1998). The cleaning verification process and its key check points are
depicted in figure 2.4.
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Figure 2.4. The key points in the cleaning verification process.
2.1.9 Commercially available cleaning verification systems.
Companies such as Texwipe provide commercially available swabs for cleaning
verification. A variety of specific designs are available. Texwipe lists the benefits of
their standard Alpha™ swab as: made from ultra low non volatile residue, gives low
particle and fibre generation, good sorbency, contains no contaminating adhesives and
has excellent chemical resistance. This standard swab is described as being suitable
for cleaning verification, cleaning with solvents, applying lubricants and other liquids
and removing excess materials. Long handled varieties can be purchased. The
rationale behind the long handled design is that they improve the workers ability to
carry out sampling in difficult to reach areas. Other designs include swabs with a
variety of head shapes including triangular, pointed and rectangular, foam covered
swabs that are designed to have improved absorbency for use in difficult to sample
areas, mini compressed swabs with a micro tip head designed to clean grooves and
channels. All of these different head designs can be purchased in a variety of handle
lengths. Swabs are available that have been processed using a proprietary treatment
Cleaning or
Re cleaning
Sample
collection
Extraction* Analysis CLEAN
Yes/No
* Some sampling techniques do not require an extraction step
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allowing the measurement of extremely low total organic carbon levels and are sold
as part of a specialist total organic carbon kit. A variety of swab designs are shown in
figure 2.5.
Figure 2.5. Four different designs of swab. The first is a standard swab, the second
has a larger rectangular head, the third swab has a foam covering and is designed to
be extra absorbent and the fourth is a microswab designed for sampling in grooves
and channels. Source: www.texwipe.com
One of the focuses of this project is on developing a sensor or system aimed at
speeding up the cleaning verification process. There would be little point in carrying
out work on sensor technology when a commercially produced alternative is already
available or imminent and so the current market has been reviewed and an assessment
made on the worth of proceeding along the line of enquiry. Cleaning verification
equipment breaks down into a small number of analytical technologies and
approaches to cleaning verification taken by manufacturers of commercial products
include: on-line UV monitoring, surface monitoring fluorimetry, total organic carbon
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analysis, ion mobility spectrometry, and surface NIR. Any sensor system would have
to offer the same low levels of detection that HPLC is capable of but offer advantages
in terms of simplicity and time taken to carry out testing.
As a technology, UV monitoring offers a number of commercially available systems.
UV technology is based around the fact that many of the compounds under
investigation during the cleaning verification process contain chromophores. UV
technology can be divided into two groups, the first group includes technologies that
monitor the surface of interest directly and the second group comprises technologies
that monitor the contents of the equipment train directly by being “on-line”.
The surface monitoring fluorimeter SMF2 manufactured by Safe Training Systems is
a direct reading spectrofluorimeter that employs a xenon flash lamp in order to excite
materials on the surfaces of interest. The resulting excitation is detected and a result
produced. The technique is not suitable for full time use in a cleaning verification
scenario for two main reasons, these are; making the device intrinsically safe is far too
costly and the data produced from steel and glass surfaces is not of the required
accuracy.
The Cleanscan system produced by Clairet Scientific was evaluated with cleaning
verification in mind. The system is designed for on-line monitoring and consists of a
UV diode array spectrometer and windows NT computer which has been enclosed in
a stainless steel air purged cabinet thus providing intrinsic safety and making the
device suitable for use in a plant environment. A fibre optic flow cell is located on
the outside of the enclosure and is attached to the reactor via a series of hoses and
28
recirculation pumps. The system has advantages and disadvantages. The
disadvantages include the fact that engineering difficulties arise because of the extra
plumbing and there are problems with the software package provided. SpectrAlliance
sell a more suitable software package along with hardware that is very similar to that
of the Cleanscan system. A significant advantage of the SpectrAlliance system is that
the data can be transmitted in a wireless fashion and the operator is not obliged to take
a blank solvent reference spectrum before data collection can commence. A stored
reference spectrum of the cleaning solvent is used, reducing the need for access to the
flow cell and reduces the requirement to bring solvent bottles into the plant area. The
system offers a series of significant advantages in terms of data storage, data
management and protocol storage.
Expo Technologies market two products for cleaning verification the ePAT 631
(figure 2.6) and the ePAT 731 (figure 2.7). The ePAT 631 is designed for monitoring
surface cleanliness and is based on a diode array UV spectrometer with a portable
analyzer and detection limits of µg/cm2 can be achieved.
Figure 2.6. The ePAT 631 analyser manufactured by Expo technologies.
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Figure 2.7. The ePAT 731 analyser manufactured by Expo technologies.
In comparison to the ePAT 631, the ePAT 731 operates from a different perspective
in that it offers monitoring of rinsate. The system is based upon a diode array based
UV/NIR spectrometer, designed to measure cleaning and final rinse solutions during
the cleaning of API and drug product vessels. The system monitors cleaning based on
a pre developed method for the active pharmaceutical ingredient of interest down to
low levels and then the manufacturing equipment can be swabbed for off line analysis
by HPLC. The system offers benefit by not ever triggering a re-clean because it
monitors elimination of the compound and then subsequent verification of cleanliness
can take place with swabbing and HPLC meaning there are no incidents where
recleaning has to take place. With this product, there is no need to swab sample the
equipment in a speculative fashion to find out if it is clean because the ePAT671 has
shown elimination of the active pharmaceutical ingredient and therefore speeds up
release of the plant.
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Another technique for which many commercially available systems are in existence is
ion mobility spectrometry. The technique involves the introduction of a sample into
the machine which is then volatilised and accelerated down a drift tube to a detector.
Different ions have different migration times and a series of plasmagrams (spectra)
are generated. The technique is employed in situations where explosive or drug
detection is needed such as airports or ports. The technique has limitations associated
with it and these include the fact that it is extremely sensitive and therefore can either
be swamped or cause cleaning to levels below those required. The linearity and
reproducibility are often not as good as that seen in liquid chromatographic methods.
One company beginning to strongly market ion mobility detection for cleaning
verification is Smiths detection (figure 2.8). The company state that technologies
delivering low level, specific, high speed detection will become the leading
technologies in the field of cleaning verification. They state that with ion mobility
spectrometry a company can reduce their analysis time and speed up release of the
plant, speed up the validation of cleaning protocols and reduce the cost per sample.
The company claim the limit of detection for their system is typically between 10 pg
and 1 ng or 1 ppb for a 10 µl injection or 1 ppm for a 1 µl injection, the limit of
quantitation is usually three times higher than the limit of detection and that R2 values
typically exceed more than 0.999. In combination with their high pressure injection
technique, Smiths have shown sensitive detection of active pharmaceutical ingredient
down to 1 µg/ml.
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Figure 2.8. Summarising the Smiths Ionscan system. The sample is introduced after
deposition on a Teflon filter and ions are accelerated down the drift tube before hitting
a detector. The system can also be coupled to a high pressure injection device that
introduces sample for analysis.
NIR is a technology that has shown some promise for cleaning verification.
Improvements in fibre optic technology coupled with improvements in data handling
are continually making NIR a more feasible option for cleaning verification.
Additionally, improved signal to noise ratios have enabled the technique to be taken
seriously as one capable of detecting at low levels. An example of a commercially
available NIR system is the Iso-Pharm™ manufactured by LT industries. As well as
offering the usual features associated with a NIR material analysing system machine
the Iso-Pharm™ has a patented system that facilitates the safe transfer of data from
one plant to another. This is particularly important because it allows raw material
calibration libraries to be transferred. Another example of a commercially available
product is the SpotView manufactured by Bruker Optics. The product is capable of in
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situ analysis with the speed and sensitivity required for cleaning verification and
consists of the Bruker Optics IRCube coupled with a patented grazing angle probe.
NIR is an emerging technology and there are advances still to be made. One of the
current problems is that of sampling. Most machines work well on flat stainless steel
surfaces but do not produce data of the same quality when working on curved surfaces,
glass and vinyl. At present there would not appear to be a NIR technology capable of
taking on the cleaning verification workload.
Two press releases by the Strategic Environmental Research and Development
Program entitled “Cleaning Verification Techniques Based on Infrared Optical
Methods” and “Visual Cleaning Performance Indicators for Cleaning Verification”
provided examples of the direction in which thought regarding cleaning verification is
heading. The project on visual cleaning performance indicators involved the use of
commercially available and environmentally safe dyes and a coupling agent so that
the binding of dye to surface contaminants could be visually detected (Strategic
Environmental Research and Development Program: Pollution Prevention PP-1138).
The other project, based on infrared optical methods involves measuring grazing
incidence infrared reflectance on the surface and sought to build two devices, one
based on a widely tunable infrared laser with high speed surface imaging capability
that is limited to the detection of organic compounds and the second capable of high
sensitivity detection of organic and inorganic compounds but at slower speeds and
therefore incapable of real time analysis (Strategic Environmental Research and
Development Program: Pollution Prevention PP-1117).
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Figure 2.9. Companies such as Shimadzu market their Total Organic Carbon analysis
systems for cleaning verification. This diagram illustrates that Total Organic Carbon
analysis is a quick and cost effective method but also highlights that it is non specific.
Source: www.ssi.shimadzu.com
Shimadzu point out that Total Organic Carbon analysis is suitable for cleaning
verification because of its high levels of sensitivity provided the sample contains
carbon and is soluble at the levels needed for the assay. The FDA perspective on
Total Organic Carbon analysis for cleaning verification has changed since the 1993
Inspection Guide on Cleaning Verification. In the 2005 questions and answers on
good manufacturing practice, level 2 guidance, the FDA stated that since the
publication of the ‘Inspection Guide on Cleaning Validation’ in 1993, a number of
studies have been published to demonstrate the adequacy of TOC in measuring
contaminant residues.
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To summarise, it can be seen that there is a wide range of commercially available
cleaning verification products. Many of the technologies are still at a developmental
stage and cannot offer the same quality of information currently offered by HPLC.
Techniques such as NIR still have to overcome some sampling difficulties
encountered when trying to take measurements on a variety of different surfaces.
Problems will always arise when trying to implement a new technology within a
company but the supplier and purchasing company can often tailor the technology to
meet the technical demands of the purchasing company.
With the FDA perspective on cleaning verification still clear it is potentially
dangerous for manufacturing firms to deviate away from existing validated cleaning
protocols and technologies. Not one of the technologies outlined in this section has
seen significant take up and this underlines the point about how reliable and trusted
the HPLC method has become. Companies manufacturing alternative cleaning
verification technologies need to be able to demonstrate sensitivity and specificity and
whilst techniques such as Total Organic Carbon analysis have the required sensitivity,
they lack the specificity.
From the technologies outlined, the ePAT 731 looks promising because it does not
take over from HPLC but eliminates the need for speculative sampling. A firm can
know that their equipment is sufficiently clean and then carry out direct sampling and
HPLC analysis. Also, the Ionscan system manufactured by Smiths detection
represents a move towards ion mobility spectrometry being more widespreadly
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adopted by the pharmaceutical industry. The emergence of technology such as ion
mobility spectroscopy has been until now driven by the security industry.
Surface enhanced Raman spectroscopy (SERS) is an optical spectroscopic technique
which will be introduced in the section on optical spectroscopies. A major point from
this section in terms of the project aims is that companies are not currently seriously
marketing optical and in particular SERS based technologies for cleaning verification.
Explosive/narcotic detection systems based on SERS exist but no company is
currently marketing a SERS based system for cleaning verification work. SERS has
the potential for cleaning verification analysis because of its high levels of sensitivity,
lack of sample preparation and quick detection time and therefore it will be a good
technique to investigate with respect to cleaning verification..
2.2 Spectroscopic techniques
Optical spectroscopic techniques are technologies that could be put to use within the
field of cleaning verification. The following section of the thesis discusses infrared,
Raman and fluorescence spectroscopy and cites instances where application into the
field of cleaning verification has been attempted. Figuire 2.10 presents a summary of
infrared, near infrared and Raman spectra on one axis for the purposes of comparison.
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Figure 2.10. A representative diagram showing infrared transmission, near infrared
transmission and Raman scattering on the same energy scale (x-axis) for polystyrene.
The intensity on the y-axis is changed for infrared and near infrared because near
infrared normally has a weaker absorption (McCreery, 1999).
2.2.1 Infrared Spectroscopy
The infrared region of the electromagnetic spectrum is normally divided into three
sections. In the direction of longer wavelengths there are: the near, the mid and the
far infrared regions. The standard mid infrared region used in infrared spectroscopy
extends from the wavelength 2.5 µm to 25 µm. This region is often expressed in
wavenumbers and extends from 4000 cm-1 to 400 cm-1 (Hollas, 2002). Wavenumber
is a convenient tool of expression because the number is directly proportional to the
amount of energy. Therefore a higher wavenumber equals a higher amount of energy.
Intensity/absorbance
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Nearly all compounds with covalent bonds absorb radiation within the infrared region
of the electromagnetic spectrum. As is seen with other types of absorption, infrared
absorption causes the molecule to be excited into a higher energy state. Again, as is
seen with the absorption of other types of radiation the process is quantised. The
absorption of infrared radiation corresponds to energy changes of the order 8 to 40
kJ/mole (Stuart, 2004). Radiation of this energy bracket matches that of the
vibrational frequencies of most covalent molecules. During the absorption process,
the frequencies of infrared that match the natural vibrations of the molecule of interest
will be absorbed. This absorption process is characterised by an increase in the
amplitude of the vibrational motion of the bonds in the molecule.
An important point to make note of is the fact that not all bonds in a molecule are
capable of absorbing infrared radiation, even if the frequency of the radiation matches
that of the bond motion. Only bonds with a dipole moment that changes as a function
of time are capable of absorbing infrared radiation (Gunzler & Gremlich, 2002). A
bond must present an electrical dipole that is changing at the same frequency as the
incoming radiation in order for energy to be transferred. The changing electrical
dipole of the bond can couple with the sinusoidally changing electromagnetic field of
the incoming radiation (Gunzler & Gremlich, 2002). Thus, a symmetric bond that has
identical or nearly identical functional groups will not absorb in the infrared region.
The fact that every type of bond has a different natural frequency of radiation,
coupled with the fact that two identical bonds in different compounds are in different
environments results in the fact that no two molecules have the same infrared
absorption patterns (Williams & Flemming, 1995). Therefore, to use a basic analogy,
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the infrared spectrum provides us with a fingerprint of the molecule. The infrared
absorption spectrum gives scientists extremely important information about a
particular molecule’s functional groups and an example spectrum is presented in
figure 2.11.
Figure 2.11. An example of an infrared spectrum for nitrobenzene. Source:
www.chem.csustan.edu
2.2.2 Modes of stretching and bending induced by absorption of infrared
radiation.
The most elementary modes of motion that are infrared active and can therefore be
induced by infrared radiation are stretching and bending. In addition, there are more
complex types of stretching and bending. Asymmetric stretching vibrations generally
occur at higher frequencies than symmetric stretching vibrations and in general
stretching vibrations occur at higher frequencies than bending vibrations (Hollas,
2002). The terms scissoring, rocking, wagging and twisting are commonly used in the
literature to describe the origin of infrared bands. These vibrations are referred to as
“fundamental absorptions” and are caused by the excitation from the ground state to
A
bsorbance
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the lowest energy excited state. The different molecular vibrations are depicted in
figure 2.12.
In any group of three or more atoms, where at least two are identical there are two
modes of stretching, symmetric and asymmetric. Examples of such groupings are: -
CH3, -CH2, -NO2, –NH2 and anhydrides. The methyl group gives rise to a symmetric
stretching vibration at about 2872cm-1 and an asymmetric stretch at about 2962cm-1
(Gunzler & Gremlich, 2002) The anhydride functional group gives two absorption
bands in the C≡O region because of the symmetric and asymmetric modes of stretch.
A similar phenomenon occurs in the amine group where a primary amino (NH2)
usually has two absorptions in the N-H stretch region, whilst a secondary amine
(RNH2) has only one absorption peak. Amides exhibit similar bonds. There are two
strong N=O stretch peaks for a nitro group, with the symmetric stretch appearing at
about 1350cm-1 and the asymmetric stretch appearing at about 1550cm-1 (Gunzler &
Gremlich, 2002).
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Types of Molecular
Vibrations
• Stretching
• Bending
– scissoring
– bending
– twisting
– wagging
Figure 2.12. Showing different modes of stretching and bending in molecules
exposed to infrared radiation. Source: www.tntech.edu/mcwells/ppt
Often the spectrum is complicated because of the presence of weak overtones,
combination bands and difference bands. Overtones are caused by excitations from
the ground state to higher energy states that correspond to integral multiples of the
frequency of the fundamental (v). A suitable example is that of weak overtone bands
being observed at 2v, 3v etc. Any type of physical vibration will result in the
generation of overtones. Two vibrational frequencies can couple together and cause a
frequency within a molecule. This is called a combination band and such bands are
the sum of the two interacting bands. Not all possible combinations can occur.
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Difference bands are similar to combination bands and the observed frequency results
from the difference between the two interacting bands.
Overtone, combination and difference bands can be calculated directly by
manipulating frequencies in wavenumbers via multiplication, addition and subtraction.
When a fundamental vibration couples with an overtone or combination band, the
coupled vibration is called Fermi resonance (Stuart, 2004). Rotational frequencies for
the whole molecule are not infrared active, they will often couple with the stretching
and bending vibrations in the molecule giving fine structure to the absorptions and
thus complicating the spectrum (Stuart, 2004). This process of rotational coupling is
one of the reasons why the bands in an infrared spectrum are broad and not sharp and
can lead to a large amount of fine structure being unresolved.
2.2.3 The infrared spectrometer
There are two types of infrared spectrometer in common use, the dispersive infrared
spectrometer and the Fourier transform-infrared spectrometer. Both machines yield
spectra in the 4000-400 cm-1 range.
A general explanation of the dispersive infrared spectrometer starts with the fact that
the instrument produces two equally intense beams of infrared radiation. The sample
of interest is placed in the path of one beam and a reference in the path of the other
beam. The beams then pass through the monochromator, dispersing each one into a
continuous spectrum of infrared frequencies. The monchromator alternately passes
the beams to a diffraction grating. The diffraction grating rotates slowly and varies
the frequency or wavelength reaching the thermocouple detector. The detector itself
42
is able to determine which frequencies have been absorbed by comparing the beam
that has been passed through the sample with the reference beam. The signal from the
detector is then amplified, allowing the apparatus to produce the spectrum.
Most modern infrared spectrometers in use throughout laboratories operate on a
different principle. The optical pathway produces a pattern called an interferogram.
This is a complex signal but it contains all the infrared frequencies in a wave like
pattern. An interferogram is essentially a plot of intensity against time. This is called
a time dispersive spectrum, dispersive spectrometers are said to record the frequency
domain (Williams & Flemming 1995). A mathematical operation called a Fourier
transformation separates the individual absorption frequencies from the interferogram
producing spectra virtually identical to that of the dispersive spectrometer. The
advantages associated with Fourier transform-infrared spectroscopy are that it takes
not much longer than a second to produce an interferogram. Therefore many
interferograms can be collected and used to obtain a spectrum by applying the Fourier
transformation.
Fourier transform spectrometers can be computer interfaced and operate in a single
beam mode. The operator obtains interferograms for the background and then
interferograms for the sample of interest. The background interferogram is then
subtracted from the sample interferogram and the Fourier transformation carried out
to yield spectra virtually identical to those produced by the dispersive machine. The
most significant advances in infrared spectroscopy have come about as a result of the
introduction of Fourier transform-infrared spectroscopy. The procedure has
dramatically improved the quality of infrared spectra and minimised the time required
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to obtain data. Additional improvements in computing power and software. have also
allowed the field to make great improvements.
One of the greatest challenges for the infrared spectroscopist can be sample
preparation. A number of sampling techniques have become available since the
introduction of Fourier transform-infrared spectroscopy with its increased sensitivity
and improved signal to noise ratio. The classic infrared sampling technique is the
alkali halide pellet preparation. This technique involves mixing the solid state sample
of interest with an alkali halide (typically KBr or KCl) at 1-2% (w/w) sample/alkali
halide ratio, pulverising into a finely ground homogenous mixture, placing the
mixture into a die (typically stainless steel) and subjecting it to approximately 10,000
psi of pressure for a period of time to produce a glass pellet (Bugay, 2000). The
resulting pellet has the sample finely dispersed throughout the glass and can be placed
into the spectrometer for analysis. This method of sampling is best in cases when
simple compound identification is the goal. The pressure required to form the pellet
and possible halide exchange can lead to transformation of the sample (Bugay, 2000).
The mineral oil mull technique is an alternative means of preparing samples. The
sample is mixed in an agate mortar with a small amount of mineral oil. The sample is
placed into an infrared window and then placed into a spectrometer. Unfortunately
the mineral oil has a number of intense spectral peaks associated with it and these
bands may overlap important peaks from the sample (Bugay, 2000). The diffuse
reflectance method (DR) is probably one of the most important sampling techniques
from the point of view of pharmaceutical problem solving. The technique is non
intrusive.
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When Fourier transform-infrared spectroscopy is applied to solid surfaces, three
different techniques of reflectance spectroscopy can be used, specular reflectance,
diffuse reflectance and reflection-absorption spectroscopy. Specular reflectance is
used on flat, clean surfaces and spectra are readily obtained from comparatively small
samples at incidence angles of about fifteen to seventy-five degrees. Diffuse
reflectance spectra are commonly obtained from rough surfaces, or from the surfaces
of powdered samples, often using specially designed accessories or spectrometers.
The third type of reflectance spectrum, commonly called a reflection-absorption
spectrum is fairly easily obtained from surfaces coated with thick fibres in the range
of 0.2 to 2.0 μm. Simple reflectance spectra obtained from such surfaces are in effect
transmission spectra obtained while the spectrometer radiation passes through the
fibre before and after being reflected from the surface. However, in the cases of
extremely thin layers such as monomolecular layers, the path length through the film
may be too short to produce a useable spectrum. In practice, layers less than 10 μm in
thickness cannot be successfully detected or characterised using conventional specular
or diffuse reflectance geometries. The problem has been acknowledged and the
method commonly known as grazing angle Fourier transform-infrared spectroscopy
has been developed (Melling et al., 2001).
Infrared microspectroscopy can be seen as the natural method of investigation for
solid state samples. Ultimately, only one sample particle is needed but limitations
with diffraction dictate that the particle needs to be bigger than 10 x 10 μm. The
sample is placed in an infrared optical window and the slide is then placed into the
microscope and visually inspected. When a sample of interest is located, the viewing
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field is reduced and depending on morphology, thickness and transmittance properties,
a reflectance and/or transmission infrared spectrum may be obtained by the infrared
microscope accessory (Aldrich & Smith, 1999).
2.2.4 Infrared spectroscopy and cleaning verification
Fourier transform-infrared spectroscopy is now a well known and approved method
for quantitative and qualitative analysis within the pharmaceutical industry (Severdia,
1995). As previously stated, swab analysis is the prominent method employed for
sample recovery but is has several limitations that include incorrect estimations
depending on the physical characteristics of the surface being investigated and
excessive consumption of time. Traditionally, conventional Fourier-transform
infrared spectroscopy has been used as a method to investigate the nature of samples
recovered from swabs.
Bley and Behnring (2001) successfully implemented a system to carry out
quantitative and qualitative evaluation of residual contamination on machine surfaces
(see figure 2.13). The measurement system was based around Fourier transform-
infrared spectroscopy with a specially designed flexible mid infrared fibre optic probe.
They found that the residues recovered from the surfaces mainly resulted from: drugs,
cooling lubricants hydraulic and guide way oils as well as machining chips and
pigments. The installed fibre optic probe system connected to a conventional Fourier
transform-infrared spectrometer proved capable of carrying out qualitative and
quantitative residue recognition tests on contaminated work pieces. The qualitative
tests (mainly used to determine the kind and composition of the residues) can be done
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easily whereas the quantitative tests require a more prolonged planning stage to
ensure accuracy.
Figure 2.13. Flexible Fourier transform monitoring system devised by Bley and
Behrning (2001).
Reflectance spectroscopy is a well known technique for obtaining Fourier transform-
infrared spectra from powdered samples and surfaces (Sommer & Hardgrove, 2000).
Mid infrared grazing-angle spectroscopy is the most sensitive optical absorption
technique available for measuring low chemical concentrations on reflective materials
(Mehta et al., 2002). The disadvantage of conventional spectroscopic methods for
applications such as cleaning verification is that samples must be physically placed
within the sample compartment of the spectrometer for measurement. This limitation
is not desirable for sampling reactor surfaces and around valves during the cleaning
verification process. It is becoming increasingly possible to use Fourier transform-
infrared spectroscopy to sample outside the compartment of the spectrometer. This
has been facilitated by the emergence of fibre optic cables that transmit in the mid
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infrared range. The result is that it is becoming increasingly feasible to carry out in
situ spectroscopic testing (Mehta et al., 2002).
Mehta et al., (2002) designed a grazing angle head with a long fibre optic lead which
allows a large surface area to be analysed at a great distance. These factors
significantly improve the sensitivity and signal to noise ratio when compared to other
methods using a mid infrared beam to sample the surface. The machine was used is a
second experiment that compared it to swab testing combined with HPLC analysis.
The mid infrared machine compared favourably showing that the low levels of residue
could be detected accurately. The authors believed that by coupling it with
chemometric methods, they would have a suitably sensitive method of measuring
contamination on surfaces.
An ideal method for cleaning verification would be a rapid, automated, in situ, multi
component analysis of the entire surface. A system of this nature would have
eliminated the inadequacies associated with surface sampling. Advances in mid
infrared fibre optics are beginning to yield instruments for in situ testing.
2.2.5 The near infrared region
The near infrared energy band is defined as 780 to 2500 nm, the mid infrared 2500 to
4000 nm and the far infrared region from 40000 to 1000000 nm. Even though official
standards, textbooks and the scientific literature generally state that the near infrared
spectral region extends from 780-2500 nm, a simple set of hydrocarbon spectra
demonstrate that the vibrational information characterised by the harmonic vibrations
of the C-H stretch fundamental and their corresponding combination bands occur
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approximately from 690 to 2000 nm (Workman et al., 2003). The predominant near
infrared spectral features include the methyl C-H stretching vibrations, methylene C-
H stretching vibrations, aromatic C-H stretching vibrations and O-H stretching
vibrations. Minor but still important features include: methoxy C-H stretching,
carbonyl associated C-H stretching, N-H from primary amides, secondary amides, N-
H from primary, secondary and tertiary amino acids and N-H from amino salts
(Workman et al., 2003).
Pharmaceutical applications of near infrared include: identification of raw materials
and product quality, moisture and solvent content in drying or solvent removal
processes, residual drug carryover in manufacturing facilities, mixing quality
evaluation and imaging of tablets and packaging systems (Wargo & Drennen, 1995).
There are a number of advantages associated with probing in the near infrared region
and these include: C-H associated vibrational information is repeated eight times from
690 to 3000 nm. Sample harmonics may be selected or more information from rich
combination regions may be seen. Low cost instruments with high signal to noise
ratios are simply made and typically exhibit signal to noise ratios of 25,000-100,000
to 1. High near infrared throughput is possible even when employing low cost fibre
optics. Variable pathlengths for individual use are possible, typically from 1 mm to
10 cm or more using different near infrared spectral regions (Ciurczak, 1998).
The ability to discriminate between components, the rapidity and the in situ
capabilities make near infrared appealing. However, there are problems with sample
size that need to be addressed. Implementation of near infrared into cleaning
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verification is still a work in progress. Instruments that have already been developed
require lots of validation work. As with conventional infrared, an ideal machine
would be rapid, sensitive and able to sample a variety of surfaces (Yoon et al., 2004).
When routinely analysing a pharmaceutical product with near infrared, two basic
procedures are involved. The first is the determination of one of several components
(quantitative analysis), using a suitable calibration step based on algorithms, these are
step wise linear regression or partial least squares. In order to carry out calibration, it
is necessary to use production samples, but this has the disadvantage of having a very
narrow concentration range. It has now been suggested that laboratory samples be
used to widen the concentration ranges of different types of molecules (Ciurczak,
1998). Quantitative methods are possible when changes in the response of the near
infrared spectrometer are proportional to changes in the concentration of chemical
components or changes in the physical characteristics of the sample undergoing
analysis (scattering/absorptive properties).
The second procedure (qualitative analysis) consists exclusively of determining
whether the product is within specification limits. This can be done by using pattern
recognition techniques. Qualification involves comparing the spectrum of the sample
with the spectra of products contained within the library that correspond to samples
fitting within the specifications. The spectra of the samples contained within the
library are represented by a certain tolerance in the wavelength domain that is due to a
natural variability in the manufacturing process. The qualification process checks if
the spectrum of the sample fits within the tolerance limits. The qualification is
produced by computing the distance at each wavelength between the sample and the
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average spectrum of the library. If the maximum distance computed does not pass a
certain threshold the sample is qualified (Workman et al., 2003).
The near infrared spectrum depends on the chemical and physical characteristics of
the product all of which affect the qualification, whereas in the quantitative analysis
only the parameters for which the calibration has been carried out can be checked.
The near infrared spectrum may change slightly due to small variations in the
manufacturing process or in the characteristics of any of the raw materials (Gonzalez
& Prous, 1995). Recent refinements of the near infrared technique include the
emergence of chemometrics and the diminishing distinction between near infrared and
infrared as measuring techniques (Ciurczak, 1998). Some would still maintain the
difference and see the two methods as complimentary, with each spectral region
providing unique advantages for the analyst. Tremendous advances have been made
in recent years in the use of near infrared spectroscopy for the analysis of
pharmaceuticals. Just fifteen years ago near infrared was used in a way that offered
relatively few advantages over other existing analytical methods. Advances in
instrumentation, software and data handling mean that rapid sample characterisation
is now possible. The pharmaceutical industry is beginning to develop near infrared
methods to monitor many phases of the manufacturing process (Ciurczak, 1998).
Over the past several years there has been a great deal of interest placed on the
development of attenuated total internal reflectance (ATR) infrared accessories
possessing a variety of sampling configurations (Sommer & Hardgrove, 2000). These
devices allow near infrared spectroscopy to be practiced in process control
environments and quality control laboratories where the method is not only robust,
51
but has the benefits of little sample preparation and the ability to analyse highly
absorbing species and/or aqueous species. The development of attenuated total
reflectance devices has increased the use of infrared spectroscopy but interest is
mainly focused on the study of trace quantities and materials in aqueous solution.
Sommer & Hardgrove, (2004) described a method for the study of solutes in aqueous
solution using a micro-attenuated total ATR accessory. The device they implemented
employed a single bounce internal reflection element (IRE) which focuses the
radiation to a 10-pl volume element (see figure 2.14). By microscopic condensation
they were able to record parts per million levels of poly ethylene glycol (PEG) and
polyacrylic acid (PAA).
Figure 2.14. An optical diagram of the internal reflection element (IRE) which
focuses infrared radiation to a 10-pl element (Sommer & Hardgrove 2000).
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2.2.6 Raman Spectroscopy
The phenomenon of inelastic light scattering is known as Raman radiation and was
first documented in 1928 by Raman and Krishnan. When a substance is irradiated
with monochromatic light, most of the scattered energy comprises radiation of the
incident frequency (Rayleigh scattering). In addition a very small quantity (0.0001 %)
of photons with shifted frequency are observed (figure 2.15). The fraction of photons
scattered from molecular centres with less energy than they had before the interaction
are said to be Stokes scattered. The anti Stokes scattered photons have greater energy
than the exciting radiation (Vankiersblick et al., 2002).
Figure 2.15. Spectroscopic transitions underlying several types of vibrational
spectroscopy. vo indicates laser frequency, v is the vibrational quantum number. The
virtual state is a short-lived distortion of the electron distribution by the electric field
of the incident light. McCreery, 2000.
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When light and matter interact with one and other the following things may occur: the
photons of light may be absorbed, scattered, not interact with the sample and simply
pass through the material. If the energy of an incident photon corresponds to the
energy gap between the ground state and the excited state of the molecule then an
excited photon may be absorbed and the molecule promoted to a higher energy state.
It is this change that gets measured in absorption spectroscopy by detecting the loss of
radiation from the light. However, it is also possible for the photon to interact with
the molecule and scatter from it. In this case there is no need for the photon to have
an energy that matches that of the difference between the ground and excited states of
the molecule. The scattered photons can be observed by collecting light at an angle to
the incident light beam and provided there is no absorption from any electronic
transitions which have similar energies to that of the incident light, the efficiency
increases as the fourth power of the frequency of the incident light. Scattering is a
commonly used technique, for example it is employed when measuring particle size
and size distributions down to 1 μm. The main scattering technique employed at the
molecular level is Raman scattering. The way in which radiation is employed in
Raman and infrared spectroscopy is different. In infrared spectroscopy, the sample is
irradiated and absorption occurs when the frequency of the incident radiation matches
that of a vibration so that the molecule is promoted to a vibrationally excited state.
The loss of radiation from the beam is detected. In Raman spectroscopy a single
frequency of light is employed to irradiate the sample. The electron cloud of the
molecule can be perturbed by molecular vibrations and it is possible for the optical
oscillation from the incident light and the vibrational oscillations of the molecule to
interact which leads to Raman scattering. In Raman scattering, light interacts with the
molecule and distorts (polarises) the cloud of electrons around the nuclei to form a
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short lived state called a “virtual state”. The state is unstable and the photon is rapidly
re-radiated. A Raman spectrum consists of scattered intensity on the y-axis against
energy in the form of wavenumbers on the x-axis (see figure 2.16). The peaks
correspond to a given Raman shift from the energy of the incident light. The
molecule can be in an excited vibrational state and if it is in such a state when an
incident photon is scattered, the photon will have more energy. This is known as anti-
Stokes scattering. Stokes and anti-Stokes peaks appear symmetrically about the y-
axis as shown in figure 2.17 but their intensities vary with the Stokes shifted photons
producing peaks with a greater intensity (McCreery, 1999).
Figure 2.16. Showing the Raman spectrum of chloroform at room temperature using
a 514.5 nm laser. The peak observable at 0 is the Rayleigh scattering which is several
orders of magnitude more intense but is reduced in a Raman spectrum by the use of a
band reject filter. The different ways in which the x-axis can be plotted are shown but
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convention is to plot the x-axis as Raman shift in reciprocal centimetres from the laser
line which is designated as 0. Additionally, convention assigns Stokes scattering to
the right and anti-Stokes scattering to right in spite of anti-stokes scattered photons
having more energy. McCreery, 2000.
When electron cloud distortion is the only factor involved in scattering, the photons
will be scattered with very small frequency changes because the electrons are
comparatively light. This scattering process is called elastic light scattering and is the
dominant process. If nuclear motion is induced during the scattering process, energy
will be transferred from the incident photon to the molecule or from the molecule to
the scattered photon. In these cases the process is inelastic and the energy of the
scattered photon is different from that of the incident photon by one vibrational unit.
This Raman scattering is an inherently weak process where every one in 106-108
photons that scatter will Raman scatter. This does not cause the process to be
insensitive because modern lasers and microscopes possess very high power densities.
A disadvantage is that high laser intensities can leave the sample vulnerable to
degradation.
Both infrared and Raman spectroscopy are concerned with measuring associated
molecular vibrations and rotational energy changes. However, the requirement for
vibrational activity in Raman spectra is not a change in dipole as in infrared spectra
but is a change in the polarisability of the molecule (it is therefore possible to obtain
Raman spectra from homonuclear molecules). The energy resulting from the shift is
equal to the vibrational energy gap that is excited in infrared spectroscopy
(Vankiersbick et al., 2002).
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Two major technologies are used to obtain Raman spectra: dispersive Raman and
Fourier-transform Raman. Each technique has unique advantages and the method that
best suits the sample should be preferred. Related techniques are important in the
pharmaceutical area, one being confocal Raman spectroscopy which is a useful
technique for non destructively probing depths of a sample without cross sectioning.
Confocal Raman spectroscopy can selectively probe any given X,Y,Z location in a
sample with spatial resolution in the micron range. It is best done by dispersive
Raman spectroscopy with short wavelengths.
A potential problem with Raman spectroscopy is fluorescence. Even weak
fluorescence is a stronger effect that Raman scattering and therefore fluorescence has
the potential to overwhelm the Raman signal. Fluorescence can originate from the
analyte of interest or from impurities in the sample and is typically a problem
associated with visible lasers. The effect of fluorescence can be reduced by using a
laser of longer wavelength such as a 1064 nm laser but these lasers have less power
and so the Raman signal reduces. There is always a trade off involved in laser
selection but the use of a longer wavelength laser has helped to get around some of
the problems associated with background fluorescence in biological samples.
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Figure 2.17. Raman spectra of Rhodamine 6G acquired with the use of a 514.5 nm
laser and 1064 nm laser. Intensity scales differ with the upper spectrum having a very
high intensity but showing the broad unresolved spectrum typical of fluorescing
samples. McCreery, 2000.
2.2.7 Surface Enhanced Raman Spectroscopy
In surface enhanced Raman spectroscopy (SERS) the Raman scattering from a
compound or ion absorbed on a structural metal surface can be 103-106 times greater
than that in solution. Surface enhanced Raman scattering is greatest on silver but is
observable on gold and copper as well. SERS arises from two mechanisms, the first
is an enhanced electromagnetic field produced at the surface of the metal. The second
is the enhanced formation of a charge transfer complex between the surface and the
analyte molecule (chemical enhancement). Molecules with lone pairs of electrons or
π clouds show the strongest surface enhanced Raman scattering. Even single
molecule detection has been reported by SERS. The technique has the big advantage
Intensity
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of permitting in situ studies and allows work to be carried out in situations previously
not thought possible (Campion & Kambhampandi, 1998).
As a field of research, SERS is approximately twenty five years old. Much discussion
has taken place during those years about the basis of the enhancement and a
consensus is emerging that the electromagnetic mechanism is responsible for the bulk
of the enhancement with the chemical enhancement playing only a small part. The
basic idea behind the electromagnetic theory is that a small metallic sphere with
dimensions smaller than the wavelength of illuminating light will sustain oscillating
surface plasmon multipoles induced by the time varying electric field vector of the
light. Under these conditions the intensity of light at certain portions near the metal
particle is enhanced (Moskovits, 2005).
For SERS to occur, the particles or metal features responsible for its operation must
be small with respect to the wavelength of the incoming light (Moskovits, 2005).
Most SERS active substrates in size terms fall between 5 and 100 nm. The majority
of SERS active systems are made up of multiple particles. Nanoparticle aggregates,
roughened metal surfaces and island films are examples of SERS active substrates
(Moskovits, 2005). When nanoparticles are aggregated the nature of the enhancement
is through the space electromagnetic coupling of particles. Xu and Kall, 2003
demonstrated an increase in signal from a SERS system when two particles are
brought in close proximity to one and other. For molecules in the gap between two
particles in close proximity to each other the enhancement factor can be as great as
1011 for silver nanoparticles aggregated with haemoglobin.
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There is no doubt about the sensitivity offered by SERS and its potential use in
sensors across a whole variety of fields. One disadvantage is inconsistency and this
lies in the production of good substrates. The nature of the electromagnetic effect
dictates that for an enhancement of signal to be achieved, the SERS hotspots must be
in close proximity to each other and for that enhancement to be consistent from
substrates to substrate the SERS architecture must be reproducibly produced.
2.2.8 Substrates
A method for the preparation of gold colloid was outlined by G Frens in 1972. The
method involves the reaction of HAuCl4 with trisodium citrate to produce gold colloid
and is commonly known as the citrate reduction method. This basic method still
persists but refinements and alternative techniques have been published in the wake of
the initial paper. In the general sense, colloids for SERS are prepared by the
reduction of metal cations from their salts. For silver these would commonly be
AgNO3 and Ag2SO4 and in the case of gold HAuCl4 and KAuCl4 with sodium citrate
or sodium borohydride (Aroca et al., 2005). Other factors in colloid preparation such
as aggregation have been studied with reference to SERS in order to develop an
understanding of how to create effective and consistent SERS structures.
Dou et al., 1999 investigated the effect of aggregation for studying glycine solutions
in conjunction with gold and silver colloids. It was found that the emergence of the
SERS effect occurred in concert with the coagulation of gold particles. Kneipp et al.,
1998 showed large enhancement of signal was possible for molecules on gold
colloidal clusters. An overall enhancement of 1014 was observed for molecules
attached to colloidal gold clusters. Aggregation into 250 nm clusters gave optimal
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enhancement of signal and sodium chloride was added to enhance aggregation. In
SERS experiments perchlorates, nitrates and chlorides are most commonly employed
as aggregating agents (Aroca et al., 2005). Munro et al., 1995 characterised the
surface of citrate reduced silver colloid for use as a SERS substrate. It was found that
colloid with a wavelength maximum absorption between 402 and 404 nm gave the
best enhancement of the Raman signal.
There is a very large variety of SERS substrates other than colloids including
roughened electrodes and metal island films. However, wet chemistry provides an
inexpensive and versatile approach to metal nanoparticle fabrication. Colloidal
nanoparticles are commonly used for SERS studies in a suspension or a sol, or the
analyte-colloid system is cast onto a sustaining surface such as glass and left to dry,
forming particles of a variety of shapes (Aroca et al., 2005).
The hallmark of SERS is selectivity, potential for remote sampling through fibre
optics and capability for detection of analytes in aqueous solutions. Despite these
advantages the widespread use of SERS based analytical technologies has been slow.
Before SERS based sensors can find broad applications in routine chemical analysis
new SERS materials must be developed that yield consistently high signals and
provide detection generality towards a wide range of chemical and environmental
analytes. The major requirements for the SERS substrate materials include controlled
nanoscale structure, periodicity and chemical selectivity (Kuncicky et al., 2006)
Other methods of producing SERS substrates are reported in the literature. Sun et al.,
2005 outlined a method were a highly concentrated well stable gold colloid was
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prepared from a direct mix of a amino bearing polyelectrolyte and HAuCl4 in aqueous
solutions. Branched polyethylenimine (BPEI) is mixed with HAuCl4 at room
temperature and over time the solution reaches a purple colour. The size of colloidal
particles was found to be variable as the molar ratio of BPEI- HAuCl4 was altered.
Pal et al., 2003 outlined a method for the photochemical preparation of gold
nanoparticles. The method involves the photoirradiation of HAuCl4 in poly
(oxyethylene) isooctylphenyl ether (Triton X-100). After irradiation the Triton X-100
acts as a stabilising agents, yielding a method that produces a colloid that is stable for
several months.
Freeman et al., 1996 prepared silver colloid clad gold nanoparticles for SERS.
Substantial SERS increases were found for pyridine, BPE and p-NMDA. When silver
was deposited on the surface of the gold nanoparticle in small amounts the
enhancement was greatest but if the layer of silver is made thicker the enhancement
diminishes. Cao & Li, 1999 demonstrated a new approach for producing surface
roughness on silver substrates for SERS. After adding the molecule of interest and
allowing it to adsorb onto the silver surface the etchants potassium ferricyanide (III)
potassium thiocyanate are added. The SERS spectra for the molecule of interest is not
present to begin with but as the etching reaction proceeds the SERS spectra appears as
the surface gains increasing amounts of roughness.
Wang et al., 2002 used silver hydrosols to generate SERS spectra for water insoluble
drugs such as salicylic acid and acetaminophen. Hossain et al., 2006 were able to
fabricate a 2D nanostructure of gold nanoparticles on glass. Using crystal violet they
were able to achieve a 108 enhancement of signal.
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Kuncicky et al., 2006 used a convective assembly method to deposit films from
chemically unmodified metallic nanoparticles on plain non functionalized glass
substrates. The substrates produced showed excellent SERS properties and the
enhancement varied as nanoporosity and substrate structure was varied so the
optimum configuration of hot spots could be created for optimised SERS.
2.2.9 Applications
Surface enhanced Raman spectroscopy provides a technique for measuring extremely
low concentrations of chemical species. The technique has been applied across many
fields and has potential uses in the area of cleaning verification. A suitable example is
that of work done by Quagliano, 2004 where it was demonstrated as possible to study
surface contaminants on semiconductors with SERS. By spraying the surface with a
silver island film to create a discontinuous film, an enhanced Raman effect was
observed. This technique is applicable across a whole range of fields where it is
desirable to probe a surface.
Work has been carried out with surface enhanced Raman spectroscopy to investigate
low levels of chemical species. Sanchez-Cortes et al., 1998 carried out a study with
dithiocarbamate fungicides adsorbed onto aqueous silver colloids. They were able to
use surface enhanced Raman spectroscopy to obtain good quality spectra from very
low aqueous concentrations and found it possible to detect the fungicide thiram at a
concentration of 10-7 M with after excitation with a 1054 nm laser. Bazzaoui et al.,
2001 used surface enhanced Raman spectroscopy to obtain spectra for
polyalkylthiopenes on gold electrodes and in silver colloids. They found that the
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spectra of polalkylthiophenes taken on silver colloids were very similar to those taken
on a gold electrode but with a large signal amplification. Bazzaoui et al., 2001
pointed out that these findings were of significance to the study of trace quantities in
any field.
Brolo et al., 1997 were able to use surface enhanced Raman spectroscopy to obtain
spectra for pyridine and pyrazine on a gold electrode. The two species were adsorbed
onto the electrode by their nitrogen lone pairs. The authors compared the SERS data
to electrochemically determined concentrations for both pyridine and pyrazine
adsorbed onto a gold electrode. They found no correlation between surface coverage
and intensity for concentrations that were greater than a monolayer but found that
when surface coverage was incomplete SERS intensity did follow surface coverage.
Fabriciova et al., 2004 used surface enhanced Raman spectroscopy to investigate the
adsorption and chemical behaviour of the anthroquinone drugs Quinizarin and
Danthron. From the differences in their spectral behaviour it was possible to draw
important conclusions about the biological significance of anthraquinone drugs
(Fabriciova et al., 2004). Wang et al., 2002 presented a study where surface
enhanced Raman spectroscopy was employed in conjunction with silver hydrosols to
obtain spectra for drugs such as aspirin, salicylic acid, acetaminophen and vitamin A
acid. The high sensitivity of surface enhanced Raman spectroscopy coupled with the
linear calibration curve made the trace quantification of the drugs feasible. Wang et
al., 2002 stated that the low levels of detection they achieved made the method
comparable or better than currently existing calorimetric or spectrophotometric
methods.
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Faulds et al., 2001 investigated SERS in solutions of amphetamine sulfate dried in
wells made on aluminium blocks. They looked at gold/silver colloids and gold/silver
thin films. It was possible to detect amphetamine sulphate down to concentrations of
10-5 mol dm-3. It was found that gold films gave the most reproducible results but it
was not possible to make the system quantitative because of the inability to focus the
laser on the entire sample. Lee & Farquharson, 1999 produced a silver doped sol-gel
for use in SERS. The gel was evaluated using p-aminobenzoic acid which is a
common contaminant in ground water supplies. Detection at the level of parts per
million was achieved for p-aminobenzoic acid but the authors stated that parts per
billion levels of detection would be possible with improved equipment and with
modifications to the sol-gel. Trachta et al., 2004, combined HPLC and SERS to the
analysis of drugs in human blood and urine by using a homemade gelatine based
silver halide dispersion to coat the wells of a microtiter plate. It is advantageous to
couple SERS to HPLC in when attempting to identify illicit drugs in human blood and
urine because of the matrix effect of those two bodily fluids. Mass spectrometry,
NMR and electrochemical detection have been applied with HPLC for identification
but SERS has potential because families of drugs have characteristic band patterns
and so with the emergence of differing forms of the same drug, identification is made
very easy due to the presence of characteristic bands. Trachta et al., 2005 found that
in most cases of the drugs they analysed, 10 µl of eluent taken at the time of peak
appearance was enough to obtain a SERS spectrum for the drug.
Chen et al., 2005 applied SERS to the study of anthraquinone dyes used in the study
of works of art. Two methods were developed, the first one involved coating dyes
already stained with the dyes of interest with silver nanoparticles and the second
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involved the use of Ag-Al2O3 that had been spin coated onto glass slides. The dye
alizarin was identified from madder root extract using the Ag-Al2O3 substrate. With a
silver coating of 50nm it was possible to detect the dye down to a limit of 7 x 10-15g.
This is an extremely good result but the method included careful removal of a small
amount of fibres for further processing so it could not be said to be a completely non-
destructive process.
SERS can be used to gain additional information about a molecule and the way in
which it is adsorbed onto the SERS substrate. Leopold et al., 2005 showed that SERS
spectra of thiamine molecules adsorbed onto colloidal gold particles at pH values of 3,
4 and 5 revealed the presence of protonated and unprotonated versions of the thiamine
molecule.
SERS has also been evaluated with respect to application in the field of detecting low
levels of excitatory amino acids. The ability to detect these excitatory amino acids at
low concentrations would be beneficial because they amino acids are often released
from damaged neurons in head trauma victims. O’Neal et al., 2003 looked at SERS
for the quantification of excitatory amino acids with aqueous silver colloids. In
aqueous solutions they were able to detect glutamate and aspartate at low levels with
them being able to quantify glutamate between 0.4 and 5 μmol/L. Glutamate was also
detectable from clear biological microdialysis solutions. The results compared
extremely well to HPLC and so SERS could be applied as a system for rapid detection
of potential neuron damage in head trauma victims.
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The work outlined above is a small sample of a field in which many applications are
being found for SERS. The limit of detection will reduce as SERS substrates and
their production are improved. Applications for SERS are constantly being found in
the fields of: environmental analysis, law enforcement, textiles, medicine, drug testing
and in the field of pharmaceuticals. One aim of this project is to investigate the
potential application of SERS in cleaning verification. The body of work that exists
on SERS shows that it can detect at the levels necessary for cleaning verification work
and it has the advantages of producing a characteristic spectra for each compound
investigated whilst being potentially non destructive.
2.2.10 New SERS technologies
The enhancement gained in SERS is a most impressive one and with it comes the
potential to sense molecules at extremely low levels. Single molecule detection has
been reported with SERS. Kneipp et al., 1997 showed SERS detection for single
molecule crystal violet in aqueous silver colloid and Maruyama et al., 2001 showed
single molecule detection for Rhodamine and adenine. These potential levels of
sensitivity make SERS an attractive technology on which to base sensor and detection
systems. SERS is sensitive and readily achievable under laboratory conditions with
favourable combinations of nanoparticle and substrate. A challenge is to make the
technique generic and so much work is being carried out on turning SERS into a
reproducible and versatile technique that can be put to use in every day situations.
A promising area of research is “Tip Enhanced Raman Spectroscopy” TERS. The
principle behind TERS is to coat a fibre optic cable or glass tip with silver or gold
particles or island films to create a probe capable of producing a SERS effect on the
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surface which it is probing. Stokes et al., 2004 showed the SERS effect was possible
from a silver island based SERS nanoprobe. A tapered nanoprobe as small as 100 nm
in diameter with 10 nm silver islands at the tip was fabricated and used to investigate
glass surfaces coated with brilliant cresyl blue and p-aminobenzoic acid. The tip was
integrated into a microscope set up and it was shown that the SERS effect was present
when the tip was brought into close contact with the substrate. Stokes et al., 2004
concluded that the observation of contact induced SERS analysis of dry surfaces was
important because it demonstrates the feasibility of probing dry samples on solid
surfaces.
Viets & Hill 2004, carried out a study of fibre optic SERS sensors and compared three
methods of preparing sensor tips. The types of probe compared in the study were
silver island films, silver films over nanoparticles and silver films over a roughened or
sand blasted fibre tip. Thiophenol was used as the reference chemical and the SERS
effect was found to be similar for all three tips. The durability and potential to
regenerate the roughened or sandblasted tips meant that they emerged from the study
as the tip with most promise. Pettinger et al., 2005 demonstrated the potential of
TERS when studying the dye malachite green isothiocyanate by achieving
enhancements of signal from the dye molecule of approximately 6 x 106 adsorbed on
a gold substrate in a region within a 50 nm radius underneath the tip
TERS has potential for inducing a localised enhancement of Raman signal that can be
used for detection of target molecules. The main disadvantage with TERS at present
is reproducibility of the tips and breakage of tips. When these initial difficulties have
been overcome, TERS may emerge as a useful variant of SERS.
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2.2.11 Cleaning limits and SERS
There are no hard and fast rules concerning the levels to which pharmaceutical
manufacturing equipment must be cleaned before the plant can be released for
production of a new compound. The 10 ppm formula, the acceptable daily intake
formula based on the eight hour acceptable worker exposure limit and the 1/1000 of
therapeutic level formula have been introduced as potential methods by which the
level to clean can be calculated. As has already been discussed, cleaning verification
is often based on the formula that yields the lowest value and this is most typically the
1/1000 of therapeutic level. (Valvis & Champion, 1999).
For the purposes of this study it is important to discuss the information for calculating
cleanliness levels relates to in terms of detection levels. Chapter four mainly deals
with SERS and attempts to implement it as a cleaning verification technology.
Therefore it is important to be working at levels of contamination appropriate for
cleaning verification.
From the literature it is apparent that there is quite a wide range of concentrations
over which detection of active pharmaceutical ingredient has been attempted. The
explanation for this is the variation in pharmacological potency between different
drug compounds with lower levels of detection a requirement for more potent
compounds where carry over of drug into the next product presents an even greater
risk to patient health.
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Zeller 1993, in validating a cleaning system applied several concentrations of product
dissolved in methanol to swabs and allowed the methanol to evaporate dry. Linearity
was found over the range 0.02 –0.1 µg/ml and quantitation possible with the sampling
procedure to 0.98 ng/cm2. These levels turned out to be much lower than the actual
levels of detection and quantitation needed based on the product’s 1/1000 of
therapeutic dose. Shifflet & Shapiro (2002) discussed a theoretical calculation in
which it was calculated as necessary to detect at levels equivalent to 25 µg/ml. Valvis
& Champion 1999, discussed cleaning validation work for a potent anticancer agent
in which it was necessary to detect down to 10 ppm in 50 L of cleaning solvent in
order to classify the equipment as clean. Ultimately validation went down to 0.1 ppm
and it was possible to clean the equipment to 2 ppm for the compound of interest.
Liu & Pack, 2007 validated a cleaning verification assay for a highly potent
compound at levels of 50ng/cm2 and 50 ng/100cm2 which equated to 5 ng/ml or 3
ng/ml when losses were allowed for. It was pointed out that for drugs where the
therapeutic dose is in the low micrograms per day, the cleaning verification
acceptance limit is going to be driven down into the nanogram range. The authors
were able to validate an LC/MS method for the determination of residues for their
target compounds which were new chemical entities belonging to Eli Lilly.
2.3 Fluorescence spectroscopy
Luminescence is the emission of light from any substance and occurs from
electronically active states. The phenomenon of luminescence can be divided into
two groups; fluorescence and phosphorescence depending on the nature of the excited
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state. In excited singlet states, the electron in the excited orbital is paired (of opposite
spin) to the second electron in the ground state orbital. Consequently, a return to the
ground state is spin allowed and occurs rapidly by emission of a photon. Typical
emission rates of fluorescence are 108s-1 meaning that a typical fluorescence lifetime
is around 10 nanoseconds (Sharma & Schulman, 1999). The lifetime of a fluorophore
is the average time between its excitation and its return to the ground state. The short
time scales involved mean that measuring time resolved fluorescence requires
sophisticated optics and electronics. Whilst time resolved fluorescence presents
technical difficulties, it is used more often than the steady state measurements because
the data provided can yield greater amounts of information.
In recent years there has been a great proliferation in the use of fluorescence
spectroscopy in the sciences. The proliferation has come about because advances in
optical technology mean that the fluorescence technique can be used within a large
number of disciplines. Fluorescence spectroscopy and time resolved fluorescence
were primarily research tools used in biochemistry and biophysics. Fluorescence is
now used in a wide range of disciplines including environmental monitoring, clinical
chemistry, DNA sequencing and genetic analysis. Fluorescence presents such a
potentially useful tool because of the high sensitivity of detection that can be achieved
and because it is much safer than other techniques such as the use of radioactive
tracers.
Fluorescent probes are the most important aspect of fluorescence spectroscopy.
Obviously the instrumentation is important but the wavelengths and time resolution
required of the machine are determined by the fluorescent properties of the
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fluorophores. In addition, the properties of the probe determine what sort of results
the experiment can achieve. For example, only probes sensitive to pH changes can be
used to measure pH. There are two major groups of fluorophore, intrinsic and
extrinsic. Intrinsic fluorophores are those that occur naturally and include the
aromatic amino acids, NADH, flavins and include derivatives of pyridoxal and
chlorophyll. Extrinsic fluorophores have to be added to a sample of interest and
include dansyl chloride, fluoroscein, rhodamine and numerous other substances
(Valeur, 2002).
In protein, the dominant fluorophore is the indole group of tryptophan. Indole
absorbs near 280 nm and emits near 340 nm (Lackowicz, 1999). The emission
spectrum of indole is highly sensitive to solvent polarity. The emission of indole may
be blue shifted if the group is buried within native proteins and its emission may shift
to longer wavelengths (red shift) when the protein is unfolded (Lakowicz, 1999).
The problem associated with many analytical techniques are high consumption of
reagents and a long time for analysis (Moreira et al., 2004). Moreover, the need for
sample preparation prior to determination makes them cumbersome thus less
attractive for large scale analyses. In this respect fluorescent detection is a simple and
rugged technique that does not require the use of reagents and solvents, is non
destructive and does not generate residues. The technique makes it possible to carry
out easy and fast determination of solid samples. The total analysis time could be as
short as couple of minutes.
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2.4 Relevant patents and commercially available equipment
Information pertinent to the area of infrared spectroscopy and cleaning verification
can be found by looking at patents and commercial websites. The major area of
patent activity at the moment with respect to infrared spectroscopy is the registration
of devices for in situ spectroscopic analysis. As has already been said, the ability to
sample directly the surface of interest would be hugely advantageous and so work is
being done in that area to produce reliable instrumentation.
Melling et al., 2001 patented a spectroscopic accessory for examining films and
coatings on solid surfaces. The accessory is designed for a Fourier transform-infrared
spectrometer and is composed of fibre optic cables that are connected to a framework
within which two mirrors are sited. The mirrors are off axis parabolas and are
positioned with respect to one and other and with respect to the fibre optic cables.
The beam from the first cable is reflected by the first mirror onto the sample surface at
or near the grazing angle, after which it is captured by the second mirror and focused
onto the end of the return cable which transmits it back to the spectrometer. Very thin
films and coatings can be spectroscopically detected and characterised using the
accessory.
The aim of the invention was to reconcile the spectroscopic advantages of the grazing
angle approach with the ease of use presented by a fibre optic cable. The desired
outcome is to permit spectroscopic testing on surfaces such as metals without having
to remove sample and place it within the sample compartment of the spectrometer
(Melling et al., 2001).
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Berard et al., (1992) filed a patent for optical fibre coupled devices for infrared
spectroscopy. The invention is directed to a probe operative in the infrared region of
the electromagnetic spectrum for in situ sensing of the absorption of infrared energy
in a sample. The probe comprises an attenuated total reflection element (ATR)
having an input and an output end respectively for receiving infrared radiation and
transmitting attenuated infrared radiation. The attenuated total reflectance element
has wall portions disposed about a central or long axis thereof for reflecting infrared
energy transverse to the central axis. A bundle of infrared transmitting fibres is
located at the input end of the attenuated total reflectance element for transmitting and
receiving infrared radiation into and out of the element. The fibres have end faces
proximate the attenuated total reflectance element lying in a plane perpendicular to
the central element (Berard et al., 1992).
The aim of the invention was to provide a convenient means of coupling an attenuated
total reflectance element to a spectrometer so that good spectra may be obtained in
moderate times from samples including those that are inconvenient or dangerous to
measure in a spectrometer.
2.5 Genotoxins and limits for genotoxic impurities in drug substances
Impurities accumulate in pharmaceuticals as a result of starting impurities and as by
products of the reactions taking place during the synthetic steps involved in a drug’s
production. In situ reactions often involving residual solvents can also be responsible
for the origin of impurities found in pharmaceutical formulations. Many of the
impurities found in pharmaceutical formulations after synthesis can be genotoxic.
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Figure 2.18 provides a representative scheme which illustrates the routes by which
genoxotoxic impuities may enter pharmaceutical products.
The International Conference on Harmonization (ICH) Guidelines Q3A(R), Q3B(R)
and Q3C are a set of documents that deal with many of the issues surrounding
genotoxic impurities in pharmaceutical formulations.
Figure 2.18. A representative scheme showing how genotoxic impurities can
potentially accumulate in the end product of a drugs’ synthesis. Adapted from
Kirkland & Snodin 2004.
Degradation product impurities are of primary concern while process related
impurities are both necessary to control in APIs. Many potential impurities result
Route 1 Route 2 Route 3 Route A Route B
+SM1 SM2
(SM2`)
INT
(INT`)
BP1, BP2 ……
DS
(DS’)
SM = starting material
SM` = starting material with
potential to form INT` and DS`
D1, D2 ……
BP = reaction by product
D = degradation product
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from the pharmaceutical manufacturing process including starting materials, isomers,
intermediates, reagents, solvents, catalysts and reaction by products (Argentine et al.,
2007).
The classification of a genotoxic impurity is an impurity that presents clear evidence
for its genotoxicity. Usually this is from positive findings in an in vivo mammalian
test (e.g. the rodent bone marrow micronucleus test) with supporting evidence from in
vitro tests (e.g. Ames bacterial mutation test, in vitro chromosomal aberration test,
mouse lymphoma tk mutation test). These tests form the recommended battery of
tests for new pharmaceuticals. Tests such as those previously outlined may not detect
certain tissue specific, sex specific or species specific carcinogens and so non
standard or modified tests may be required (Kirkland & Snodin, 2004).
Compounds that are genotoxic in vivo are usually animal carcinogens and therefore
suspect human carcinogens. Genotoxins have traditionally been assumed to cause
DNA damage that can potentially lead to tumour initiation and progression. It is
becoming increasingly acknowledged that genotoxic events may result from threshold
mediated processes (Kirkland & Snodin, 2004).
Genotoxic and carcinogenic properties may be acceptable for some active
pharmaceutical ingredients such as cytotoxic cancer chemotherapies; where as
impurities in most drug substances and products have limited, if any, beneficial
effects and therefore carry risk without significant associated benefit (McGovern &
Jacobson-Kram, 2006). Scrutiny of genotoxic impurities in pharmaceutical
formulations has increased significantly in the recent past for two major reasons and
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these are improvements in analytical technology meaning it has become much easier
to identify impurities and an increased awareness towards the dangers of many
compounds and the associated risk to human health.
Regulatory documentation addressing the issues of impurities and residual solvents
exist and the ICH guidelines ICH Q3A(R), Q3B(R) and Q3C(R) represent a
consensus on how impurities should be controlled in marketed products. However
important issues are not addressed in the guidelines, for example, acceptable levels of
impurities in drugs in development and control of genotoxic impurities (Jacobson-
Kram & McGovern, 2007).
In December 2002, the Safety Working Party (SWP) of the European Committee for
Proprietary Medicinal Products (CPMP) published a position paper on the limits for
genotoxic impurities. The European Union intended to supplement the gap in the
International Conference on Harmonization guidelines on qualification of impurities,
as it was deemed that impurities with genotoxic potential where a special case not
specifically covered in terms of qualification by the Q3A and Q3B guidelines. The
SWP’s proposed approach follows a safety factor based risk assessment process
similar to that in ICH guidelines Q3C limits for residual solvents rather than a
qualification process described in ICH Q3A and Q3B (Kirkland & Snodin, 2004).
The SWP acknowledge threshold mechanisms and in their paper recommend that
genotoxic impurities should be avoided if at all possible and particularly if there is no
threshold mechanism known. If genotoxic impurities are unavoidable then they
should be reduced to the lowest feasible levels and/or alternative reagents/synthetic
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routes used. Based on the ICH guidelines for exposure to residual solvents, the
“permitted daily exposure” PDE for a genotoxic impurity with a threshold mechanism
of genotoxicity is calculated using the No Observed Effect Limit (NOEL) or Lowest
Observed Effect Limit (LOEL) from the most relevant animal studies and
incorporation of safety factors (Jacobson-Kram & McGovern, 2007).
For genotoxic impurities without evidence for a threshold mechanism of genotoxicity
the guidelines set out by the SWP propose a policy of controlling levels to as “low as
reasonably practicable” (ALARP principle). The SWP assert that in the case of
compounds lacking evidence for a threshold mechanism during production of the
compound every effort must be made to reduce the genotoxic impurities through
technical efforts such as purification steps. Compounds that fall into this group of not
having clear evidence for a threshold mechanism include alkylating agents and
intercalating agents. Regulatory agencies perform risk assessments to calculate the
increased levels of adverse events resulting from exposure to the genotoxic impurity
and set exposure levels which result in “acceptable risks”. This is often a chance of
10-5 or 10-6 of additional cancers from lifetime exposure (Jacobon-Kram & McGovern,
2007).
A white paper was presented at a public meeting of the Pharmaceutical Research and
manufacturing Association (PhRMA) after development by a task force. The
document outlines a procedure for testing, classification, qualification and
toxicological risk assessment of potentially genotoxic impurities in pharmaceutical
products. A staged threshold of toxicological concern approach was proposed by the
task force with respect to genotoxic impurities since some medicines, particularly
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those in development were only administered for limited time spans. The proposed
short term limits are based on a 10-6 risk of additional lifetime cancers and the limits
for greater than twelve months are based on a 10-5 risk. The limits of exposure result
from a linear extrapolation of the threshold of toxicological concern for a lifetime
daily exposure to shorter term daily exposures. (McGovern & Jacobson-Kram, 2006).
Table 2.1. PhRMA Genotoxic Impurity Task Force Proposal, (McGovern &
Jacobson-Kram, 2006).
Duration of clinical trial exposure
(months). <1 1-3 3-6 6-12 >12
Allowable daily intake (µg/day)
for all phases of development 120 60 20 10 1.5
The FDA perspective on this matter is an acknowledgment that complete removal of
genotoxic impurities may not always be possible and that pharmaceutical companies
should strive to reduce genotoxic impurities to the lowest possible levels where they
represent an insignificant risk to patients or clinical trial subjects. The exact level
should be based on compound specific data and a staged implementation of the
threshold of toxicological concern is acceptable for developmental products. In some
cases the thresholds may be increased if the drug is of significant therapeutic potential.
The FDA Center for Drug Evaluation and Research (CDER) is currently developing
guidance to address the issue of genotoxic impurities in pharmaceutical products
(Jacobson-Kram & McGovern, 2007)..
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In summary, whilst no official legislation exists, the daily limit agreed upon for a
genotoxic impurity is 1.5 µg/day when the drug in question is one prescribed for a
period greater than twelve months. The levels of genotoxic impurities may increase
for drugs taken for shorter periods of time and for drugs still in the developmental
stage.
2.5.1 Examples of impurity formation and analytical techniques for
detection of genotoxic impurities.
The development of analytical technology and methodologies for the determination of
genotoxic impurities in active pharmaceuticals is of great importance because it
allows for the development of a greater understanding of synthetic processes and
degradation pathways and is a key aspect in establishing regulatory controls.
Analytical specificity and sensitivity are primary considerations for the determination
of genotoxic impurities in pharmaceuticals. Techniques with appropriate selectivity
are necessary to avoid false positives caused by interferences and detectability
requirements are usually lower than for other impurities, sometimes extending down
to the low parts per million range. The potential specification limit for an impurity is
a key factor in determining the sensitivity requirement for the analytical method and
in certain cases could dictate the analytical technique required for control (Argentine
et al., 2007).
Sulfonic acids such as methane sulfonic acid, benzene sulfonic acid and ρ-toluene 
sulfonic acid are routinely employed to produce conjugates with active
pharmaceutical ingredients in order to improve pharmacological properties. The
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formation of these conjugate salts usually improves the solubility, absorption and
physical properties of APIs and thus increases the feasibility of a successful
formulation. The use of these sulfonic acids can potentially lead to the formulation of
trace levels of sulfonic acid esters in the final API (Calon & Richoll, 2005).
There are two main means by which sulfonic acid esters can enter the final API.
1) As a process related impurity carried over into the API
2) Formed in situ by the reaction of these acids with residual solvents used
during synthesis.
The likelihood of formation of sulfonic acid esters is increased if alcohol groups are
present in the formulation or used in any stage during synthesis (Taylor et al., 2005).
The potential toxicity of sulfonic acid esters has been documented. Methyl methane
sulfonate and ethyl methane sulfonate can alkylate cellular DNA. Methods have been
developed to quantitate the degree of alkylation by measuring ethylated and
methylated DNA adducts, mostly by HPLC methods. Gas chromatography has been
used for the determination of S – methylcysteine and other alkylated amino acids as a
marker of exposure to methyl methane sulfonate and other alkylating agents (Calon &
Richoll, 2005).
Calon & Richoll 2005 developed a sensitive detection system for methyl and ethyl
esters or methane sulfonic acid, benzene sulfonic acid and –toluene sulfonic acid
based on solid phase microextraction to prepare the sample and then GC/MS in the
SIM mode for analysis. They were able to validate the system down to 5 ppm.
81
Taylor et al., 2005 were able to carry out low level determination of -
toluenesulfonate and benzenesulfonate esters by HPLC/MS and GC achieving
detection at less than 0.1 ppm. The authors stated that their method had the advantage
of not being coupled to solid phase extraction, solid phase micro extraction or liquid
phase micro extraction.
Carbonic acid chloromethyl tetrahydro-pyran-4-yl ester (CCMTHP) is commonly
used as an alkylating reagent in the synthesis of APIs. As specified in the European
Agency for the Evaluation of Medicinal Products (EMEA) position paper on the
limits of genotoxic impurities, alkylating agents are considered to be the archetypal
class belonging to the group of genotoxic impurities. Therefore, the CCMTHP
content in the final drug product should be as low as technically feasible (Li &
Slugget, 2005)
Detection of CCMTHP requires sensitive trace analysis techniques (method should be
sensitive, selective and robust). The GC-MS SIM method they developed and
described is a relatively simple analytical procedure for the accurate determination of
trace levels of CCMTHP down to 10 ppm in an API. The method requires no
extraction, derivitization or cleanup and can be readily adapted for the analysis of
other halogen containing alkylating agents used in the manufacture of pharmaceutical
products (Li & Slugget, 2005).
Regulatory authorities recognise the fact that analysis of genotoxic impurities is not
without its challenges, however in most cases current analytical chemistry techniques
are adequately sensitive and available to industry. Various LC/GC methods either
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alone or coupled to MS should in most cases provide the necessary technological
platforms for appropriate method development (McGovern & Jacobson-Kram, 2006).
Separation, identification and quantification may be more challenging in certain cases
when the impurities of interest are degradants that form only in the presence of
excipients, residual solvents or from contact with container closure components i.e.
leachables. Also, separation of the impurity from the matrix of the drug product may
pose analytical challenges regarding the development of routine methods for the
assessment of drug products (McGovern & Jacobson-Kram, 2006).
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3 Characterisation of commercially
available swabs for cleaning
verification
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This chapter presents recovery and debris generation data for seven commercially
available swabbing materials. The difference in recovery rate from a stainless steel
surface and after direct spiking is also examined for two of the better performing
swabs. Recovery rates and debris generation are compared and conclusions on swab
performance are made.
3.1 Introduction
As discussed in the introductory section of the thesis, there are many important
aspects of swab sampling. Within the cleaning verification field there is currently
little published work comparing commercially available swabs for cleaning
verification work. For this chapter it was decided to undertake experimental work
aimed at investigating the swabbing properties of seven commercially available swabs
or swab materials. Claims are made about the suitability of different swabbing
products for cleaning verification but little data exists and so this chapter is aimed at
comparing different commercially available swabs. The ability of the swab to recover
compound is a crucial element in its suitability for cleaning verification and this is
something we decided to investigate. Recovery rates of 60 per cent are acceptable but
higher rates are desirable (Miscoscio, 1997). The tendency of the swab to leave
behind debris on the sampled surface is another factor that should be taken into
account when selecting a swab for cleaning verification work (Miscoscio, 1997) and it
was decided to investigate this process too.
With the knowledge gained from experiments on the swabbing process we gain a
better understanding of swabs and their properties with relevance to cleaning
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verification and are in a position to draw conclusions about the best combinations of
swab and solvent for cleaning verification work. Sampling is a vital aspect of the
cleaning verification process and this work will enhance the understanding of it. As
well as gaining an understanding of what recoveries are achievable it will also be
possible to see what sort of levels of variation are inherent in the process. For the
experiments presented in the section of the thesis all swab sampling is done by one
person but in a pharmaceutical company, swab sampling is done by a number of
different employees and ensuring reproducibility of results across the entire workforce
is something pharmaceutical companies invest a lot of time and money in. Good
consistency of results is also important from the point of view of safety of the final
product. Underestimating the amount of residue left on the equipment could result in
the plant being released before it is sufficiently clean and therefore leading to the
manufacture of an overly contaminated batch of new product. Overestimation is more
of an economic problem in that it means the plant will be re-cleaned when further
cleaning is unnecessary.
The experiments will be conducted with water and ethanol as the solvents. Water is
polar and is often used in the pharmaceutical industry during the cleaning process.
Ethanol is less polar and is an example of an organic solvent that might be used for
cleaning verification. The drugs or drug like compounds for which recoveries will be
measured are: acetaminophen, nicotinic acid, diclofenac and benzamidine.
Acetaminophen is a drug compound that readily dissolves in both water or ethanol.
Benzamadine is a drug like compound which is also readily dissolved in water or
ethanol. In this study, acetaminophen was dissolved in water and benzamidine
ethanol. Diclofenac is a hydrophobic drug molecule. It’s log p value is 3.42 and was
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used as an example of a hydrophobic compound. It was dissolved in ethanol.
Nicotinic acid is a polar compound (log p = 0.56) with structural and functional
similarities to many drug compounds and was dissolved in water for the experiments
in this study.
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3.2 Materials and methods
The swabs under investigation were either purchased from the supplier or received as
gifts. The seven swabs used in the study were: Absorbond™, MiracleWipe™,
Technicloth™, Betawipe™, Alphawipe™, Super Polx 1200™ and Texwipe ™. All
of the swabs apart from the Super Polx 1200™ are manufactured by Texwipe (New
Jersey, US). Super Polx 1200 is manufactured by Berkshire (Surrey, UK).
Table 3.1. Swabbing materials investigated (information supplied by manufacturer).
Absorbond™ 100% hydroentangled polyester
MiracleWipe™ 100% continuous filament nylon
Technicloth™ Hydroentangled, non woven 55% cellulose & 45% polyester
Betawipe™ Polypropylene and cellulose wiper
Alphawipe™ 100% continuous filament polyester
Super Polx 1200™ 100% continuous filament polyester
Texwipe™ 100% cotton woven wiper.
Acetaminophen, nicotinic acid, diclofenac and benzamidine were purchased from
Sigma (Poole, Dorset, UK). Isopropyl alcohol was analytical grade and purchased
from Fisher Scientific (Loughborough UK)
A stainless steel surface was thoroughly washed with isopropyl alcohol and then left
to dry prior to use. A known amount of compound was spread across the surface in 1
ml of solvent (water or ethanol). The solvent was then allowed to evaporate. The
surface was wiped clean with swabbing material soaked in solvent (water or ethanol).
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The swabbing material was placed into an 18 ml vial with a further 5 ml of solvent,
ultrasonicated for 10 minutes and then vortexed for 2 minutes. UV-vis spectroscopy
was carried out in 1 ml sample quartz cuvettes using a UV 2100 spectrophotometer
(Shimadzu, Milton Keynes, UK). Calibration curves were made for each of the
compounds under investigation. Acetaminophen was measured at 245 nm, nicotinic
acid at 245 nm, diclofenac at 269 nm and benzamidine at 284 nm. The calibration
curve for acetaminophen was linear over the range of 0 - 0.2 mg/ml (R2 = 0.998). The
calibration curve for nicotinic acid was linear over the range of 0 – 0.2 mg/ml (R2 =
0.996). The calibration curve for diclofenac was linear over the range of 0 - 0.04
mg/ml (R2 = 0.999). The calibration curve for benzamidine was linear over the range
of 0 – 0.3 mg/ml (R2 = 0.999). All UV measurements were carried out three times
and each contamination and subsequent extraction was performed four times for each
compound in order to produce reliable results
In order to examine debris generation, a stainless steel surface was pre cleaned with
isopropyl alcohol and allowed to dry. The surface was then loaded with 1 ml of
acetaminophen solution at a concentration of 1 mg/ml. The surface was allowed to
dry and then wiped clean with a swab soaked in water. The surface was allowed to
dry and then investigated with the aid of a microscope (Karl Zeiss (UK) Axioskop –
Welwyn Garden City, Herts, UK). Debris generation per square cm was measured
after the swabbing materials had been used to clean a stainless steel surface. Five
counts were performed in order to produce reliable results.
Images of swabs were also captured by microscope (Karl Zeis (UK) Axioskop).
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The metal surface was swabbed as described below.
Figure 3.1. Showing the swabbing procedure for one sample collection.
1
2
3
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3.3 Results
3.3.1 Images of swabs
The swabs were imaged under a microscope and their properties summarised in order
to aid characterisation.
3.3.2 Absorbond™
To the hand the swab had a soft feel with no stretching ability and to the eye the swab
was found to have a glossy appearance. Under the microscope a filamentous
arrangement of fibres was observed.
Figure 3.2. Image taken of fibres from an Absorbond™ swab (x 20). The swab had a
filamentous appearance under the microscope.
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3.3.3 MiracleWipe™
The fibres were found to have a bundled appearance under the microscope.
Figure 3.3. Image of fibres from a MiracleWipe™ swab (x 40).
Figure 3.4. Showing the MiracleWipe™ swab at x 4 magnification.
The pattern revealed the bundled nature and inherent stretching ability of the swab.
To the hand MiracleWipe™ had a soft feel and was able to be stretched.
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3.3.4 Technicloth™
The Technicloth™ was similar to Absorbond™ under the microscope with a
filamentous appearance apparent. To the hand Technicloth™ had a coarse feel and
had no noticeable stretching ability.
Figure 3.5. Showing fibres from a Technicloth™ swab (x 20).
3.3.5 Betawipe™
Like Absorbond ™ and Technicloth™, the Betawipe™ had a filamentous appearance
under the microscope.
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Figure 3.6. Images of fibres from a Betawipe™ swab (x 20).
Figure 3.7. Image of the Betawipe™ swab at x 4 magnification.
Visible as white circles on the swab, Figure 3.7 shows the depressions that were
apparent on the Betawipe™ swab surface.
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Betawipe™ had a sponge like feel to the hand. It was thicker than all the other swabs
and had small depressions on its surface (visible to the eye but shown under x 4
magnification in Figure 3.7).
3.3.6 Alphawipe™
Like MiracleWipe™, Alphawipe™ had bundled fibres. To the hand, Alphawipe™
had a soft feel and possessed the ability to stretch.
Figure 3.8 Image of fibres from Alphawipe™ (x 20).
3.3.7 Super Polx 1200™
The fibres were bundled in appearance and showed similarity to MiracleWipe™ and
Alphawipe™. To the hand Alphawipe™ had a soft feel and possessed the ability to
stretch.
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Figure 3.9. Images of fibres from a Super Polx 1200™ swab (x 20).
3.3.8 Texwipe™
The fibres had a filamentous appearance and showed similarity to Absorbond™,
Technicloth™ and Betawipe™. To the hand Texwipe™ had a coarse feel and did not
possess the ability to stretch.
Figure 3.10. Image of fibres from a Texwipe™ swab (x 20).
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3.3.9 Summary of swab properties
Table 3.2. Summarising the physical properties of the investigated swabs.
Wiper Microscopic
appearance
Macroscopic
appearance
General Comments
Texwipe™ Filamentous Coarse N/A
Absorbond™ Filamentous Soft Glossy appearance
MiracleWipe™ Bundled Soft Stretchy
Technicloth™ Filamentous Coarse N/A
Betawipe™ Filamentous Foam like Contains small
holes
Alphawipe™ Bundled Soft Stretchy
Super Polx 1200™ Bundled Soft Stretchy
In summary, the swabs fell into two broad categories. MiracleWipe™, Alphawipe™
and Super Polx 1200™ had fibres with a bundled appearance under the microscope.
These swabs had a soft feel to the hand and had the ability to stretch. Technicloth™
and Texwipe™ had a filamentous appearance under the microscope. These two
swabs had a coarse feel to the hand and no discernable stretchiness. Betawipe™ and
Absorbond™ were slightly anomalous. Both had a filamentous appearance under the
microscope but unlike Technicloth™ and Texwipe™ they did not have the coarse feel.
Absorbond™ had a very smooth feel and glossy appearance but did not possess any
stretching ability. Betawipe™ felt thick to the hand in spite of being found to have a
slightly rough feel. The Betawipe™ swab also had a spongy quality.
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3.3.10 Compound recovery
Acetaminophen and nicotinic acid were dissolved in water before contamination and
recovered in water. Diclofenac and benzamidine were dissolved in ethanol before
contamination and recovered in ethanol.
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Figure 3.11. Mean percentage recovery of compound from seven commercially
available swabbing materials used to wipe clean a stainless steel surface pre loaded
with 0.1 mg of acetaminophen. The bars represent standard deviation.
The mean percentage recovery of acetaminophen in the overall sense was high with
highest recovery of 88.2% achieved with the Technicloth™. The lowest mean
percentage recovery was 61.6% and from the MiracleWipe™. This amounted to a
wide disparity. Betawipe™, Alphawipe™, Super Polx 1200™ and Texwipe™ all had
recovery rates in the 70-80% range and they were 71.6%, 71.7%, 76.0% and 78.9%
respectively. The Absorbond™ wiper was the only other one to achieve an above
80% recovery rate at 84.5%.
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Figure 3.12. Mean percentage recovery of compound from seven commercially
available swabbing materials used to wipe clean a stainless steel surface pre loaded
with 0.1 mg of nicotinic acid. The bars represent standard deviation.
When compared to acetaminophen, much lower rates of recovery were achieved on
stainless steel surfaces pre loaded with nicotinic acid. Texwipe™ had the highest
observed recovery rate at 64.8%. Technicloth™ had the second highest recovery rate
at 60.2%. MiracleWipe™, Betawipe™, Alphawipe™ and Super Polx 1200™ all
displayed recovery rates in the 50-60% range with precise rates of 50.0%, 58.7%,
53.0% and 56.8% respectively. Absorbond™ had the lowest recovery rate for
nicotinic acid at 48.6% and this was in fact the lowest recovery seen throughout the
study. The high variations observed in measurement are worth noting. Since nicotinic
acid is the most polar compound of all tested in this work a potential conclusion could
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be that the low recovery is a result of enhanced affinity of a polar species to polar
steel surface.
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Figure 3.13. Mean percentage recovery of compound from seven commercially
available swabbing materials used to wipe clean a stainless steel surface pre loaded
with 0.1 mg of diclofenac. The bars represent standard deviation.
Diclofenac recovery rates were good with all swabbing materials, achieving a
recovery of above eighty per cent apart from with MiracleWipe™ and Betawipe™
(77.8% and 78.0% respectively). Absorbond™ and Super Polx 1200™ had the
highest recoveries at 86.5% and 86.3% respectively. Technicloth™, Alphawipe™
and Texwipe™ achieved recoveries of 82.3%, 82.1% and 83.2% respectively.
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Figure 3.14. Mean percentage recovery of compound from seven commercially
available swabbing materials used to wipe clean a stainless steel surface pre loaded
with 1 mg of benzamidine. The bars represent standard deviation.
Recoveries for benzamidine were again generally high. The lowest recovery observed
was for Texwipe™ at 70.3%. Technicloth™, Betawipe™ and Alphawipe™ showed
recoveries in the 70-80% range, more precisely achieving recovery rates of 73.7%,
77.7% and 72.3% respectively. Absorbond™, MiracleWipe™ and Super Polx
1200™ achieved recovery rates of 88.0%, 86.8% and 85.8% respectively.
3.3.11 Debris generation
This section presents a series of images of fibres and particles found on a stainless
steel surface after wiping with the various swab materials.
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Figure 3.15. Residual particles deposited by a Betawipe™ (x10)
Figure 3.16. A fibre deposited by a Texwipe™ (x10).
70 µm
30 µm
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Figure 3.17. Residual particle deposited by an Alphawipe™ (x10)
Figure 3.18. A fibre deposited by a Technicloth™ (x40).
30 µm
70 µm
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Figure 3.19. Residual particle deposited by a MiracleWipe™ (x40).
Figure 3.20. A fibre deposited by an Absorbond™ (x40)
Counts were made of fibre and particle generation as debris on wiped surfaces. The
results were collated and a presented in figure 3.21.
30 µm
30 µm
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Figure 3.21. Mean amount of debris left behind on a stainless steel surface after
wiping clean with seven different commercially available swabbing materials.
Debris generation fell between the range of 3.0 pieces/cm2 and 10.6 pieces/cm2 for six
of the seven swabs. Debris generation for Betawipe™ was high at 55 pieces/cm2.
3.3.12 Compound recovery from spiked swabs in comparison to compound
recovery from contaminated surfaces.
In order to obtain some additional information on the swabbing process
Technicloth™ and Absorbond™ were selected to be spiked directly with compound.
Technicloth™ was selected because it had good recoveries for all compounds.
Absorbond™ was selected because it had good recoveries for acetaminophen,
diclofenac and benzamidine but showed the lowest recovery in the entire study for
nicotinic acid. Therefore it would be particularly interesting to compare the recovery
of nicotinic acid from Absorbond™ when spiked directly and when used to sample a
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contaminated surface. Once spiked the compound was recovered using the procedure
employed for swabs used to wipe the metallic surface.
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Figure 3.22. Recovery of all four compounds from a directly spiked Technicloth™
swab(black) and from a contaminated steel surface (white) wiped with the
Technicloth™ swab. The bars represent standard deviation.
Technicloth™ showed increased recoveries and smaller variation after direct spiking
with compound. The most significant gain was with nicotinic acid where recovery
increased from 60.2% to 79.6%. Benzamidine also increased significantly from
73.7% to 98.5%. This increase in compound recovery indicated that for
acetaminophen, diclofenac and benzamidine on a contaminated surface; the major
loss of compound occurred through the compounds remaining present on the steel
surface. Spiking the swab improved recovery for nicotinic acid markedly but a
significant amount of compound (approx 20%) remained unaccounted. Another point
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worth noting is that unlike acetaminophen, diclofenac and benzamidine where direct
spiking of the swab caused a reduction in standard deviation, the high standard
deviation for nicotinic acid remained when the swab had been spiked directly.
Acetaminophen, diclofenac and benzamidine all showed high recoveries and small
standard deviations where as nicotinic acid still showed a large standard deviation in
spite of the recovery improving.
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Figure 3.23. Recovery of all four compounds from a directly spiked Absorbond™
swab (black) and from a contaminated steel surface (white) wiped with the
Absorbond™ swab.
Absorbond™ showed increased recoveries and much smaller variations after direct
spiking with compound for nicotinic acid, diclofenac and benzamidine with nicotinic
acid again displaying a marked increase from 48.6% to 74.7%. Acetaminophen
recovered slightly less well from a spiked swab, falling from 84.5% to 82.1%. As
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with the data where a contaminated steel surface had been wiped, better performances
(92.7% for diclofenac and 95.2% for benzamidine) for compounds dissolved in
ethanol than in water (82.1% for acetaminophen and 74.7% for nicotinic acid) were
observed. For Absorbond™, when spiking the swab directly, the standard deviation
of nicotinic acid was similar to those of acetaminophen, diclofenac and benzamidine.
Table 3.3. Summarising recovery rates and their standard deviations from the
combinations of compounds and swabs used in the study.
Wiper Acetaminophen
Nicotinic
Acid Diclofenac Benzamidine
Absorbond™ 84.5 ± 6.5 48.6 ± 22.0 86.5 ± 19.3 88.0 ± 9.9
Miraclewipe™ 61.6 ± 3.2 50.0 ± 16.7 77.8 ± 20.0 86.8 ± 2.1
Technicloth™ 88.2 ± 4.6 60.2 ± 14.0 82.3 ± 15.3 73.7 ± 6.8
Betawipe™ 71.6 ± 5.1 58.7 ± 17.8 78.0 ± 15.0 77.7 ± 5.3
Alphawipe™ 71.7 ± 1.7 53.0 ± 19.8 82.1 ± 16.5 72.3 ± 14.1
Super Polx
1200™ 76.0 ± 2.8 56.8 ± 19.8 86.3 ± 19.6 85.8 ± 21.7
Texwipe™ 78.9 ± 5.1 64.8 ± 19.8 83.2 ± 19.7 70.3 ± 7.7
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Table 3.4. Summarising debris generation for the swabs used in the study.
Mean S.D.
Absorbond 5.1 3.2
MiracleWipe 9.7 6.8
Technicloth 4.0 1.8
Betawipe 55.0 9.2
Alphawipe 3.0 2.6
Super Polx 3.4 0.9
Texwipe 10.6 1.9
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Table 3.5. The overall average recoveries and standard deviations for the swabs used
in the study.
Wiper
Mean
percentage
recovery
for entire
study Mean S.D.
Absorbond™ 76.9 14.4
Miraclewipe™ 69.1 10.5
Technicloth™ 78.3 10.2
Betawipe™ 71.5 10.8
Alphawipe™ 75.2 15.7
SuperPolx
1200™ 76.3 16.0
Texwipe™ 74.3 13.1
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Table 3.6. Recoveries and standard deviations for spiked Technicloth™ and
Technicloth™ used to wipe a contaminated steel surface.
Technicloth™
Spiked
Swab S.D.
Contaminated
Surface S.D.
Acetaminophen 97.8 2.5 88.2 4.6
Nicotinic acid 79.6 11.0 60.2 14.0
Diclofenac 96.6 0.9 82.3 15.3
Benzamidine 98.5 2.6 73.7 6.8
Table 3.7. Recoveries and standard deviations for spiked Absorbond™ and
Absorbond™ used to wipe a contaminated steel surface.
Absorbond™
Spiked
Swab S.D.
Contaminated
Surface S.D.
Acetaminophen 82.1 1.3 84.6 6.5
Nicotinic acid 74.7 1.4 48.6 22.0
Diclofenac 92.7 1.7 86.5 19.3
Benzamidine 95.2 1.9 88.0 9.9
111
3.4 Discussion
All of the swabs used in the study achieved overall recoveries in excess of 70% apart
from MiracleWipe™ which achieved an overall recovery of 69.1% (see table 2.4).
The figure quoted from the literature of 60% (Miscoscio, 1997) was met in the overall
sense if the sets of data for each swab are averaged. For reference purposes, recovery
data is tabulated in tables 3.3-3.7.
Acetaminophen recovered well for all seven swabs within a range of 61.6% – 88.2%.
Again all recoveries from the swabs were in the 70-90% range apart for
MiracleWipe™ which achieved 61.6%. The combination of Technicloth™,
acetaminophen and water as the recovery solvent achieved 88.2%. This is a high
recovery and demonstrates that high recoveries can be achieved with particular
combinations of swab, compound and extraction solvent.
Diclofenac recovered well from all seven swabs with a range of 77.8 - 85.6 %. The
standard deviations were on the whole higher with diclofenac than with
acetaminophen and benzamidine. Absorbond™ and Super Polx 1200™ both
performed well in combination with diclofenac and ethanol as the extraction solvent
achieving recoveries of 86.5 and 86.3% respectively. Again this demonstrated that
high recoveries were achievable with a particular combination of swab, compound
and extraction solvent.
Benzamidine recovered well for all seven swabs with a range of 70.3 – 88.0 %.
Absorbond™ performed well in combination with ethanol as the extraction solvent to
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achieve the rate of 88.0%. Standard deviations were on the whole lower for
benzamidine than diclofenac but the Super Polx 1200™ had a noticeably large
standard deviation of 21.7 (the largest in the entire study) where as the other swabs in
combination with benzamidine fell between 2.1 and 14.1.
Of the four compounds investigated in the study, nicotinic acid performed least well
in terms of recovery. The range of recoveries fell between 48.6% (Absorbond™) and
64.8% (Texwipe™). Only Technicloth™ and Texwipe™ were able to achieve the
satisfactory milestone of a 60% recovery as quoted by Miscoscio, 1997. Standard
deviations were high too, showing that variability of recovery was also an issue with
the combination of swabs, compound and extraction solvent.
To help gain further understanding of recoveries and the swabbing process,
Absorbond™ and Technicloth™ were spiked directly with compound and then
subjected to the same extraction process as the swabs used in the previous section of
the study focused on recoveries from a contaminated steel surface. It was observed
that recoveries increased in all cases except for Absorbond™ where the recoveries fell
from 84.5 to 82.1%. This was a small drop that fell within the standard deviation of
6.5 for the recovery found with acetaminophen from the contaminated surface. All
other recoveries increased and in particular nicotinic acid showed a marked increase
going from 48.6% and 60.2% in Absorbond™ and Technicloth™ respectively to 74.7
and 79.6% respectively. These gains in recovery are significant and show that
somewhere in the process of sampling with and extracting from a contaminated swab
be it Absorbond™ or Technicloth™, a significant amount of nicotinic acid is lost.
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The other three compounds tested showed increases in recovery when the swab was
directly spiked. Recoveries of 97.8, 96.6 and 98.5% were observed for acetaminophen,
diclofenac and benzamidine respectively in combination with the Technicloth™ swab.
These were up from 88.2, 82.3 and 73.3 for acetaminophen, diclofenac and
benzamidine when recovering from a steel surface. The fact that such high recoveries
were achievable when the swab was spiked would suggest that for acetaminophen,
diclofenac and benzamidine in combination with the Technicloth™ swab, a
significant amount of compound was left behind on the steel surface. This statement
can be made because it is known that when the swab was directly spiked the
recoveries were close to one hundred percent.
For the Absorbond™ swab a minor decrease in recovery for acetaminophen (84.5 to
82.1%.) was observed but it fell within one standard deviation of the mean recovery
from the contaminated surface. Nicotinic acid, diclofenac and benzamidine all
showed increased recoveries when the swab was spiked directly, 48.6, 86.5 and 88.0
% respectively to 74.7, 92.7 and 95.2 % respectively. From this data we can draw the
conclusion that when in combination with diclofenac and benzamidine the
Absorbond™ swab does not absorb all of the contaminating compound because
recoveries of greater than 90 percent are observed when the swab is directly spiked
with the two compounds. For acetaminophen and nicotinic acid the same conclusion
cannot be drawn because a proportion of compound is still unaccounted for. When
the swab was spiked directly, recoveries of 82.1 and 74.7 were observed. In the case
of acetaminophen there is a high degree of similarity between the recoveries from a
contaminated steel surface and from a spiked Absorbond™ swab. This may suggest
that a certain amount of acetaminophen remains bound to the Absorbond™ swab
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fibres in spite of the extraction process. The fact that the swab is spiked means that a
known amount of compound is present to begin with and so it cannot be said that
some is left behind on the surface.
The increased recoveries for nicotinic acid are not so easily explained. Recoveries of
74.7 and 79.6% respectively from directly spiked Absorbond™ and Technicloth™
swabs are a significant improvement on recoveries from a contaminated steel surface
but approximately 20-25% of the compound is still unaccounted for. A possible
explanation is that nicotinic acid has a different affinity for the swab fibres to the
other compounds tested. The extraction process would be less efficient if the affinity
between compound and fibres was high and would result in more nicotinic acid
remaining bound within the swab after extraction. Another possible explanation is a
lower affinity between the swab fibres and nicotinic acid meaning a smaller amount
of compound is recovered from the metallic surface. Thirdly, nicotinic acid might
have a higher affinity for the steel surface than the other compounds tested.
The Super Polx 1200™ and Absorbond™ swabs showed excellent recoveries when in
combination with the two compounds dissolved in ethanol. Super Polx 1200™ was
found to have recoveries of 86.3 and 85.8% for diclofenac and benzamidine and
Absorbond™ had recoveries of 86.5 and 88.0% for diclofenac and benzamidine.
Neither swab is unique, both are made from polyester and they differ in that
Absorbond™ has a fibrous appearance under the microscope and Super Polx 1200™
has a bundled appearance under the microscope. Absorbond™ has a soft finish and a
glossy appearance where as Super Polx 1200™ has a soft feel and is stretchable.
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To summarise, the data on recoveries showed that high recoveries from a stainless
steel surface can be achieved with the correct combination of swab, compound and
extraction solvent., e.g. 88.2% for acetaminophen, Technicloth™ and water, 88.0%
for benzamidine, Absorbond™ and ethanol. Low recoveries can also be achieved,
48.6% for nicotinic acid in combination with Absorbond™ swab and water.
Analytical scientists within pharmaceutical companies need to be aware that an
incorrect match in compound, swab and solvent can lead to low recoveries and should
choose and validate combinations of compounds, swab and extraction solvent
appropriately.
Debris generation produced more uniform levels of performance apart from
Betawipe™ which produced a much higher amount of debris than the other swabs.
Betawipe™ generated a mean amount of debris of 55.0 pieces.cm2. The other six
swabs generated debris in the range of 3.0 to 10.6 pieces/cm2. Betawipe was
particularly spongy and so extra pressure can be applied during the wiping process.
The slightly abrasive nature of the swab combined with the spongy quality may
account for the generation of higher amounts of debris. The debris was mainly small
particles as shown in Figure 3.15 where as the other swabs tended to leave behind
fibres and particles. Fibres and particles were rarely apparent to the eye and the low
and consistent levels of particle generation back up the manufactures claims about
low particle generation from their swabs.
A significant factor in this work on swabbing is the problem of sampling. The data
sets quite often showed large standard deviations and some of this variation must be
introduced during the wiping process. This is going to be true for both the recoveries
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and debris generation. The data from swabs spiked directly showed less variation and
this will be partly due to there not being a sampling step involved. Some of the
variation in the recovery data from sampled surfaces as shown by standard deviation
will result from the compound remaining on the steel surface but it is inevitable that
some error will be introduced by the individual carrying out the wiping. In this study,
all wiping was carried by one person and so this will have helped to reduce operator
based error. Pharmaceutical companies work hard to make sure that their operatives
can swab consistently because it is vital to show that your swabs are representative of
the actual levels of contamination on the manufacturing equipment. A point of
importance to come out of this study is that of variation and that the swab sampling
process has a certain amount of error inherent in it.
3.5 Conclusions
From the data it can be argued that in the overall sense Technicloth™ performed best
with its recovery rate of 78.3% (highest in the study) and average standard deviation
of 10.2 (lowest in the study). For cleaning verification sampling it can be argued that
Technicloth™ represents the best all purpose choice. However, the data presented in
this chapter shows that recovery rates of up to 88.2% can be achieved with a
favourable combination of compound, swab and extraction solvent and that an
unfavourable combination such as that seen with nicotinic acid and Absorbond™ can
result in a recovery as low as 48.6%.
Debris generation was low for six of the swabs but Betawipe™ produced a
significantly higher amount of debris.
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Spiking swabs directly produced improved recoveries thus demonstrating that in the
case of swabbing experiments, some compounds remain behind in significant
amounts on the steel surface.
Analytical scientists working in this area need to be mindful of the problems
associated with swab sampling. This study has shown significant differences in
recoveries for different swab/compound/solvent combinations and emphasised the
levels of variation in the recoveries produced when just one individual is responsible
for sampling. Studies of this nature do not exist within the academic domain and
most data on this topic is held within companies as part of their individual cleaning
regimes. Some of the problems associated with swab sampling have been highlighted
by this study as well as the achievability of high recoveries of drugs when particular
combinations of solvent and swab are employed.
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4 Raman spectroscopy and SERS for
Cleaning Verification in the
Pharmaceutical Industry.
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Having introduced Raman spectroscopy and SERS in chapter 2, this chapter
introduces and discusses the rationale for testing SERS with relevance to cleaning
verification and the necessary levels of detection for cleaning verification work are
introduced. Results are presented that show the difficulties associated with using
SERS to detect contamination from the swab directly and that provide a support for
the use of solid SERS substrates for the identification of residual compounds on a pre
contaminated stainless steel surface at concentrations relevant to cleaning verification.
4.1 Introduction
As stated in the introductory section of the thesis, SERS is a highly sensitive
spectroscopic technique, potentially capable of detecting chemical species at the
levels necessary for cleaning verification work. There are difficulties associated with
spectroscopic probing methods for direct measurements on manufacturing equipment
in pharmaceutical facilities that include the requirement to make all devices
intrinsically safe so that can be used in the solvent rich plant atmosphere and the
problems of sampling curved surfaces and pipes with spectroscopic sampling
accessories, therefore the swab is a potentially useful point in the cleaning verification
process that could be investigated with the aim of speeding the process up.
The main aims of the chapter is to show that Raman spectroscopy can detect
contamination on swabs and find the level of contamination at which the signal is lost,
to show that SERS can be carried out on the Raman microscope, to obtain SERS
spectra for compounds of interest at concentrations relevant to cleaning verification
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work and to modify the swab so that a SERS signal can be obtained and
contamination determined directly from the swab surface by SERS. Should it not
prove possible to detect contamination directly from the swab by SERS, alternative
SERS methods will be tested.
As has already been pointed out, SERS is an evolving technology and some problems
exist regarding the consistency of signal and reproducibility of results. Obtaining the
correct SERS chemistry is of paramount importance and this is another initial aim of
the chapter. By demonstrating SERS as possible and generating SERS spectra for
various compounds on our Raman system it will then be possible to employ the
technique to look at the cleaning verification problem.
As pointed out in the literature review, the wide disparity in levels to which it is
necessary to clean adds some difficulty to the experiments with SERS. The initial
Raman spectroscopy work with steel surfaces will employ a contamination level of
111µg/100 cm2 or 1.1µg/cm2. Additionally, some of the work will be carried out in
the ppm range and for the purposes of comparison to cleaning verification this will be
mainly around the 10 ppm range. When trying to implement SERS as a cleaning
verification technology the contamination levels investigated will be from
approximately 100 ng.cm2 to 1 ng/cm2.
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4.2 Materials and Methods
Raman spectroscopy and SERS were carried out with a Horiba Olympus BX40
Raman microscope (Horiba Jobin-Yvon, Stanmore, UK). Images presented in this
chapter were taken through the camera attachment of the Raman microscope.
Gold colloid was prepared by mixing 1 ml of a 0.1% sodium citrate solution with 40
mls of 1% hydrogen tetrachloroaurate trihydrate (gold chloride) solution at 60 oC.
The reaction mixture was then heated up to boiling point and cooled in ice when the
mixture had taken on a red colour. The method was taken from a paper by Frens,
1973 and is a frequently cited method of preparing gold colloid in the SERS literature.
SERS experiments performed in liquid were carried out by attaching the Horiba liquid
sampling accessory to the microscope. Liquid samples were pipetted into a 1 ml
quartz cuvette, placed into the sampling accessory and then a spectrum was recorded.
The solutions were made up by mixing in the ratio of 100 µl analyte, 900 µl gold
colloid and 50 µl of 3% NaCl solution (Faulds et al., 2002).
Solutions for SERS experiments were prepared by mixing the analyte solution with
gold colloid and 3% wt NaCl solution in a 10 µl, 100 µl, 5 µl fashion. In a typical
experiment, a solution was prepared by mixing 10 µl of analyte with 100µl of gold
colloid and 5 µl of 3% wt NaCl solution. A 5 µl drop of solution was placed on a
glass microscope and allowed to evaporate dry before inspection under the Raman
microscope. Gold colloid for these experiments had a mean particle size of 5 or 20
122
nm and was purchased from Sigma (Poole, Dorset, UK). The method was adapted
from a paper by Li et al., 2003.
Swabs were impregnated with gold colloid by folding the wiper into a 15 ml funnel
and then pouring the gold colloid solution prepared using the citrate reduction method
through. The filtrate was collected and poured through a further two times. The
swabs were left on the bench over night to dry before use in experiments.
Swabs were sputter-coated using an Agar Scientific Automatic Sputter Coater
(Stanstead, Essex, UK). The device was used on the routine sample coating setting.
After loading the swab into the chamber, the argon supply was opened and the
regulator valve set to at 0.3 bar. The manual mode was then selected and the “flush”
button pressed. After 3 – 5 seconds the “leak” button was pressed and the pressure
was allowed to stabilise at 0.08 mb. The auto mode was selected and then the “cycle”
button was pressed resulting in a forty second gold coating of the swab. The duration
of the coating time was changed to twenty seconds in order to produce partially
coated sputter coated swabs.
In experiments where a contaminated stainless steel surface was swabbed, prior to
contamination the surface was cleaned with isopropyl alcohol. Once dry the
compound of interest was deposited onto the surface in 1 ml of solvent, spread across
the surface and subsequently allowed to evaporate dry. The surface was then wiped
with a moistened swab.
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One set of gold substrates were prepared by Dr Jin Sung Kim in the Department of
Engineering and Computer Science at the University of Michigan. The diagram of
the preparation method can be found in Appendix 1.
Klarite substrates were purchased from Mesophotonics Ltd (Southampton, UK) and in
this project used by pipetting a 5 µl drop of liquid onto the roughened gold surface
and allowing to dry. Once the solvent evaporated the surface was inspected with the
Raman microscope and a spectrum recorded.
Acetaminophen, nicotinic acid, ibuprofen, diclofenac, trichloroacetic acid, maleic acid,
ascorbic acid, citric acid, thiamine, sodium citrate, hydrogen tetrachloroaurate
trihydrate were purchased from Sigma (Poole, Dorset, UK). Methanol, ethanol and
isopropyl alcohol were purchased from Fisher Scientific (Loughborough, UK).
Principal component analysis
When interpretation of a spectrum becomes difficult, statistical analysis methods such
as Principal Component Analysis (PCA) can be used to help interpret the data. PCA
provides an approximation of a data table, data matrix (X) in terms of the product of
two small matrices (T & P). The matrices capture the essential data patterns of X.
Almost any data matrix can be simplified by PCA and it estimates the correlation
structure of the variables. In a principle component model the importance of a
variable is indicated by the size of it residual variance (Wold. S, 1987). A basic
assumption in the use of PCA is that the score and loading vectors corresponding to
the largest eigenvalues contain the most information relating to the specific problem
and that the remaining ones comprise noise. Therefore the vectors are usually written
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in terms of their eigenvalues (Wold. S, 1987). In this study PCA was used on the
SERS spectra for acetaminophen and ibuprofen. A 3-D plot was produced showing
PCA scores on all three axes for spectra of acetaminophen and ibuprofen. PCA was
carried out using the computer software Matlab.
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4.3 Results
4.3.1 Raman spectroscopy of commercially available swabs
Raman spectroscopy was carried out on commercially available swabs so that the spectra for
the swabs could be compared. It would be potentially useful if one swab or certain swabs
were found to possess a minimal Raman spectrum as this would make it easier to distinguish
peaks owing to contamination.
Texwipe™
Texwipe™ was made from cotton which is cellulose based. The spectrum showed
two large characteristic peaks at 1612 and 1725 cm-1 and significant activity in the
“fingerprint” region between 1250 cm-1 and 250 cm-1. The swab had a filamentous
appearance but many of the individual fibres were obscured because of the swab
having depth. The Raman spectrum above in Figure 4.1 was taken by focusing the
laser onto the fibre pointed out by the arrow in Figure 4.2.
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Figure 4.1. Raman spectrum from the surface of a Texwipe™ swab.
Figure 4.2. Image taken on the Raman microscope of the surface of a Texwipe™
swab (x10).
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Absorbond™
The Absorbond™ swab showed a very similar Raman spectrum to Texwipe™. The
two large peaks at 1612 and 1725 cm-1 observed with Texwipe™ were also apparent
with Absorbond and identical patterning of bands in the fingerprint region was also
apparent.
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Figure 4.3. Raman spectrum from the surface of an Absorbond™ swab.
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Figure 4.4. Image taken on the Raman microscope of the surface of the Absorbond™
swab (x 10).
Absorbond™ was found to have a filamentous appearance under the microscope and
the swab having depth meant that a number of fibres were out of focus when sampling.
The Raman spectrum in Figure 4.3 was taken by focusing the laser onto the fibre
indicated by the arrow in Figure 4.4.
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MiracleWipe™
MiracleWipe™ was constructed from nylon and so a totally different Raman
spectrum was found. The patterning in the fingerprint region was different to the
spectra for Absorbond™ and Texwipe™ and additionally much more activity
apparent in the 2800 cm-1 to 3200 cm-1 range. The MiracleWipe™ swab had a
bundled appearance and this made a Raman spectrum more difficult to acquire
because individual fibres upon which to focus the laser are less apparent. The Raman
spectrum in Figure 4.5 was acquired by focusing the laser onto the spot indicated by
the arrow in Figure 4.6.
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Figure 4.5. Raman spectrum from the surface of a MiracleWipe™ swab.
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Figure 4.6. Image taken on the Raman microscope of the surface of a MiracleWipe™
swab (x10).
Technicloth™
This spectrum was identical to the spectra acquired for Absorbond™ and Texwipe™
except that the small peaks at 2971 and 3081 cm-1 were not present. The
Technicloth™ swab was made from a blend of cellulose and polyester whilst the
Absorbond™ swab was made from polyester and the Texwipe™ swab made from
cotton. A high similarity in Raman spectra was observed from three swabs
(Texwipe™, Absorbond™ and Technicloth™) that were of different polymeric
materials.
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Figure 4.7. Raman spectrum from the surface of a Technicloth™ swab.
Figure 4.8. Image taken on the Raman microscope of the surface of a Technicloth™
swab (x10).
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The Technicloth™ swab had a filamentous appearance under the Raman microscope
and the Raman spectrum in Figure 4.7 was taken by focusing the laser onto the spot
indicated by the arrow in Figure 4.8.
Betawipe™
Betawipe™ was made from polypropylene and consequently a different Raman
spectrum was acquired. No activity beyond 1458 cm-1 was apparent until reaching the
2750 to 3250 cm-1 range where six peaks between 2840 .cm-1 and 2960 cm-1 were
apparent.
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Figure 4.9. Raman spectrum from the surface of a Betawipe™ swab.
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Figure 4.10. Image taken on Raman microscope of the surface of the Betawipe™
swab (x10).
The image above taken using the Raman microscope revealed a filamentous
appearance for the Betawipe™ swab. The Raman spectrum in Figure 4.9 was
acquired by focusing the laser spot on the point indicated by the arrow in Figure 4.10.
Alphawipe™
Alphawipe was made from polyester and a similar Raman spectrum to that acquired
for Absorbond™ and Technicloth™ which also contain polyester was acquired. The
two peaks at 1612 and 1725 cm-1 were particularly apparent.
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Figure 4.11. Raman spectrum for the surface of an Alphawipe™ swab.
Figure 4.12. Image taken on Raman microscope of the surface of the Alphawipe™
swab (x10).
Alphawipe™ had a bundled appearance under the Raman microscope and the Raman
spectra above was acquired by focusing the laser onto the spot indicated by the arrow.
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Super Polx 1200
Super Polx 1200™ was made from polyester and the spectrum was the same as those
acquired from Absorbond™, Technicloth™ and Alphawipe™ which were all
polyester containing swabs. Again, the two peaks at 1612 and 1725 cm-1 were
particularly apparent.
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Figure 4.13. Raman spectrum for the surface of a Super Polx 1200™ swab.
Super Polx 1200™ was made from polyester and the spectrum was the same as those
acquired from Absorbond™, Technicloth™ and Alphawipe™ which were all
polyester containing swabs. Again, the two peaks at 1612 and 1725 cm-1 were
particularly apparent.
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Figure 4.14. Image taken on Raman microscope of the surface of the Super Polx
1200 swab (x10).
Super Polx™ was found to be similar to Alphawipe™ under the Raman microscope
because it had a bundled appearance and spectroscopically because it is constructed
from polyester. The Raman spectrum for Super Polx 1200™ was acquired by
focusing the laser onto the spot indicated by the arrow.
Summary of swab spectra
Absorbond™, Technicloth™, Alphawipe™, Super Polx™ and Texwipe™ all had
extremely similar Raman spectra. The main characteristic peaks were found at 1612
and 1725 cm-1 and these were due to a carbonyl group, with one of the bands resulting
from an asymmetric combination These swabs were made from polyester,
polyester/cellulose or cotton. A well defined chemical structure for the swabs from
the proprietary companies was lacking but significant amounts of similarity in the
Raman spectra for these five swabs was apparent.
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MiracleWipe™ was made from nylon and had a markedly different Raman spectrum
from the swabs just discussed. Again nylon is only a general description because
there are a number of variants of nylon but the peak at 1633 cm-1 is due to a carbonyl
group. Increased activity in the C-H region was observed compared to the five swabs
previously mentioned.
Betawipe™ was made from polypropylene and had a Raman spectrum different from
that of the swabs previously mentioned. There was increased activity in the 2750 –
3250 cm-1 range. The polymer polypropylene contains a number of C-H, CH2 and
methyl groups which gave rise to the total of six peaks found between 2840 and 2925
cm-1.
These investigations revealed that the swabs all had well defined Raman spectra. The
information gained in this section can be used to distinguish between peaks due to
contamination and peaks originating from the swab itself. No one particular swab
was less active with Raman spectroscopy and therefore no particular swab could be
labelled as useful for looking for signs of contamination because of its minimal
Raman contribution.
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Sampling from the swab surface.
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Figure 4.15. Two Raman spectra from different areas of the same Texwipe™ swab.
Blue – fibre from top ofswab. Pink – fibre within swab.
Figure 4.15 shows how the area sampled can have an effect on the intensity of signal
and resolution of peaks. These two spectra were from the same swab but different
fibres. The blue spectrum was taken from an individual fibre onto which the laser
spot could be easily focused. The pink spectrum was from a less prominent fibre,
partially obscured by others and less able to be covered by the laser spot. Surface
detail and the actual spot sampled can have an effect on the quality of the spectrum
acquired.
From experiments carried out in the previous section it became apparent that a Raman
spectrum with good peak amplitude and a favourable signal to noise ratio was more
easily acquired from a swab of filamentous appearance under the microscope than
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from a swab of bundled appearance. Texwipe™, Absorbond™, Technicloth™ and
Betawipe™ produced more consistent Raman spectra with good peak amplitude and a
favourable signal to noise ratio.
4.3.2 Raman spectra from contaminated swabs
Swabs were contaminated with acetaminophen, ibuprofen and diclofenac at a
theoretical level of 111 µg/cm2 by wiping a contaminated stainless steel surface as
outlined in the Materials and Methods section before analysis by Raman microscope.
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Figure 4.16. Raman spectrum from a Texwipe™ used to clean a stainless steel
surface contaminated to 111.1 µg/cm2 of acetaminophen.
Figure 4.16 shows the spectrum of acetaminophen absorbed onto a Texwipe™ swab.
The spectrum showed none of the characteristic peaks associated with the Texwipe™
swab and compared well to a reference spectrum for acetaminophen.
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Figure 4.17. Raman spectrum from a Texwipe™ used to clean a stainless steel
surface contaminated to 111.1 µg/cm2 of ibuprofen.
Similarly, when contaminated with ibuprofen, the spectrum showed none of the
characteristic peaks associated with the Texwipe™ swab and compared well to a
reference spectrum for ibuprofen.
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Figure 4.18. Raman spectrum from a Texwipe™ used to clean a stainless steel surface
contaminated to 111.1 µg/cm2 of diclofenac.
The spectrum presented in figure 4.18 showed none of the characteristic peaks
associated with the Texwipe™ swab and compared well to a reference spectrum for
diclofenac.
Figures 4.16, 4.17 and 4.18 showed that it was possible to non-destructively sample
the swab surface for signs of contamination. A large number of attempts were made
to detect contamination and therefore the levels of sensitivity required improvement
so that detection can take place at levels encountered during cleaning verification.
4.3.3 SERS
As pointed out in the introductory section of this thesis, SERS is a very sensitive
technique and if successfully applied enables the detection of residues at low
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concentrations. Here the initial aim was to detect contamination from the surface of
the swab itself.
SERS with gold colloid
Figure 4.19. Aggregated gold colloid on a microscope slide. A 5 µl drop of a mixture
of colloid, compound and 3% NaCl solution was pipetted onto the microscope slide
and allowed to evaporate dry before examination under the Raman microscope.
Acetaminophen was initially tested and the spectrum as shown in Figure 4.20 was
characteristic of acetaminophen and the result of surface enhancement because no
signal could be detected from a 5 µl drop of 0.1 mg/ml solution of acetaminophen left
to evaporate dry on a glass microscope slide.
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Figure 4.20. Raman spectra for a 0.1 mg/ml acetaminophen solution investigated
with the 5 µl drop method. The pink line represents the 20 nm colloid and the blue
line represents 5 nm colloidal particles.
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Figure 4.21. Raman spectra for a 0.1 mg/ml diclofenac solution investigated with the
5 µl drop method. The pink line represents the 20 nm colloid and the blue line
represents 5 nm colloidal particles.
The pink spectrum representing 20 nm colloidal particles showed none of the
characteristic peaks for diclofenac. The blue spectrum representing 5 nm colloidal
particles showed the characteristic spectrum of diclofenac. The spectrum is a result of
a surface enhancement and the presence of gold colloid because nothing was
detectable from a 5 µl drop of 0.1 mg/ml diclofenac left to evaporate dry on a glass
microscope slide.
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Figure 4.22. Raman spectra for a 0.1 mg/ml trichloroacetic acid solution investigated with
the 5 µl drop method. The pink line represents the 20 nm colloid and the blue line represents
5 nm colloidal particles.
Both spectra showed some of the characteristic peaks for trichloroacetic acid. Neither
are spectrally complete but the spectrum obtained with 5 nm colloidal particles
showed a greater number of characteristic peaks and greater enhancement of signal.
146
0
200
400
600
800
1000
1200
1400
1600
1800
2000
250 750 1250 1750 2250 2750
Raman Shift cm-1
In
te
ns
ity
Figure 4.23 Raman spectra for acetaminophen powder (pink) and 0.1 mg/ml
acetaminophen solution and 5 nm gold colloidal particles added as 5µl of solution
(blue).
Figure 4.23 shows the enhancement of signal for a 5 µl drop of 0.1 mg/ml
acetaminophen and 5 nm gold colloidal particles relative to the spectrum of
acetaminophen powder on a glass slide. The enhancement of signal was powerful and
showed that with the 5 µl drop method a SERS spectrum can be obtained for a low
concentration acetaminophen solution allowed to evaporate dry.
SERS with liquid samples
SERS with liquid samples would be advantageous because it would allow the probing
of extract from the swabs. The Raman microscope had a liquid sampling accessory
which worked in conjunction with a 1 ml cuvette. Solutions containing analyte, gold
colloid and 3 % NaCl were pipetted into the cuvette and then analysed on the machine.
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Figure 4.24. Raman spectra for 0.1 mg/ml nicotinic acid mixed with 5 nm gold
colloidal particles and 3% NaCl solution (blue), 0.1 mg/ml nicotinic acid mixed with
20 nm gold colloidal particles and 3% NaCl solution (pink) and 0.1 mg/ml nicotinic
acid solution (red).
Figure 4.24 showed that SERS was achievable from liquid samples in our
measurements as characteristic peaks for nicotinic acid in solutions containing both 5
nm and 20 nm gold colloidal particles were seen. A signal for nicotinic acid could not
be collected from a 0.1 mg/ml solution lacking gold colloid and therefore it was
concluded that the presence of gold colloid was responsible for the production of
signal. Whilst SERS was achievable with nicotinic acid it was not achievable for any
of the other compounds tested and this meant that liquid sampling was unsuitable for
cleaning verification work because one crucial aspect is generic capability. The
technology must be capable of detecting a number of different types of molecules
without too much method optimisation for each compound.
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4.3.4 SERS on gold colloid impregnated swabs
Impregnation of the swab with gold colloid significantly increased the magnitude of
the Raman spectrum. An enhancement of signal was detected for all swabs as shown
in Figures 4.25 – 4.30.
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Figure 4.25. Raman spectrum from an Absorbond™ swab (blue) and from an
Absorbond™ swab impregnated with gold colloid (pink).
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Figure 4.26. Raman spectrum from a MiracleWipe™ swab (blue) and from a
MiracleWipe™ swab impregnated with gold colloid (pink).
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Figure 4.27. Raman spectrum from a Technicloth™ swab (blue) and from a
Technicloth™ swab impregnated with gold colloid (pink0.
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Figure 4.28. Raman spectrum from a Betawipe™ swab (blue) and from a Betawipe™
swab impregnated with gold colloid (pink).
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Figure 4.29. Raman spectrum from an Alphawipe™ swab (blue) and from an
Alphawipe™ swab impregnated with gold colloid (pink).
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Figure 4.30. Raman spectrum from a Super Polx 1200™ swab (blue) and from a
Super Polx 1200™ swab impregnated with gold colloid (pink).
This section showed that it was possible to enhance the Raman spectrum of the swab
by impregnating the swab fibres with gold colloid.
4.3.5 SERS on contaminated gold impregnated swabs
This section presents results where gold colloid impregnated swabs were used in an
attempt to identify contamination on a stainless steel surface. Figure 4.31 showed an
enhanced spectrum from an uncontaminated gold colloid impregnated swab and a
spectrum from a gold colloid impregnated swab contaminated with citric acid. Good
amplitude in the peaks from the citric acid contaminated swab was seen. A difference
in spectrum from the uncontaminated swab was seen and showed contamination was
apparent.
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Figure 4.31 Raman spectra from a gold impregnated Texwipe™ swab (blue) and a
Texwipe™ swab used to wipe a surface contaminated with citric acid at 111.1 µg/cm2(pink).
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Figure 4.32. Raman spectra from a gold colloid impregnated swab used to wipe a
stainless steel surface contaminated with citric acid at 111.1 µg/cm2 (blue) and a swab
used to wipe a stainless steel surface contaminated with citric acid at 111.1 µg/cm2.
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Figure 4.32 shows that a spectrum for citric acid can be enhanced by using a swab
impregnated with gold colloid. The spectrum from the gold colloid impregnated swab
has greater amplitude in its peaks.
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Figure 4.33. Raman spectra from a gold impregnated Betawipe™ swab used to wipe
a stainless steel surface contaminated with citric acid at 111.1 µg/cm2.
Figure 4.33 contained characteristic peaks for citric acid and showed that it was possible to
detect contamination in this case. Similar results were obtained with other swabs
impregnated with gold colloid (Figures 4.34 & 4.35)
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Figure 4.34. Raman spectra from a gold impregnated Alphawipe™ swab used to
wipe a stainless steel surface contaminated with citric acid at 111.1 µg/cm2.
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Figure 4.35. Raman spectra from a gold colloid impregnated swab used to wipe a
stainless steel surface contaminated with nicotinic acid at 111.1 µg/cm 2 (blue) and a
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swab used to wipe a 900 cm2 stainless steel surface contaminated with nicotinic acid
at 111.1 µg/cm 2 (pink).
Thus far, the results in this section have shown a minority of instances where it was
possible to visualise contamination on a swab used to wipe a contaminated stainless
steel surface. A large number of attempts were made to detect contamination and the
results presented in this section represent a few positive examples from many attempts
where good Raman spectra were collected. It can be concluded that the
heterogeneous nature of the swab creates a problem when trying to collect a Raman
spectrum indicative of contamination. The remainder of this section presents some
images taken on the Raman microscope that further illustrate the point about sampling
difficulties.
Figure 4.36. An image from a Texwipe™ swab used to wipe a stainless steel surface
contaminated with nicotinic acid at 111.1 µg/cm 2. The area in the middle pointed to
by the arrow was a deposit of nicotinic acid that had formed on the swab post wiping.
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A Raman spectrum for nicotinic acid can be acquired very easily by focusing the laser
onto the deposit.
Figure 4.37. An image from a Texwipe™ swab (x50) used to wipe a stainless steel
surface contaminated with nicotinic acid at 111.1 µg/cm 2. The pink dot in the centre
of the fibre is the laser spot with the filter set to 0.001%. To the left of the laser spot
is an area indicated by an arrow. This is another deposit of nicotinic acid and a
Raman spectrum for the compound can be acquired in this case by turning the laser
filter off and then taking a spectrum.
Whilst some enhancements of signal were seen from gold colloid impregnated swabs
the frequency with which contamination was detected did not improve. This was
mainly due to the heterogeneous nature of the swab and the need to encounter visible
deposits of compound. Impregnating the swab with gold colloid was found not to be
a feasible method for achieving a SERS signal from swabs.
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Figure 4.38. An image taken of a gold colloid impregnated Texwipe™ swab (x10).
The area indicated by the arrow in the centre of the image is an aggregation of gold
particles. There are other smaller clusters of gold aggregate in the image. SERS
spectra are obtained from these swabs by focusing the laser on areas containing
aggregated gold particles.
4.3.6 Sputter coated swabs
In an attempt to improve the homogeneity of the swab surfaces, sputter coating with
gold was carried out. The sputter coated swabs were then used to wipe contaminated
surfaces.
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Figure 4.39. An image of a sputter coated Texwipe™ swab (x50). The swab was
completely covered in gold meaning that only a certain number of fibres were able to
be visualised underneath the gold coating.
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Figure 4.40. Raman spectra from a sputter coated swab used to wipe a surface
contaminated with acetaminophen. The spectrum had a high baseline and two broad
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unresolved peaks. The spectrum showed fluorescence because of the high amount of
gold coverage on the swab surface. In response to this finding the gold coating was
reduced by altering the deposition time of the sputter coater from forty seconds to
twenty seconds to produce a partially coated swab.
Figure 4.41. An image of a fibre from a partially sputter coated Texwipe™ swab
(x50). Raman spectra were taken from the points indicated by arrows A and B.
Figures 4.41 and 4.42 showed how the deposition of gold affects the ability to
enhance the spectrum from the swab. A partial coating produced a significant
enhancement of signal and this was probably due to the fact that gold and fibre are
present under the laser spot.
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Figure 4.42. Raman spectra from an uncoated section of a Texwipe™ fibre (blue)
corresponding to arrow A in the previous figure and from a section of Texwipe™
fibre partially sputter coated in gold (pink) corresponding to arrow B in the previous
figure.
Completely sputter coated swabs produced a Raman spectrum high in background
fluorescence as shown by figure 4.40 and it was not possible to enhance the
background at all in the completely covered swabs or resolve any sign of
contamination from swabs used to wipe a contaminated stainless steel surface. Whilst
the partially coated swabs produced a significant enhancement of the swab signal it
was not possible to detect contamination after wiping a contaminated steel surface.
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4.3.7 SERS with nanofabricated substrates from the University of Michigan
SERS spectroscopy was carried out with two different solid substrates. One substrate
was received as a gift from Dr Jin-Sung Kim at the University of Michigan and one
substrate was purchased from Mesophotonics Ltd and is known as Klarite™.
The substrates provided by Dr Jin-Sung Kim fell into four categories. There were
diamond and square substrates where the gold patterning on the surface was either
arranged in a square shape or in a diamond shape and there were lift off and non lift
off samples. The non lift off samples were composed of a glass layer, a polymer layer
and the gold patterning on top and in the lift off sample the polymer layer had been
dissolved away to leave the gold patterning on top of the glass layer (see appendix 1).
Figure 4.43. Image of the square non lift off substrate (x50). Some patterning or
surface roughness was slightly apparent at this magnification.
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Figure 4.44. Raman spectra from the four SERS substrates after pipetting 5µl of
acetaminophen at 100 ppm and allowing to evaporate dry.
It was not possible to detect contamination by acetaminophen diclofenac, ibuprofen
and nicotinic acid with any of the substrates (Figures 4.44-4.47). The characteristic
peaks in the diamond and square lift off samples (yellow and blue spectra) were from
the polymer layer between the glass layer and the gold patterning. The non lift off
samples gave a broad unresolved spectrum that did not present any evidence for the
presence of compound.
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Figure 4.45. Raman spectra from the four SERS substrates after dropping 5µl of
diclofenac at 100 ppm and allowing to evaporate dry.
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Figure 4.46. Raman spectra from the four SERS substrates after dropping 5µl of
ibuprofen at 100 ppm and allowing to evaporate dry.
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Figure 4.47. Raman spectra from the four SERS substrates after dropping 5µl of
nicotinic acid at 100 ppm and allowing to evaporate dry.
The substrates were ineffective in providing an enhancement of signal for the
compound of interest introduced onto their surface. No spectra were collected that
revealed the presence of compound of interest and the only spectral information was
found from non lift off samples where the presence of the polymer between the glass
layer and gold patterning was detected.
4.3.8 Klarite™ substrates
Klarite™ substrates are a commercially available SERS substrate. They povide a
regular and consistent enhcancement of the SERS signal. To date they have been
used for the detection of low levels of particular analytes. In this study they will be
used as potential substrates for analysis of cleaning verification samples.
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Figure 4.48. Images of the Klarite™ substrate at three different magnifications.
Substrate at x10 showing the plain gold border around the SERS area (right), SERS
area at x50 magnification (middle) and SERS area at x100 magnification (left).
Acetaminophen
Testing was carried out with solutions of acetaminophen.
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Klarite - Acetaminophen 1000 ppm
Acetaminophen powder
Figure 4.49. Raman spectrum from a dried 5 µl drop of acetaminophen at 1000 ppm
taken from the surface of a Klarite™ slide (blue) and neat acetaminophen powder
(pink).
x 10 x 50 x 100
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The peaks from acetaminophen on the Klarite™ substrate had an extremely high
amplitude and the spectrum showed significant enhancement of signal at 1000, 100,
10 and even 1 ppm levels (Figures 4.49 – 4.52).
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Klarite - Acetaminophen 100 ppm
Acetaminophen powder
Figure 4.50. Raman spectrum from a dried 5 µl drop of acetaminophen at 100 ppm
taken from the surface of a Klarite™ slide (blue) and neat acetaminophen powder
(pink).
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Klarite - Acetaminophen 10 ppm
Acetaminophen powder
Figure 4.51. Raman spectrum from a dried 5 µl drop of acetaminophen at 10 ppm
taken from the surface of a Klarite™ slide (blue) and neat acetaminophen powder
(pink).
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Klarite - Acetaminophen 1 ppm
Acetaminophen powder
Figure 4.52. Raman spectrum from a dried 5 µl drop of acetaminophen at 1 ppm
taken from the surface of a Klarite™ slide (blue) and neat acetaminophen powder
(pink).
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Further loss of characteristic peaks and amplitude had taken place at 1 ppm but the
spectrum still identified acetaminophen as past of a sequence of decreasingly
concentrated samples.
Ibuprofen
Similar results to those seen with acetaminophen were obtained for ibuprofen
(Figures 4.53-4.56)
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Klarite - Ibuprofen 1000 ppm
Ibuprofen powder
Figure 4.53. Raman spectrum from a dried 5 µl drop of ibuprofen at 1000 ppm taken
from the surface of a Klarite™ slide (blue) and neat ibuprofen powder (pink).
The peaks from ibuprofen on the Klarite™ substrate had an extremely high amplitude
and the spectrum showed significant enhancement of signal at 1000, 100 and 10 ppm
levels.
169
0
500
1000
1500
2000
2500
3000
3500
4000
400 600 800 1000 1200 1400 1600 1800
Raman Shift cm-1
In
te
sn
tiy
Klarite -Ibuprofen 100 ppm
Ibuprofen powder
Figure 4.54. Raman spectrum from a dried 5 µl drop of ibuprofen at 100 ppm taken
from the surface of a Klarite™ slide (blue) and neat ibuprofen powder (pink).
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Klarite - Ibuprofen 10 ppm
Ibuprofen powder
Figure 4.55. Raman spectrum from a dried 5 µl drop of ibuprofen at 10 ppm taken
from the surface of a Klarite™ slide (blue) and neat ibuprofen powder (pink).
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Four characteristic peaks remained (circled) but definition of those characteristic
peaks was greatly reduced for ibuprofen at 10 ppm. A SERS spectrum for ibuprofen
was achieved but the point was reached where identification of the sample from this
one spectrum alone was not possible.
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Figure 4.56. Raman spectrum from a dried 5 µl drop of ibuprofen at 10 ppm taken
from the surface of a Klarite™ slide (blue) and neat ibuprofen powder (pink).
This spectrum had broad and poorly resolved peaks and taken in isolation would not
be identifiable as ibuprofen. The identification of ibuprofen at 1 ppm was not
possible.
Diclofenac
Similar results to those obtained for acetaminophen and ibuprofen were obtained for
diclofenac (Figures 4.57-4.59)
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Figure 4.57. Raman spectrum from a dried 5 µl drop of diclofenac at 100 ppm taken
from the surface of a Klarite™ slide (blue) and neat diclofenac powder (pink).
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Figure 4.58. Raman spectrum from a dried 5 µl drop of diclofenac at 10 ppm taken
from the surface of a Klarite™ slide (blue) and neat diclofenac powder (pink).
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Figure 4.59. Raman spectrum from a dried 5 µl drop of diclofenac at 1 ppm taken
from the surface of a Klarite™ slide (blue) and neat diclofenac powder (pink).
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The peaks from diclofenac on the Klarite™ substrate had an extremely high
amplitude and the spectrum showed significant enhancement of signal at 100, 10 and
1 ppm levels. The spectrum for 10 ppm levels (Figure 4.58) had a poorer signal to
noise ratio that had been seen with other spectra originating from the Klarite™
substrate but diclofenac was still easily identifiable on the basis of its characteristic
peaks. The spectrum for 1 ppm (Figure 4.59) had an especially poor signal to noise
ratio and but for the presence of two poorly resolved peaks (circled) the compound
would be unidentifiable as diclofenac.
Klarite™ slides showed regular and consistent enhancements of signal and the Raman
spectra presented in this section were taken instantly after sample had dried. Repeats
were done to confirm the presence of the compound and ensure the reproducibility of
the result but the most impressive aspect of the Klarite™ substrate alongside the
magnitude of the signal enhancement was the consistency.
4.3.9 SERS spectra of other compounds with Klarite™ substrates.
To evaluate the generic nature of the Klarite™ substrates Raman spectra were
collected for other compounds.
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Figure 4.60. Raman spectra of nicotinic acid on a Klarite™ substrate at 100 ppm
(blue) and at 10 ppm (pink).
The spectra were characteristic of nicotinic acid and therefore it was possible to detect
the compound at 100 and 10 ppm.
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Figure 4.61. Raman spectra of maleic acid on a Klarite™ substrate at 100 ppm (blue)
and at 10 ppm (pink).
The spectra at 100 ppm were extremely characteristic of maleic acid, the spectra of 10
ppm is less so with one characteristic peak remaining (arrow).
176
0
500
1000
1500
2000
2500
400 600 800 1000 1200 1400 1600 1800 2000
Raman Shift cm-1
In
te
ns
ity
100 ppm
10 ppm
Figure 4.62. Raman spectra of thiamine on a Klarite™ substrate at 100 ppm (blue)
and at 10 ppm (pink).
The spectra were characteristic of thiamine and therefore it was possible to detect the
compound at 100 and 10 ppm.
4.3.10 Simulation of cleaning verification by SERS with Klarite™ slides
Having shown the Klarite™ slide capable of providing characteristic spectra at
concentrations of compound that mimic those encountered in cleaning verification it
was decided to simulate the cleaning process. This was done by contaminating a
stainless steel surface with a known amount of compound and then analysing the
extract from the swab. The swabs were moistened with solvent prior to wiping of the
surface. Once the surface had been wiped, the swab was folded into quarters and then
5 µl of the solvent was extracted by pipette and subsequently dropped onto the
Klarite™ substrate.
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Figure 4.63. Raman spectra for acetaminophen recovered with a Technicloth™ swab
from a contaminated steel surface. The surface was contaminated at three different
levels: 111.1 ng/cm2, 11.1 ng/cm2 and 1.1 ng/cm2.
The first experiment was performed with acetaminophen (see Figure 4.63). The
spectra in this figure showed that it was possible to detect acetaminophen over
concentrations relevant to cleaning verification. With highly potent pharmaceutical
compounds it is desirable to detect at 5 ng/cm2 and with acetaminophen it was
possible to detect at 1.1 ng/cm2. The spectra lose resolution as the amount of drug
present on the steel surface reduces but with acetaminophen, some of the
characteristic peaks were arguable at the lowest level of contamination used in the
study.
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Figure 4.64. Raman spectra for ibuprofen recovered with a Technicloth™ swab from
a contaminated steel surface. The surface was contaminated at three different levels:
111.1 ng/cm2, 11.1 ng/cm2 and 1.1 ng/cm2.
Figure 4.64 shows contamination of the surface by ibuprofen. The spectra were less
well resolved than those presented earlier for ibuprofen but some of the characteristic
peaks remain meaning that the compound was identifiable.
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Figure 4.65. Raman spectra for diclofenac recovered with a Technicloth™ swab from
a contaminated steel surface. The surface was contaminated at three different levels:
111.1 ng/cm2, 11.1 ng/cm2 and 1.1 ng/cm2.
The spectra fpr diclofenac in Figure 4.65 are less well resolved than the two presented
in this section for acetaminophen and ibuprofen. The experiments with diclofenac
and Klarite™ substrates in the previous section showed that diclofenac was not as
easily detectable as acetaminophen and ibuprofen. In figure 4.65 very few
characteristic peaks remain and those that do are broad and unresolved. The
compound is identifiable at 111.1 ng/cm2 by the presence of two peaks just after 1600
nm. These peaks remain in the other two spectra but for diclofenac at 1.1 ng.cm2 the
peak is very broad.
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4.3.11 Summary of results chapter
The series of experiments that make up this chapter are summarised below in a
diagram which depicts the order of experiments and direction taken during the study.
Figure 4.66. Schematic representation of the experimentation carried out for this
chapter.
Raman of swabs
Clear distinct spectra were
acquired for the swabs
themselves.
Raman on swabs used to wipe contaminated
surfaces.
Very few successful detections from over 50 attempts. Level at which detection of
contamination was made was too high for cleaning verification. Demonstrated that
SERS had potential for non destructive sampling from the swab and so the
creation of a SERS swab was attempted.
SERS
Gold colloid impregnated swabs
4 successful detections from over 400 attempts – too
few
Gold colloid enhanced the swab spectrum
Swab proved too heterogeneous for reliable
enhancement of signal
Sputter coated swabs
An attempt to increase homogeneity of the swab
surface. Complete sputter coating produced
spectrum containing background fluorescence.
Partial sputter coating significantly and reproducibly
enhanced the swab signal but in 50 attempts no
evidence of contamination was found.
Liquid samples
8 compounds were tested and
only SERS spectrum
obtained was for nicotinic acid.
Solid substrates
Lift off and non
lift off substrates
Only characteristic spectra
obtained in 32
attempts were for polymeric
layer between glass layer
and gold patterning.
No contamination detected
Klarite™
Showed reproducible
SERS properties at levels
relevant to cleaning
verification.
Proof of concept that SERS
can be applied to cleaning
verificationSwab worked stopped and others SERS
approaches investigated
SERS
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4.4 Discussion
Absorbond™, Technicloth™, Alphawipe™, Super Polx™ and Texwipe™ all showed
highly similar Raman spectra. These swabs were composed of polyester, cellulose
and cotton. MiracleWipe™ displayed a different Raman spectrum and is made from
nylon. Betawipe™ also had a different Raman spectrum and is made from
polypropylene. The swabs all showed significant numbers of distinct Raman peaks.
An aim of these experiments was to compare swab spectra to see if any were less
active because the presence of fewer interfering peaks might result in it being easier to
discriminate peaks owing to contamination. All seven swabs showed significant
activity in conjunction with Raman spectroscopy and therefore no swab could be
identified as particularly useful but the spectra were highly reproducible and the major
peaks identified and noted for the use in the rest of the study.
Beneath the Raman microscope all of the swabs had significant depth and therefore
different fibres could be focused upon to obtain a characteristic Raman spectrum.
Focusing the laser spot onto individual fibres produced clearer Raman spectra with a
higher intensity and a more favourable signal to noise ratio. The surface
heterogeneity of the swabs meant that poor quality Raman spectra for the swabs could
also be obtained. The act of sampling proved critical in determining the quality of the
Raman spectrum produced.
Raman spectra for contamination could be seen when the swab was used to wipe a
surface contaminated at a level of 111.1 µg/cm2. The problem is one of sensitivity
with Raman spectroscopy not being a sensitive enough technique to determine the
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presence of contaminating residues in actual cleaning verification work. The spectra
and images presented in the section on Raman spectra from contaminated swabs
represented a few positive spectra from many attempts. The images of residue in
close proximity to swab fibres were found rarely and therefore the process of
detecting contamination from swabs by Raman spectroscopy is an incredibly
inefficient process. To progress the idea of measuring contamination by directly
probing the swab it was necessary to improve the sensitivity of the system and this
was carried out by investigating SERS.
Initially it was necessary to prove that SERS was achievable for a range of drugs and
substrates. This was done by using mixtures containing gold colloid, drug and NaCl
solution. The drops were placed on a microscope slide and allowed to evaporate dry.
Once dry, the remaining residue was probed under the microscope and Raman spectra
taken. An enhancement of signal was found to be the case and with the 5 µl method,
SERS spectra for nicotinic acid, trichloroacetic acid, diclofenac and acetaminophen
were collected. All spectra showed clear characteristic peaks for the compounds of
interest and compared well to reference spectra. Gold colloidal particles of mean
diameter 5 nm and 20 nm were used and it was found that the aggregates of 5 nm
particles tended to perform better. Figure 4.23 which presented a SERS spectrum for
acetaminophen showed a particularly impressive enhancement of signal.
SERS was also carried out on liquid samples in order to see if it was possible to
acquire characteristic spectra for low levels of compound in solution. It was possible
to obtain a SERS spectra for nicotinic acid when in solution with aggregated gold
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colloid but the result came about through large amounts of experimentation. Several
other compounds were also tested but without success.
Having demonstrated that a surface enhancement of signal was possible as a result of
having gold colloid present, the swabs were impregnated with aggregates of gold
colloid. The spectra from gold impregnated swabs were all much stronger with higher
intensities than the spectra of ordinary swabs. Some swabs showed greater levels of
signal enhancement than others but the experiments showed that it was possible to
consistently enhance the spectrum of the swab by introducing aggregates of gold
colloid amongst the swab fibres.
With this information in mind, testing was carried out by swabbing a contaminated
surface and then examining under the Raman microscope for contamination.
Contamination was detected on three swabs but modest enhancements of signal were
seen with the Texwipe™, Betawipe™ and Alphawipe™. A significant enhancement
of signal was seen for nicotinic acid on a gold colloid impregnated Texwipe™. Again,
one of the main problems encountered was due to sampling. Many spectra were taken
in order to obtain the results presented and the overwhelming majority were
characteristic for the swab rather than residue of the contaminating species. The
heterogeneous nature of the swab in combination with the relatively small amount of
residue present and the diffuse nature of colloidal aggregates throughout the swab
meant that the system was not suitable to reveal contamination in the desired manner.
It was concluded that by increasing the homogeneity of the swab surfaces it might
proven easier to detect contamination.
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In an attempt to add homogeneity to the system, the swabs were sputter coated with
gold. The rationale behind this approach was the heterogeneous nature of the swab in
combination with the complete gold coverage offered by the sputter coating system
might offer more suitable conditions from which to gain a reproducible SERS signal
from the swab. Initial experimentation with completely sputter coated swabs was
unsuccessful because the only spectra attainable contained significant levels of
background fluorescence through which none or very few peaks were resolvable. It
was concluded that the fluorescence was due to the thick gold coating. A partial
sputter coating of the swab was then tested and this was carried out by altering the
deposition time of the sputter coater so that gold coverage of the surface would be
incomplete. Testing with partially coated fibres showed that an enhancement of
signal could be achieved if the correct area of the swab was sampled from. The
enhancement of signal was significant and provided convincing evidence that a
significant surface enhancement of signal from the swab surface was possible with
sputter coating. However, after wiping contaminated surfaces with partially sputter
coated swabs, it was not possible to produce any spectra indicative of contamination
on the swab.
At this point it was decided to change the focus of the study away from the swab
because experimentation had shown it too heterogeneous on the microscopic scale to
produce consistent and significant enhancement of signal. A significant enhancement
of signal indicative of contamination was seen rarely throughout the experiments
previously discussed and this was not the ideal basis for a technique aimed for
industrial application, particularly a process where a wide range of drug compounds
would require detection. A generic system was required and the results obtained from
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experiments designed to produce a SERS swab showed that obtaining a SERS
spectrum for the compound of interest was too time consuming a process.
The focus of the study was switched from the swab to solid SERS substrates.
Substrates were provided as a gift from a lab at the University of Michigan and
Klarite™ substrates were purchased from Mesophotonics Ltd.
The substrates from the lab at the University of Michigan were unsuccessful in
revealing contamination. A 5 µl drop of drug in solution was pipetted onto the
surface and allowed to evaporate dry before investigation under the Raman
microscope. Acetaminophen, ibuprofen, diclofenac and nicotinic acid were tested and
it was not possible to detect any contamination because no characteristic spectra were
obtained.
The substrates were classified as either lift off or non lift off. A lift off sample
contained the gold patterning on a glass substrate and the non lift off substrates had a
layer of polymer between the glass and gold patterning. It was possible to detect
peaks characteristic of the polymer in the non lift off samples where as the lift off
samples produced broad unresolved spectra.
5 µl of solution containing compound of interest was pipetted onto a Klarite™
substrate. Acetaminophen showed excellent enhancement of signal and very strong
SERS spectra were detected for the compound at concentrations of 1000 ppm, 100
ppm and 10 ppm. Characteristic peaks for the compound were also present at 1 ppm
and the compound was identifiable. Identification of acetaminophen on the basis of
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the 1 ppm spectrum alone would have been difficult but in sequence with the other
spectra it was identifiable. All the spectra had good amplitude of peaks and a good
signal to noise ratio. SERS spectra were collected for ibuprofen at concentrations of
1000 ppm, 100 ppm and 10 ppm. Identification of the compound was possible and
the spectra showed good amplitude of peaks and good signal to noise ratio. SERS
spectra were also collected for diclofenac at concentrations of 100 ppm, 10 ppm and 1
ppm. Again the compound was easily identifiable at 100 and 10 ppm but at 1 ppm
two characteristic peaks remained meaning identification was possible but the
unfavourable signal to noise ratio meant the peaks were poorly resolved.
As mentioned previously, experiments were carried out by dropping a 5 µl drop onto
the Klarite™ surface and allowing it to dry prior to inspection under the Raman
microscope. The crucial difference between the results presented for the Klarite™
substrates and other substrates and methods used in an attempt to produce SERS
spectra in this study was that the spectra presented from Klarite™ were the result of
one collection. The Klarite™ substrate had proven to be a highly consistent enhancer
of Raman signal and therefore was useful for demonstrating the potential of SERS for
analysis of cleaning verification samples.
SERS spectra were also obtained at 100 ppm and 10 ppm for thiamine, maleic acid
and nicotinic acid and this showed the generic nature of the Klarite™ substrate as a
signal enhancer. Generic capability is a well known problem with many SERS
substrates with some not working for particular compounds. The Klarite™ substrates
provided a reliable and quick enhancement of signal compared to the other SERS
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strategies employed in the study were large amounts of time were invested to obtain a
small number of spectra indicative of contamination.
By contaminating a surface, wiping with a swab, extracting 5 µl of solution from that
swab, depositing on the Klarite™ surface and then analysing, it was possible to detect
acetaminophen, ibuprofen and diclofenac at levels of contamination relevant to
cleaning verification. Acetaminophen and ibuprofen could be identified by eye at
111.1 ng/cm 2 and evidence of contamination was visible for the two compounds at
11.1 ng/cm2 and 1.1 ng/cm2 . An often quoted worst case scenario for cleaning
verification work is 5 ng/cm2. In this study it was possible to detect at levels close to
that and so the potential of SERS for cleaning verification was therefore demonstrated.
To take this work further and definitively prove the capability of SERS with well
defined detection limits for compounds it will be necessary to employ chemometric
techniques.
Some basic chemometric analysis was performed on the data produced from Klarite™
slides and swabs used to wipe a contaminated surface. The Savitzky-Golav
smoothing filter was applied to smooth spectra and principal component analysis
(PCA) was carried out on the data from acetaminophen and ibuprofen to see if spectra
from the two drugs could be differentiated.
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Figure 4.67. Raman spectra for 5µl extracts from swabs used to wipe a surface
contaminated with acetaminophen at 111.1 ng.cm2, 11.1 ng/cm2 and 1.1 ng/cm2.
Figure 4.68. Raman spectra smoothed with the Savitzky-Golav smoothing filter for
5µl extracts from swabs used to wipe a surface contaminated with acetaminophen at
111.1 ng.cm2, 11.1 ng/cm2 and 1.1 ng/cm2.
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Figure 4.69 shows how samples of acetaminophen (A – green circle) can be
differentiated from ibuprofen (B – red circle).
Figure 4.69. Three dimensional plot of PCA scores from SERS spectra of
acetaminophen and ibuprofen recovered from a stainless steel surface.
The results presented in this chapter are novel in terms of the application of SERS for
cleaning verification work. The idea of detecting contamination directly from the
swab represents an elegant solution to the problem of cleaning verification but the
attempts made to modify the swab in order for it to produce a SERS signal revealing
of contamination were unsuccessful. Current technologies such as infrared and near
infrared which spectroscopically probe a surface have been shown to be quite
effective on flat surfaces. Curved surfaces, depressions and pipes are much more
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difficult to sample from. By analysing the swab it is possible to detect contamination
from all points of the equipment train. The results presented in this chapter showed
that it was possible to enhance the Raman signal from a swab and in some instances
detect contamination. Unfortunately, the detection of contamination occurred too
infrequently to form the basis of an industrial process. Potential future work to
circumnavigate these problems could include the production of more homogenous
swabs to improve sampling, or making swabs from polymer so that gold can be
reacted to give a more homogenous coating thus increasing the number of SERS “hot
spots” necessary for the enhancement of signal.
Should it not prove possible to develop a SERS swab for cleaning verification then as
shown in this chapter it is possible to use SERS substrates to produce the necessary
enhancement of signal for swab extract analysis. A myriad of options exist for
producing a SERS system for cleaning verification work and potential ideas include, a
SERS surface used in conjunction with a portable or laboratory Raman system, SERS
vials in which the inside of the vial is coated with an enhancing gold or silver
substrate or tip based SERS in which fibre optic tips are coated with gold particles so
that surfaces can be probed. The disadvantages with analysis of swab extract is that
further processing steps and complexity are introduced into the process. HPLC is a
time consuming process but it is important to be mindful of the need for simplicity in
the replacement technology.
Another important aspect of cleaning verification work to be considered is the
quantitative aspect. If SERS is to be implemented as a technology for cleaning
verification the method must be quantitative. The field of quantitative SERS work is
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growing and a key aspect is sampling. Reproducibility is a key aspect of sampling
with quantitative SERS and one method of ensuring good reproducibility and of
producing samples amenable to quantitative work is to ensure all of the sample is
covered by the laser spot. Future work based on results in this chapter could include
experimentation with smaller volumes than 5 µl on the Klarite™ slide and different
sizes of laser spot.
An important aspect of Raman microscopy and therefore SERS by Raman
microspectroscopy is that of sampling. Numerous options exist when looking at
samples and taking Raman spectra; these include acquisition time, number of
acquisitions, laser strength and objective. The microscope used during this
investigation had three objectives and they were: x 10, x 50 and x 100. Acquisition
times employed were between five and thirty seconds and the maximum number of
acquisitions was five. It is possible to improve the quality of a Raman spectrum by
adjusting the acquisition time and number of acquisitions. The overriding aim of this
chapter was to speed up the cleaning verification process and that was kept in mind
when selecting the acquisition time and number of acquisitions with very few samples
taking more than two attempts to obtain a spectrum. The Klarite™ substrates came
with clear instructions about their use from the manufacturer. High objectives were
not recommended because of the tendency for the laser to damage the substrate
surface through these objectives. The use of five to ten second accumulation times
was also recommended when using Klarite™ slides so as to not go over the maximum
count of Raman scattered photons and flood the CCD. In deciding how best to
produce a spectrum, the strength of the laser can be an important factor. Using the
laser at full power can give the most well defined spectrum with good peak amplitude
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but it is also possible to obtain background fluorescence and in the case of SERS
measurements flood the CCD. With SERS measurements the signal can be so intense
from the laser on full power that it was necessary to drop the laser power in order to
resolve the spectrum.
SERS offers a number of advantages over other technologies currently employed
within the cleaning verification field. It has sensitivity and specificity similar to
HPLC whilst possessing the rapid detection times of spectroscopic techniques, ion
mobility spectroscopy and total organic carbon analysis. This study has shown SERS
detection with Klarite™ slides was possible at levels of contamination encountered
within the industrial cleaning verification scenario. Future work would involve the
formulation of a portable/handheld Raman system for analysis of cleaning directly
from the manufacturing equipment itself.
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5 Optical detection of genotoxic
impurities
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This chapter presents an introduction to the compound known as 2,6-diphenyl-4-
(2,4,6-triphenyl-1-pyridinio)phenolate or Reichardt’s dye. Additional introductory
information on genotoxic impurities of specific importance to the experiments
undertaken is also presented. Results are presented that showed Reichardt’s dye as a
potential candidate dye for use in the optical sensing of alkylating agents present as
genotoxic impurities in pharmaceutical formulations.
5.1 Introduction
The importance of genotoxic impurities, the limits for genotoxic impurities, the
current analytical methods used for genotoxic impurity detection and the need for
improved analytical techniques were discussed in the introductory section to the thesis.
The main aim of this chapter is to develop a sensitive and rapid assay system for
alkylating agents (a class of genotoxic impurities). The methods described in the
literature which are commonly employed for detection of these compounds in
industrial settings are traditional analytical chemistry techniques such as HPLC and
GC/MS. The aim of this chapter was to develop an optical system based on
fluorescent/UV-visible dyes that can quantify alkylation by alkylating agents.
5.1.1 Reichardt’s Dye
Reichardt’s dye (figure 5.1) also known as 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate is a well known solvatochromic dye and has been used in several
experiments to determine the polarity of solvents or a medium. The dye or related
molecules are sometimes referred to in the literature as betaine dyes.
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The zwitterionic compound known as Reichardt’s dye exhibits one of the largest
observed solvatochromic effects of any known organic molecule. Charge-transfer
absorption wavelength shifts amount to several hundred nanometers in going from a
polar solvent ( abs max  453 nm in water) to a non polar solvent ( abs max  925 nm in
hexane) (Fletcher et al., 2001).
N
+
O
Figure 5.1. 2,6-diphenyl-4-(2,4,6 triphenylpyridinio)phenolate, also known as
Reichardt’s dye or Reichardt’s betaine.
Et (30) values are defined as molar transition energies (kcal mol-1) for the longest
wavelength, intramolecular charge transfer UV-visible absorption band of the
dissolved standard betaine dye. The values are known for more than three hundred
solvents and numerous binary solvent mixtures and they have found many
applications in analytical chemistry (Linert et al., 1992). The term solvatochromism
describes a shift in an electronic absorption band of a molecule in response to changes
in polarity of its solvational cage. The shift results from physical intermolecular
solvent-solute interactions (dipole-dipole, dipole induced, hydrogen bonding, etc)
which alter the energy difference between the electronic ground and excited states of
the absorbing species. Reichardt’s dye exhibits one of the largest solvatochromic
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effects observed and this results from the highly dipolar zwitterionic ground state and
the less polar excited state, brought about by the intramolecular charge transfer from
the phenoxide group into the pyridinium moiety occurring on the absorption of light.
In the ground state the positive charge on the pyridinum group is delocalized and
sterically shielded, while the phenoxide moiety has a highly basic electron donating
capacity (Krech & Pehrsson, 1997)
The solvatochromic abilities of the dye and related dyes are extremely well
documented. Paley & Harris, 1991 synthesised a number of different but related dye
molecules to utilise the dyes solvatochromic properties in order to investigate second-
harmonic generation. Dickert et al., 2000 utilised Reichardt’s dye and related dyes as
optochemical sensor materials. By measuring in UV-visible region the
solvatochromic effect of the dye was monitored in response to the presence of various
solvents in the gaseous phase. They were able to immobilise the dye by a sol gel
process and under mild conditions produce a sensor system with optically transparent,
highly porous and stable layers.
Reichard et al., 2001 synthesised three new “fluorophillic” fluorine and perfluoroalkyl
substituted N-phenolate betaine dyes (figure 5.2).
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Figure 5.2. The three dyes prepared by Reichardt et al., 2001.
The new dyes performed well and extended the Et (30) scale to new solvents of
interest and therefore increased the supply of solvatochromic indicator dyes. The
newly synthesised dyes were particularly useful for the determination of Et (30)
values of more acidic solvents, polymers and surfaces where the normal dye is
protonated. In spite of the introduction of fluorine and perfluoroalkyl substituents Et
(30) values are still lacking for perfluoroalkanes because lack of solubility means UV-
vis spectroscopy is not possible (Reichardt et al., 2001).
Krech & Rose-Pehrsson, 1997 were able to incorporate Reichardt’s dye into several
polymer films of differing polarity and sorbency. The polymers employed were:
polyisobutylene, polypichlorohydrin, polyvinyl pyrrolidone and polystyrene.
Solutions of the dye in methanol or chloroform were mixed with a stock solution of
polymer and sprayed onto a surface. Reversible and reproducible changes in the
absorption maximum of the dye were observed when the polymer films were exposed
to a series of vapours of different polarities. The incorporation of environment
sensitive dyes into various polymeric films could produce a low cost sensor array with
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in situ detection capabilities for several analyte vapours (Krech & Rose-Pehrsson,
1997).
Imai & Chujo, 2000 investigated the potential use of Reichardt’s dye with organic-
inorganic polymer hybrids. These hybrids are the molecular composite of organic
polymers and a three dimensional siloxane network. They are prepared by the sol-gel
reaction of alkoxsilanes in the presence of organic polymers such as poly (2-methyl-2-
oxazoline) and poly (N-vinylpyrrolidone). The solvatochromic polymer was prepared
by attaching Reichardt’s dye to a side chain of poly (2-methyl-2-osazoline).
Reichardt’s dye was also used in the experiment to dope sol-gel glasses and it was
found that the dye containing organic-inorganic hybrids and the dye doped glass
performed almost as well as the dye on it’s own for solvatochromic changes. In the
organic-inorganic polymer hybrid the local polarity was affected by the
tetramethoxysilane to methyltrimethoxysilane ratio and the presence of organic
polymer. The authors concluded that better control of the microenvironment around
the dye molecules was possible (Imai & Chujo, 2000).
Reichardt’s dye was used by Fletcher et al., 2001 in part of a study on ionic liquids
and their potential as alternative solvents. The authors investigated the change in the
longest wavelength intramolecular charge-transfer -*absorption band of
Reichardt’s dye in bmim PF6(the ionic liquid of interest) and selected solvents at
ambient conditions (figure 5.3).
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Figure 5.3. Longest wavelength intramolecular charge-transfer -*absorption band
of Reichardt’s betaine dye in 90 wt % glycerol in water (GW), bmimPF6 (IL),
acetontirile (ACN) and dichloromethane (DCM) under ambient conditions.
Linert et al., 1992 and Carreno et al., 1999 used the decrease in the solvatochromic
long wavelength UV-visible absorption band of Reichardt’s dye when reacted with
iodomethane to make observations about the kinetics of the reaction mechanism,
looking at parameters such as the substituent, solvent and temperature dependence of
the reaction (figure 5.4).
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Figure 5.4. Decrease of solvatochromic, long wavelength UV-visible absorption band
of Reichardt’s dye during methylation with iodomethane in chloroform at 19.9oC.
The first spectrum was recorded sixty seconds from the reaction commencing and the
other spectra were recorded at 200 second intervals (Linert et al., 1992).
5.1.2 Reichardt’s dye and genotoxic impurities
In this section of the project we have employed Reichardt’s dye for the direct
measurement of alkylation reactions. Figure 5.3 shows the lateral shift in the longest
wavelength intramolecular charge-transfer -*absorption band as a result of
solvatochromic changes. Figure 5.4 shows a decrease in the solvatochromic long
wavelength UV-visible absorption band as a result of alkylation. It is therefore
anticipated that alkylation of the dye will result not in a shift of wavelength but in a
reduced absorption maximum. The proposed reaction would operate by an SN2
mechanism and take place at the phenoxide moiety. Observing a decrease in the
solvatochromic long wavelength UV-visible absorption band should indicate that
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alkylation of Reichardt’s dye has taken place. It is also known that the dye molecule
is active with fluorescence spectroscopy. Fluorescence is a potentially sensitive
spectroscopic technique and so fluorescence spectroscopy will also be investigated as
a potential method for measuring alkylation of Reichardt’s dye. Additionally, to gain
further confirmation of alkylation of Reichardt’s dye and to confirm the products of
the reactions; investigations were carried out with NMR spectroscopy.
Experimental work for this chapter involved attempting to quantify the alkylation of
Reichardt’s dye and two related dye molecules with fluorescence spectroscopy and
UV-vis spectroscopy (figure 5.5). NMR experiments were also carried out to confirm
alkylation of Reichardt’s dye. The assay was then tested with drug samples to see if
sample interference is a problem and whether sample preparation and clean up is
necessary; as it is with many of the analytical methods currently employed by the
pharmaceutical industry to measure genotoxic impurities. Making extra sample
processing redundant would be a big advantage to any analytical system and in this
case it would be desirable if the drug substances did not interfere with the dye. Were
this proven to be the case, drug samples for alkylating agent testing could be
dissolved immediately and testing carried out.
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Figure 5.5. The three betaine dyes to be investigated experimentally. 2,6-diphenyl-4-
(2,4,6-triphenyl-1-pyridinio)phenolate (Reichardt’s dye - left), 2,6-dichloro-4-(2,4,6-
triphenyl-1-pyridinio)phenolate (centre) and 1-(4-hydroxyphenyl)-2,4,6-
triphenylpyridinium hydroxide inner salt (right).
5.1.3 Other candidate dye molecules
The azo dyes 4-phenylazophenol and Fat Brown B were also considered for testing
because it was suspected they too may have susceptibility to alkylation.
O N
N
O N
N O
Figure 5.6. 4-phenylazophenol (left) and Fat brown B (right).
5.1.4 Alkylating agents under investigation
The classes of alkylating agent used in this study:
1) Alkyl halides.
OH
Cl
Br
2) Sulfonate esters
O
S
O O
3) Diazonium salts
N
2+
OMe
NO2
BF4-
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Figure 5.7. Summarising 4-chloro-1-butanol formation as a result of the reaction
between tetrahydrofuran (THF) and hydrochloric acid.
1-Bromobutane is not a common genotoxin but it has been included in the study as an
additional alkyl halide to help develop an understanding of the alkylation of
Reichardt’s dye.
Ethyl methane sulfonate is a common genotoxic impurity and belongs to the class of
alkylating agents know as sulfonate esters. These impurities arise from the use of
sulfonic acids such as methane sulfonic acid, benzene sulfonic acid and ρ-toluene 
sulfonic acid (Calon & Richoll 2005). The likelihood of producing sulfonate esters as
impurities is increased if solvent or intermediates with an alcohol group are present
during synthesis (Taylor et al., 2005).
Fast Red B is a diazonium compound and is representative of a class of compounds
normally used as reaction intermediates during the synthetic stages of drug production,
they are sometimes utilised when trying to introduce an N-N coupling into a molecule.
Experiments in this chapter were carried out at concentrations of alkylating agent
relevant to industrial situations. As previously stated in the introductory chapter the
limit for genotoxic impurities in a drug for which a patient is taking for a period of
greater than one year is 1.5 µg of genotoxic impurities per day. This limit increases
(THF)
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for drugs which are taken for shorter amounts of time and can go up to 120 µg of
genotoxic impurities per day when the drug is taken for no longer than a month
(McGovern & Jacobsen-Kram, 2006). For experiments in this chapter, alkylating
agents were initially tested in parts per million ranges similar to those investigated by
pharmaceutical companies 0-100 ppm. For experiments where drug is dissolved
alongside the dye and alkylating agent; alkylating agents were present in µg/ml. The
reason for this is that it is then easier to relate the amounts of genotoxic impurity to
the amount of drug dissolved alongside the alkylating agent and dye. If the dissolved
drug were a lifetime drug, provided the daily maximum dose was dissolved, no more
than 1.5 µg of genotoxic impurities should be present.
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5.2 Materials & Methods
4-chloro-1-butanol, 1-bromobutane, ethyl methane sulfonate, Fast Red B, 4-
phenylazophenol, Fat Brown B, 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate,
2,6-dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate and 1-(4-hydroxyphenyl)-2,4,6-
triphenylpyridinium hydroxide inner salt, acetaminophen, ibuprofen and diclofenac
were purchased from Sigma (Poole, Dorset, UK). N,N-dimethylformamide (DMF)
and Acetonitrile (ACN) were purchased from Fisher.Scientific (Loughborough, UK)
Fluorescence measurements were carried out on an RF-5001PC spectrofluorimeter
(Shimadzu, Milton Keynes UK) and UV-vis measurements were carried out on a
UV2100 UV-visible spectrophotometer (Shimadzu, Milton Keynes UK). Samples
measured using fluorescence spectroscopy were excited at 347 nm collected at 693
nm.
400 µM stock solutions of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate, 2,6-
dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate and 1-(4-hydroxyphenyl)-2,4,6-
triphenylpyridinium hydroxide inner salt were prepared in Acetonitrile or N,N-
dimethylformamide. 40 µM stock solutions of Fat Brown B and 4-Phenylazophenol
were prepared in acetonitrile or N.N-dimethylformamide. 1000 ppm stock solutions
of 4-chloro-1-butanol, 1-bromobutane, ethyl methane sulfonate and Fast Red B were
prepared in acetontirile or N.N dimethylformamide. Appropriate dilutions of
alkylating agents were subsequently made for experimentation.
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400 µM Dye solutions were mixed with solutions of alkylating agent in 18 ml glass
vials. Volumes of dye and alkylating agent were always mixed in a 1:1 fashion thus
giving a final dye concentration of 200 µM. Analysis was then carried on the
spectrofluorimeter or on the UV-vis spectrophotometer. Clean pipette tips were used
for every transfer of solution and the cuvette was washed out with solvent and dried
with tissue paper between each reading. Samples in glass vials requiring heat were
placed in a 5000 ml beaker containing 50 mls of water and heated on a hot plate for 4
hours. A thermometer was used to ensure a temperature in the water of 85oC.
Dye samples containing drug for the drug interference experiments were made to
concentrations of 10.0 or 100.0 mg/ml of acetaminophen, ibuprofen or diclofenac. To
create buffer solutions of pH 5.0, 7.0 and 9.0 monosodium phosphate monohydrate
and disodium phosphate were weighed out using approximate calculations and then
adjusted to final concentrations using a pH meter.
NMR spectroscopy was carried out using a Jeol ECX 400 NMR spectrometer (Jeol,
Welwyn Garden City, UK). Deuterated DMF was purchased from Goss Scientific
(Great Baddow, Essex, UK).
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5.3 Results
Results are presented that establish the potential use of reichardt’s dye for the optical
detection of genotoxic impurities.
5.3.1 Visual changes of the dyes in response to the addition of 1-
bromobutane and 4-chloro-1-butanol.
Visual changes in Reichardt’s dye were initaly observable to the eye at high
concentrations of alkylating agent. Figures 5.8-5.10 show photgraphs of bleaching by
4-chloro-1-butanol and 1-bromobutane.
Figure 5.8. 200 µM 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate (left), 200
µM 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and 500 ppm 4-chloro-1-
butanol (middle) and 200 µM 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate
and 500 ppm 1-bromobutane (right).
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Figure 5.9. 200 µM 2,6-dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate (left), 200
µM 2,6-dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate and 500 ppm 4-chloro-1-
butanol (middle) and 200 µM 2,6-dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate
and 500 ppm 1-bromobutane (right).
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Figure 5.10. 200 µM 1-(4-hydroxyphenyl)-2,4,6-triphenylpyridinium hydroxide inner
salt (left), 200 µM 1-(4-hydroxyphenyl)-2,4,6-triphenylpyridinium hydroxide inner
salt and 500 ppm 4-chloro-1-butanol (middle) and 200 µM 1-(4-hydroxyphenyl)-
2,4,6-triphenylpyridinium hydroxide inner salt and 500 ppm 1-bromobutane (right).
To the eye, all three dyes showed significant bleaching in the presence of 4-chloro-1-
butanol. The dye colour was completely lost in the presence of 4-chloro-1-butanol at
500 ppm indicating complete alkylation of the dye by the compound.
2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and 2,6-dichloro-4-(2,4,6-
triphenyl-1-pyridinio)phenolate showed a slight lightening in colour in response to the
presence of 1-bromobutane at 500 ppm. This indicated a partial alkylation of the dye
molecules in solution by 1-bromobutane.
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1-(4-hydroxyphenyl)-2,4,6-triphenylpyridinium hydroxide inner salt changed colour
from purple to brown in the presence of 500 ppm 1-bromobutane. This means a
solvatochromic change occurred alongside the partial bleaching which took place .
5.3.2 Fluorescent response to the addition of 1 –Bromobutane and 4-
Chloro-1-butanol.
Changes in the dyes appearance in response to the addition of 1-bromobutane and 4-
chloro-1-butanol were measured using fluorescence spectroscopy (figures 5.11 –
5.14).
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Figure 5.11. Changes in fluorescence of 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of 35 ppm of 1-bromobutane or 4-
chloro-1-butanol. n = 9.
212
The dye was present at a concentration of 200 µM and fluorescence decreased slightly
in the presence of 1-bromobutane at 35 ppm. 4-Chloro-1-butanol caused a more
significant decrease in fluorescence with a drop from 5.8 in the control to 4.6 AU.
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Figure 5.12. Changes in fluorescence of 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of 35 ppm of 1-bromobutane and 4-
chloro-1-butanol. n = 10
The dye was present at a concentration of 2 µM and fluorescence decreased slightly in
the presence of 1-bromobutane at 35 ppm going from 17.1 in the control sample to
15.2 AU in the sample containing 1-bromobutane at 35 ppm. 4-Chloro-1-butanol at
35 ppm caused a smaller decrease in fluorescence with a drop from 17.1 in the control
to 16.5 AU.
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When attempting to create an optical sensor system such as this one it is preferable to
have maximum possible distinction so that changes due to alkylation can be easily
determined and quantified. Diluting the dye from 200 µM to 2 µM caused the
fluorescence intensity to increase from the approximate range of 5-6 AU to the
approximate range of 15-20 AU. Increasing the fluorescence intensity will make
changes in fluorescence that result from alkylation more apparent.
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Figure 5.13. Changes in fluorescence of 2,6-dichloro-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of 35 ppm of 1-bromobutane and 4-
chloro-1-butanol. n = 10
The dye is present at a concentration of 2 µM and fluorescence increased slightly in
the presence of 1-bromobutane at 35 ppm going from 15.8 in the control sample to
16.1 AU in the sample containing 1-bromobutane at 35 ppm. 4-chloro-1-butanol at
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35 ppm caused a small decrease in fluorescence with a drop from 15.8 in the control
to 15.7 AU.
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Figure 5.14. Changes in fluorescence of 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate (dye 1), 2,6-dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate
(dye 2) and 1-(4-hydroxyphenyl)-2,4,6-triphenylpyridinium hydroxide inner salt (dye
3) in response to the addition of 35 ppm of 1-bromobutane and 4-chloro-1-butanol. n
=3. The red columns indicate control measurements where dye is present in solvent,
the green columns represent fluorescence when 1-bromobutane is present at 35 ppm
and the blue columns represent fluorescence when 4-chloro-1-butanol is present at 35
ppm.
All three dyes showed different responses to the addition of 1-bromobutane and 4 –
chloro-1-butanol. 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate (dye 1 –
black) showed a very slight decrease in fluorescence (17.1 to 16.93) when 1-
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bromobutane was present at 35 ppm but a slight increase in fluorescence (17.1 to 17.9
AU) when 4-chloro-1-butanol was present at 35 ppm. 2,6-dichloro-4-(2,4,6-
triphenyl-1-pyridinio)phenolate (dye 2 – blue) showed a small decrease in
fluorescence when 1-bromobutane was present at 35 ppm (20.4 to 19.6 AU) and a
larger decrease in fluorescence (20.4 to 16.8 AU) when 4-chloro-1-butanol was
present at 35 ppm. 1-(4-hydroxyphenyl)-2,4,6-triphenylpyridinium hydroxide inner
salt (dye 3 - pink) showed a decrease (23.6 to 20.1 AU) in fluorescence when 1-
bromobutane was present at 35 ppm and a smaller decrease in fluorescence (23.6 to
22.6 AU) when 4-chloro-1-butanol was present at 35 ppm.
The data presented in this section failed to show a significant correlation between the
presence of 1-bromobutane and 4-chloro-1-butanol and changes in the fluorescent
response of the dye. Some of the data showed decreases in fluorescence in response
to the presence of the two alkylating agents but the magnitude of the decreases were
small and to produce a reliable sensor system it is desirable to have more significant
changes in the parameter being measured.
Changes in the appearance of the dye resulting from alkylation were far more
apparent to the eye than by using fluorescence detection. The conclusion from this
section of work was that fluorescence spectroscopy does not represent a particularly
sensitive or reproducible measurement technique for alkylation of the three dyes 2,6-
diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate, 2,6-dichloro-4-(2,4,6-triphenyl-1-
pyridinio)phenolate and 1-(4-hydroxyphenyl)-2,4,6-triphenylpyridinium hydroxide
inner salt.
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5.3.3 Use of UV-vis spectroscopy to measure changes in dye absorption in
response to the addition of alkylating agent.
The UV-vis absorbance spectra were recorded for the three dyes in the presence of 4-
chloro-1-butanol and 1-bromobutane. Results are presented in figures 5.15 – 5.17.
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Figure 5.15. Changes in absorbance of 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate at 200 µM (blue) in response to the presence of 50 ppm of 1-
bromobutane (pink) and 4-chloro-1-butanol (black).
The control sample of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate at 200
µM showed a maximum absorption of 0.986 AU. The maximum absorption in
response to the addition of 50 ppm of 1-bromobutane changed to 0.933 AU and to 50
ppm of 4-chloro-1-butanol the maximum absorption changed to 0.695 AU.
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Figure 5.16. Changes in absorbance of 2,6-dichloro-4-(2,4,6-triphenyl-1-
pyridinio)phenolate (blue) in response to the presence of 50 ppm of 1-bromobutane
(pink) and 4-chloro-1-butanol (black).
The control sample of 2,6-dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate at 200
µM showed a maximum absorption of 0.624 AU. The maximum absorption in
response to the addition of 50 ppm of 1-bromobutane changed to 0.602 AU and in
response to the addition of 50 ppm of 4-chloro-1-butanol changed to 0.486 AU.
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Figure 5.17. Changes in absorbance of 1-(4-hydroxyphenyl)-2,4,6-
triphenylpyridinium hydroxide inner salt (blue) in response to the presence of 50 ppm
of 1-bromobutane (pink) and 4-chloro-1-butanol (black).
The control sample of 1-(4-hydroxyphenyl)-2,4,6-triphenylpyridinium hydroxide
inner salt at 200 µM showed a maximum absorption of 0.416 AU and changed in
response to the addition of 50 ppm of 1-bromobutane to 0.343 AU and to 0.198 AU in
response to the addition of 50 ppm of 4-chloro-1-butanol. This loss in absorption
would suggest some alkylation of the dye by 1-bromobutane and 4-chloro-1-butanol.
The wavelength of the absorption maximum changed significantly for 1-(4-
hydroxyphenyl)-2,4,6-triphenylpyridinium hydroxide inner salt. The control sample
maximum was at 559.5 nm where as for 1-bromobutane and 4-chloro-1-butanol it was
found at 541.5 nm and 480.5 nm respectively.
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This significant change in the wavelength of the absorption maximum for 1-(4-
hydroxyphenyl)-2,4,6-triphenylpyridinium hydroxide inner salt suggests a
solvatochromic change is taking place alongside alkylation.
To try and detect a solvatochromic effect and therefore help confirm whether changes
in absorbance were due to alkylation of the dye rather than the aforementioned
solvatochromic effect, the dyes under normal circumstances were compared to dye
samples where cyclohexane was present at 25 ppm. 25 ppm was selected because it is
a concentration around which a pharmaceutical company would look for the presence
of alkylating agents. Cyclohexane was chosen because of its similarity in size and
solubility to 1-bromobutane and 4-chloro-1-butanol.
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Figure 5.18. Changes in absorbance for all three dyes in response to the addition of
25 ppm of cyclohexane.
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For 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate the presence of
cyclohexane at 25 ppm caused an increase from the control value of 0.945 to 0.996
AU. For 2,6-dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate the presence of
cyclohexane at 25 ppm caused an increase from the control value of 0.636 to 0.646
AU. For 1-(4-hydroxyphenyl)-2,4,6-triphenylpyridinium hydroxide inner salt the
presence of cyclohexane at 25 ppm caused a decrease from the control value of 0.333
to 0.321 AU.
Cyclohexane caused a slight increase in absorption for 2,6-diphenyl-4-(2,4,6-
triphenyl-1-pyridinio)phenolate and 2,6-dichloro-4-(2,4,6-triphenyl-1-
pyridinio)phenolate where as a slight decrease for 1-(4-hydroxyphenyl)-2,4,6-
triphenylpyridinium hydroxide inner salt was observed.
The results help show that when a drop in absorbance is detected in response to the
addition of 1-bromobutane or 4-chloro-1-butanol it can be said with confidence that
the change is due to alkylation of the dye rather than a solvatochromic effect.
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Figure 5.19. Changes in absorbance for all three dyes in response to the addition of
35 ppm of ethyl methane sulfonate.
For 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate the presence of ethyl
methane sulfonate at 35 ppm caused a decrease from the control value of 0.853 to
0.837 AU. For 2,6-dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate the presence of
ethyl methane sulfonate at 35 ppm caused an increase from the control value of 0.586
to 0.601 AU. For 1-(4-hydroxyphenyl)-2,4,6-triphenylpyridinium hydroxide inner
salt the presence of ethyl methane sulfonate at 35 ppm caused an increase from the
control value of 0.348 to 0.365 AU.
Ethyl methane sulfonate at 35 ppm caused a slight decrease in absorbance for 2,6-
diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and slight increases for 2,6-
dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate and 1-(4-hydroxyphenyl)-2,4,6-
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triphenylpyridinium hydroxide inner salt. Ethyl methane sulfonate at 35 ppm was
found to have no evidence of an alkylating effect.
The results presented in this section showed that the UV-vis spectrum of the dyes
changed in the fashion shown by Figure 5.4 when Reichardt’s dye was reacted with
iodomethane. Therefore it can be suggested that alkylation was responsible for the
change in dye appearance. The addition of cyclohexane as a similarly sized but non
alkylating agent did not produce the response seen in the presence of alkylating agents.
The change in absorbance was very small which also shows that the introduction of
molecules of similar molecular weight and solubility at the 35 ppm level did not
induce solvatochromic changes. Ethyl methane sulfonate was also tested in the way
that 4-chloro-1-butanol and 1-bromobutane were and in all three dyes there was no
evidence of alkylation.
5.3.4 Linearity of the assay and assay conditions.
In the previous section, the dyes were shown to undergo alkylation and present a
change in absorbance when measured by UV-vis spectroscopy. In this section results
are presented where a range of concentrations of alkylating agent are reacted with dye
in order to see if a linear relationship can be established.
In the case of combinations of dye and alkylating agent that do not produce linear
responses, the reaction conditions will be varied to determine whether a linear
response to the presence of a particular alkylating agent can be established.
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Figure 5.20. Changes in absorbance for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of 4-chloro-1-butanol at 0 ppm (blue),
10 ppm (pink), 50 ppm (orange), 125 ppm (sky blue), 250 ppm (purple) and 500 ppm
(brown).
The graph showed absorbance decreasing in a proportional manner to increasing
concentration of 4-chloro-1-butanol. The absorption maxima can be taken and plotted
to form the basis of a linear assay for 4-chloro-1-butanol using 2,6-diphenyl-4-(2,4,6-
triphenyl-1-pyridinio)phenolate.
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Figure 5.21. Changes in absorbance for 2,6-dichloro-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of 4-chloro-1-butanol at 0 ppm (blue),
10 ppm (pink), 50 ppm (orange), 125 ppm (sky blue), 250 ppm (purple) and 500 ppm
(brown).
The graph showed absorbance decreasing in a proportional manner to increasing
concentration of 4-chloro-1-butanol. Again, the absorption maxima can be taken and
plotted to form the basis of a linear assay for 4-chloro-1-butanol using 2,6-dichloro-4-
(2,4,6-triphenyl-1-pyridinio)phenolate.
The following plots show the absorption maxima on the y-axis and concentration of
alkylating agent on the x-axis. The bars represent standard deviation and all
experiments were carried out in triplicate.
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R2 = 0.9665
R2 = 0.9904
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Figure 5.22. Changes in absorbance at 618 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate (blue) and 2,6-dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate
(pink) in response to the addition of 4-chloro-1-butanol at the concentrations of 0 ppm,
10 ppm, 50 ppm, 125 ppm, 250 ppm and 500 ppm.
2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate showed good linearity with an
R2 value of 0.9665 but that value was affected by the last point at 500 ppm which lies
beyond the range where 4-chloro-1-butanol induced partial bleaching of the dye. The
graph showed the linear nature of the response but a lower and equally extensive
range of concentrations must be subjected to similar experimentation in order to fully
how linear the assay can become.
2,6-dichloro-4-(2,4,6-triphenyl-1-pyridinio)phenolate showed excellent linearity with
an R2 value of 0.9904. The figure showed that 2,6-diphenyl-4-(2,4,6-triphenyl-1-
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pyridinio)phenolate was less sensitive to 4-chloro-1-butanol but that the dye can form
the basis of a linear assay for that particular alkylating agent.
R2 = 0.9976
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Figure 5.23. Changes in absorbance at 618 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of 4-chloro-1-butanol at the
concentrations of 0 ppm, 10 ppm, 25 ppm, 50 ppm, 75 ppm and 100 ppm.
Over the range of 0 to100 ppm 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate
showed excellent linearity in response to the presence of 4-chloro-1-butanol with an
R2 value of 0.9976.
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Figure 5.24. Changes in absorbance at 618 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of 1-bromobutane at the
concentrations of 0 ppm, 10 ppm, 25 ppm, 50 ppm, 75 ppm and 100 ppm
Over the range of 0 to 100 ppm 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate
showed no discernable reactivity with 1-bromobutane. Bleaching of the dye did not
take place and so 1-bromobutane did not alkylate the dye compound.
Over the range of 0 to 100 ppm 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate
showed no discernable reactivity with ethyl methane sulfonate. Bleaching of the dye
did not take place and so ethyl methane sulfonate did not alkylate the dye compound.
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Figure 5.25. Changes in absorbance at 618 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of ethyl methane sulfonate at the
concentrations of 0 ppm, 10 ppm, 25 ppm, 50 ppm, 75 ppm and 100 ppm
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Figure 5.26. Changes in absorbance at 618 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of the diazonium compound Fast Red
B at the concentrations of 0 ppm, 10 ppm, 25 ppm, 50 ppm, 75 ppm and 100 ppm.
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 10 20 30 40 50 60 70 80 90 100
[1-bromobutane] ppm
A
bs
or
ba
nc
e
Figure 5.27. Changes in absorbance at 618 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of 1-bromobutane at the
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concentrations of 0 ppm, 10 ppm, 25 ppm, 50 ppm, 75 ppm and 100 ppm at 85oC for
4 hours.
Over the range of 0 to 100 ppm and after 4 hours at 85oC, 2,6-diphenyl-4-(2,4,6-
triphenyl-1-pyridinio)phenolate showed no discernable reactivity with 1-bromobutane.
Bleaching of the dye did not take place and so 1-bromobutane did not alkylate the dye
under these reaction conditions.
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Figure 5.28. Changes in absorbance for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of ethyl methane sulfonate at the
concentrations of 0 ppm, 10 ppm, 25 ppm, 50 ppm, 75 ppm and 100 ppm at 85oC for
4 hours.
Over the range of 0 to 100 ppm and after 4 hours at 85oC, 2,6-diphenyl-4-(2,4,6-
triphenyl-1-pyridinio)phenolate showed no discernable reactivity with ethyl methane
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sulfonate. Bleaching of the dye did not take place and so ethyl methane sulfonate did
not alkylate the dye under these reaction conditions.
Acetonitrile had been used as a solvent and had proven useful in the reactions
between 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and 4-chloro-1-
butanol and Fast Red B. These reactions showed excellent linearity over a range of
concentrations that are industrially relevant without any heating or the use of any sort
of catalyst. 1-Bromobutane and ethyl methane sulfonate would not react with the dye
in acetonitrile under normal conditions or over a four hour time period at 85oC.
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Figure 5.29. Changes in absorbance for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of 4-chloro-1-butanol at the
concentrations of 0 ppm, 10 ppm, 25 ppm, 50 ppm, 75 ppm and 100 ppm in
acetonitrile (blue – 618 nm) in DMF (pink – 624 nm).
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Both assays showed excellent linearity (R2 values of 0.9976 in acetonitrile and 0.9962
in DMF) but the assay in DMF showed greater separation of the data points over the
concentration range of 0 to 100 ppm. Acetonitrile was identified as a potentially
useful solvent for this work because it has low activity in the UV-vis region and
therefore would not attenuate the UV beam too heavily. DMF is well known as a
good solvent for SN2 reactions and so it was also tested as a potential solvent.
R2 = 0.9741
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Figure 5.30. Changes in absorbance at 624 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of 1-bromobutane at the
concentrations of 0 ppm, 10 ppm, 25 ppm, 50 ppm, 75 ppm and 100 ppm at 85oC for
4 hours in DMF in the presence of the catalyst tetrabutylammonium iodide at 200 µM.
2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate showed good linearity in
response to the presence of 1-bromobutane producing an R2 value of 0.9741.
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Figure 5.31. Changes in absorbance at 624 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of ethyl methane sulfonate at the
concentrations of 0 ppm, 10 ppm, 25 ppm, 50 ppm, 75 ppm and 100 ppm at 85oC for
4 hours in DMF in the presence of the catalyst tetrabutylammonium iodide at 200 µM.
2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate showed good linearity in
response to the presence of 1-bromobutane producing an R2 value of 0.9756.
It was then necessary to check if heat and the catalyst tetrabutylammonium iodide had
affected the rate of the reaction and so the reactions were repeated but at 0, 50 and
100 ppm. Measurements were made where the samples were not heated, where
catalyst was not added but heat was present and where catalyst and heat were both
present.
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Figure 5.32. Changes in absorbance at 624 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of 1-bromobutane at the
concentrations of 0 ppm, 50 ppm and 100 ppm at 85oC for 4 hours in DMF in the
presence of the catalyst tetrabutylammonium iodide at 200 µM (blue), with no
catalyst present (pink) and with tetrabutylammonium iodide present for 4 hours but
with no heat (black).
The graph showed no decrease in absorbance when 1-bromobutane was added at 50
or 100 ppm but not heated over the 4 hour time course (black). Absorbance decreased
when the sample was heated at 85oC for four hours (pink) but the absorbance decrease
was greatest after four hours at 85oC of in the presence of tetrabutylammonium iodide.
Therefore it can be concluded that for 1-bromobutane the catalyst
tetrabutylammonium iodide sped up the alkylation of 2,6-diphenyl-4-(2,4,6-triphenyl-
1-pyridinio)phenolate.
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Figure 5.33. Changes in absorbance at 624 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to the addition of ethyl methane sulfonate at the
concentrations of 0 ppm, 50 ppm and 100 ppm at 85oC for 4 hours in DMF in the
presence of the catalyst tetrabutylammonium iodide at 200 µM (blue), with no
catalyst present (pink) and with tetrabutylammonium iodide present for 4 hours but
with no heat (black).
A decrease in absorbance was not observed when ethyl methane sulfonate was added
at 50 or 100 ppm but not heated over the 4 hour time course (black). Absorbance
decreased when the sample was heated at 85oC for four hours (pink) and absorbance
decreased similarly after four hours at 85oC of in the presence of tetrabutylammonium
iodide. Therefore it can be concluded that for ethyl methane sulfonate, the catalyst
tetrabutylammonium iodide did not have an effect on the alkylation of 2,6-diphenyl-4-
(2,4,6-triphenyl-1-pyridinio)phenolate.
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5.3.5 Reactions of Azo dyes with alkylating agents.
Reichardt’s dye reacted well with 4-chloro-1-butanol and Fast Red B giving linear
response to changes in concentration with high R2 values. 1-Bromobutane and ethyl
methane sulfonate showed linear responses in DMF after heating to 85oC for four
hours. Also, the addition of tetrabutylammonium iodide increased the reaction of 1-
bromobutane and 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate.
4-pheynlazophenol and Fat Brown B were tested with the alkylating agents to see if a
linear assay could be produced, in particular for 1-bromobutane and ethyl methane
sulfonate that did not rely on heating or the presence of catalyst.
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Figure 5.34. Changes in absorbance for 4-phenylazophenol in response to the
addition of 4-chloro-1-butanol at 0 ppm, 10 ppm 25 ppm, 50 ppm, 75 ppm and 100
ppm.
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The UV-vis spectra for 4-phenylazophenol did not present a linear decrease in
absorbance in response to increasing concentrations of 4-chloro-1-butanol like
Reichardt’s dye.
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Figure 5.35. Changes in absorbance for 4-Phenylazophenol in response to the
addition of 1-bromobutane at 0 ppm, 10 ppm, 25 ppm, 50 ppm, 75 ppm and 100 ppm
The UV-vis spectra for 4-phenylazophenol did not present a linear decrease in
absorbance in response to increasing concentrations of 1-bromobutane like
Reichardt’s dye had displayed. The changes in absorbance did not follow step with
the concentration increases and so 4-phenylazophenol was not be tested further.
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Figure 5.36. Changes in absorbance for Fat Brown B in response to the addition of 1-
Bromobutane at 0 ppm, 10 ppm 25 ppm, 50 ppm, 75 ppm and 100 ppm
The UV-vis spectra for Fat Brown B did not present a linear decrease in absorbance in
response to increasing concentrations of 1-bromobutane like Reichardt’s dye had.
The changes in absorbance were not in step with the changes in concentration of 1-
bromobutane and the separations between absorption maxima were very small in
comparison to other changes observed in this study.
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Figure 5.37. Changes in absorbance for Fat Brown B in response to the addition of
ethyl methane sulfonate at 0 ppm, 10 ppm 25 ppm, 50 ppm, 75 ppm and 100 ppm.
The UV-vis spectra for Fat Brown B did not present a linear decrease in absorbance in
response to increasing concentrations of ethyl methane sulfonate like Reichardt’s dye.
The changes in absorbance were not in step with the changes in concentration of ethyl
methane sulfonate and the separation between absorption maxima was also very small.
The azo dyes 4-phenylazophenol and Fat Brown B were found to be unsuitable for the
UV-vis spectrophotometric detection of alkylation and work with the two compounds
was terminated at this point.
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5.3.6 NMR spectroscopy on the reactions between 2,6-diphenyl-4-(2,4,6-
triphenyl-1-pyridinio)phenolate and the alkylating agents 4-chloro-1-
butanol and ethyl methane sulfonate
Confirmation of the products of the reaction was necessary to ensure that it was
indeed alkylation of the dye that was responsible for the bleaching. It was known
from the paper by Reichardt et al., 1992 that a decrease in the UV absorption
maximum for Reichardt’s dye was observed when the dye was alkylated by
iodomethane. As shown in the results section of this chapter, the decrease in the
absorption maximum was observed when Reichardt’s dye was reacted with the
alkylating agents used in this study. The objective of this study is to produce a sensor
for industrial implementation. Therefore it was prudent practice to carry out NMR
spectroscopy in order to confirm the products of the reaction.
4-chloro-1-butanol and ethyl methane sulfonate were the two alkylating agents of
most industrial importance and therefore their reactions with 2,6-diphenyl-4-(2,4,6-
triphenyl-1-pyridinio)phenolate were investigated.
2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate
An NMR spectrum of Reichardt’sdye was recorded and is presented in figure 5.38.
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Figure 5.38. 1H NMR spectrum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in deuterated chloroform .
All the peaks owing to the dye were seen in the region between 6.0 and 9.0 ppm.
With proton NMR this is the region in which phenyl groups are seen and with the dye
being composed entirely of phenyl groups this was the region where its characteristic
peaks were seen.
4-chloro-1-butanol and 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate.
4-chloro-1-butanol and 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate were
reacted together in methanol. The product of the reaction was isolated and then
investigated with NMR spectroscopy by dissolving in deuterated DMF.
242
0
0.05
0.1
0.15
0.2
0.25
0.3
012345678910
Chemical Shift [ppm]
A
bu
nd
an
ce
Figure 5.39. 1H NMR spectrum of the product from the reaction between 4-chloro-1-
butanol and 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate.
The peaks between 7 and 9.5 ppm belonged to the dye molecule because they were
present in the phenyl region. Between 0 and 4.5 ppm the peaks from the 4 carbon
chain added to the dye by 4-chloro-1-butanol were found. The two large peaks
between 2.8 and 3 ppm were due to the solvent (DMF) and the large peak at
approximately 3.5 ppm was due to water.
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Figure 5.40. A zoomed in version of the previous 1H NMR spectrum between 5 and
1.5 ppm from the product of the reaction between 4-chloro-1-butanol and 2,6-
diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate.
As previously stated, the large peaks between 2.8 and 3 ppm were due to solvent
(DMF) and the large peaks at 3.5 were due to water. The other five peaks labelled by
arrows were due to the four carbon chain added to 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate by 4-chloro-1-butanol. The integrals of the five labelled peaks
were all very similar.
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Figure 5.41. The alkylated product of the reaction between 4-chloro-1-butanol and
2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate. The arrows correspond to the
peaks highlighted in Figure 5.40.
From the proton NMR spectra presented, peaks D and E cannot be identified with
certainty but it can be said with absolute certainty that they are both due to the points
of the molecule indicated by either arrows D and E. Both peaks are due to the CH2
groups in the middle of the for carbon chain. Peak A is in the position expected of an
OH group and is a triplet which is indicative of being next to a CH2 group, peak B is a
triplet which indicates it can only be next to a CH2 and therefore it must be in the
position indicated by arrow B and peak C is difficult to resolve but is not a triplet and
is indicative of having a CH2 on one side and an OH on the other.
245
-0.02
-0.01
0
0.01
0.02
0.03
0.04
020406080100120140160180
Chemical Shift [ppm]
Th
ou
sa
nd
th
s
Figure 5.42. 13C NMR spectrum from a dept 135 experiment on the product of 4-
chloro-1-butanol and 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate.
A dept 135 experiment eliminates the solvent peaks and produces a result where CH
and CH3 groups point upwards and CH2 groups point downwards. From this
spectrum the CH groups of the dye present in the region between 120 and 140 ppm
were observed and four signals pointing downwards in the region of 20 to 60 ppm
were seen, indicating the presence of four CH2 groups.
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Figure 5.43. 13C NMR spectrum from a dept 135 experiment on the product of 4-
chloro-1-butanol and 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate between 0
and 100 ppm..
This spectrum is a zoomed in view of the previous one and shows in greater detail the
presence of the four peaks which helped confirm the presence of four CH2 groups that
were added to the dye molecule by alkylation.
Ethyl methane sulfonate and 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate.
The reaction between 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and ethyl
methane sulfonate was slower than the reaction between 2,6-diphenyl-4-(2,4,6-
triphenyl-1-pyridinio)phenolate and 4-chloro-1-butanol and required heating up to
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85oC over a four hour time course. Proton NMR was used to study the progress of the
reaction in deuterated DMF and identify the products.
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Figure 5.44. 1HNMR spectrum five minutes after the beginning of the reaction
between 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and ethyl methane
sulfonate.
The spectrum showed the presence of the dye molecule between 6 and 9 ppm. This is
the region where phenyl groups are apparent in 1HNMR spectroscopy. The peaks
owing to ethyl methane sulfonate and the beginnings of new peaks formed during the
reaction were found between 0 and 4.5 ppm and are indicated by the arrows present.
The two large peaks between 2.8 and 3.0 ppm were due to the solvent (DMF) and the
large peak at approximately 3.1 ppm was due to water.
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Figure 5.45. 1H NMR spectrum four hours after the beginning of the reaction
between 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and ethyl methane
sulfonate.
This spectrum is from a time point when the reaction was complete. The arrows help
to illustrate how the peaks in the region between 0 and 4.5 ppm changed during the
course of the reaction. We saw the emergence of two peaks at approximately 0.6 and
2.4 ppm and the disappearance of two peaks at approximately 4.4 and 1.4 ppm.
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Figure 5.46. 1H NMR spectrum five minutes after the beginning of the reaction
between 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and ethyl methane
sulfonate.
This proton NMR spectrum presents a zoomed in view of the phenyl region in which
the dye spectrum was found. At the beginning of the reaction a series of sharp and
well defined peaks can be seen.
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Figure 5.47. 1H NMR spectrum four hours after the beginning of the reaction
between 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and ethyl methane
sulfonate.
This proton NMR spectrum presents a zoomed in view of the phenyl region in which
the dye spectrum was found and at the end of the reaction it was found that the
number of peaks had doubled whilst the integrals for the peaks had approximately
halved. This doubling of the peaks and halving of the integrals was indicative of the
formation of two species. In this case the production of alkylated dye was observed
with NMR and the ratio of ethyl methane sulfonate and 2,6-diphenyl-4-(2,4,6-
triphenyl-1-pyridinio)phenolate employed during the reaction meant that it ended with
an approximate 50:50 ratio of alkylated and unalkylated product as there was only
enough ethyl methane sulfonate used to alkylate half of the dye molecules present..
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Figure 5.48. 1H NMR spectrum five minutes after the beginning of the reaction
between 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and ethyl methane
sulfonate.
This spectrum showed the early stages of the reaction between 2,6-diphenyl-4-(2,4,6-
triphenyl-1-pyridinio)phenolate and ethyl methane sulfonate and in this region four
peaks have been highlighted.
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Figure 5.49. 1H NMR spectrum one hour after the beginning of the reaction between
2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and ethyl methane sulfonate.
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Figure 5.50. 1H NMR spectrum four hours after the beginning of the reaction
between 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and ethyl methane
sulfonate.
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Figure 5.51. Ethyl methane sulfonate, 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate and the products of their reaction. The labelled arrows in this
figure correspond to the peaks highlighted by labelled arrows in figure 5.50.
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Figure 5.52. The relationship between integrals of four selected peaks over the four
hour time period for which the reaction between 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate and ethyl methane sulfonate was carried out.
The plot of the integrals of the peaks highlighted in Figures 5.50 and 5.51 over time
shows how the peaks owing to ethyl methane sulfonate diminished and how the peaks
owing to the two products grew.
Summary of NMR findings
The product of the reaction between 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate and 4-chloro-1-butanol was isolated and investigated with NMR
spectroscopy. 1H NMR, a 13C dept experiment and an HMQC confirmed the
alkylated product as shown in Figure 5.41. The reaction between 2,6-diphenyl-4-
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(2,4,6-triphenyl-1-pyridinio)phenolate and ethyl methane sulfonate was slower and
could be tracked in an NMR tube. 1H NMR showed the disappearance of peaks from
ethyl methane sulfonate and the appearance of peaks from the alkylated dye and the
methyl sulfonate ion.
The importance of this section lies in the confirmation of the chemistry of the reaction.
It is therefore possible to proceed with certainty that the bleaching of the dye is a
result of alkylation by 4-chloro-1butanol and ethyl methane sulfonate.
5.3.7 Summary of results
With the proof of alkylation of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate
by ethyl methane sulfonate and 4-chloro-1-butanol from NMR spectroscopy the
results of the reactions between 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate
and the 4-chloro-1-butanol, 1-bromobutane, ethyl methane sulfonate and Fast Red B
are summarised below.
The two most industrially relevant alkylating agents used in the study were 4-chloro-
1-butanol and ethyl methane sulfonate. 1-bromobutane was used to help show a
generic element to the alkyl halide detection and Fast Red B was representative of the
diazonium salts. Diazonium salts are becoming less frequently used in chemical
syntheses because of their associated alkylating behaviour as trace impurities.
The table shows the assays which established linearity for each alkylating agent and
the reaction conditions necessary to achieve linearity.
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Table 5.1. Summarising outcomes of testing with alkylating agents and 2,6-diphenyl-
4-(2,4,6-triphenyl-1-pyridinio)phenolate. Green boxes indicate the successful
establishment of a linear change in absorbance in response to addition of alkylating
agent over the concentration range of 0-100 ppm. Red boxes indicate that it was not
possible to establish a linear change in absorbance in response to the addition of
alkylating agents over the concentration range of 0-100 ppm.
Alkylating
Agent
ACN DMF Heat and
DMF
Catalyst R2
4-Cb Yes Yes N/A N/A 0.9962
1-Bb No No Yes Yes 0.9741
EMS No No Yes No 0.9756
FR B Yes Yes N/A N/A 0.9930
5.3.8 Measurement of alkylation in the presence of drug compounds.
Following on from the initial development of linear assays for 4-chloro-1-butanol and
ethyl methane sulfonate it was then decided to investigate the changes in absorbance
when drug was dissolved in the appropriate solvent. This would provide insight into
whether preparation would be necessary for industrial samples or whether
pharmaceutical formulations could be simply dissolved and assayed. 100 per cent
pure acetaminophen was used for testing.
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Figure 5.53. Changes in absorbance at 624 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to increasing concentrations of 4-chloro-1-butanol
when acetaminophen is present at a concentration of 10 mg/ml.
This figure showed that 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate was
capable of maintaining its linear change in absorbance in response to increasing
concentrations of 4-chloro-1-butanol with acetaminophen present at 10 mg/ml.
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Figure 5.54. Changes in absorbance at 624 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to increasing concentration of ethyl methane
sulfonate when acetaminophen is present at a concentration of 10 mg/ml. The
samples were heated at 85oC for 4 hours before UV-vis analysis was carried out.
This figure showed that 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate was
capable of maintaining its linear change in absorbance in response to increasing
concentrations of ethyl methane sulfonate with acetaminophen at 10 mg/ml.
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Figure 5.55. Changes in absorbance at 624 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to increasing concentration of 4-chloro-1-butanol
when acetaminophen is present at a concentration of 100 mg/ml.
This figure showed that 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate
maintained its linear response to the addition of 4-chloro-1-butanol at 100mg/ml of
acetaminophen.
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Figure 5.56. Changes in absorbance at 624 nm for 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate in response to increasing concentration of ethyl methane
sulfonate when acetaminophen is present at a concentration of 100 mg/ml. The
samples were heated at 85oC for 4 hours before UV-vis analysis was carried out.
This figure shows that 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate
maintained its linear response to the addition of ethyl methane sulfonate at 100mg/ml
of acetaminophen.
The linearity of the assay seemed to remain but R2 values were poorer in the presence
of acetaminophen at 10 mg/ml and 100 mg/ml. The increase in concentration of
acetaminophen from 10 mg/ml to 100 mg/ml caused the overall absorbances to
decrease meaning that the magnitude of the change was also smaller. It can therefore
be concluded that the presence of acetaminophen, particularly at a concentration of
100 mg/ml was having a deleterious effect on the assay.
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In light of this finding it was decided to investigate possible explanations for the loss
of the assay’s resolution and linearity. Acetaminophen is slightly acidic and it was
postulated that a pH effect might explain the changes in dye behaviour. Whilst the
experiments involving acetaminophen were carried out, ibuprofen (more acidic
compound) was also investigated. At concentrations of 10 mg/ml and 100 mg/ml
ibuprofen bleached the dye. This bleaching was reversed when base was added so in
this case it was found that the slightly more acidic ibuprofen was affecting the dye.
Also the presence of water in the assay as an impurity in the acetaminophen was
another possible explanation for the decreased performance. It was therefore decided
to investigate effects of apparent pH and water on dye behaviour.
5.3.9 Effects of apparent pH on dye behaviour in the presence of 4-chloro-1-
butanol
The molecule 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate is extremely
sensitive to its environment, Having already shown that the assay for 4-chloro-1-
butanol and ethyl methane sulfonate does not work as well in acetaminophen as it did
in earlier experiments it was decided to investigate the effect of apparent pH on dye
bleaching.
Initial experiments were run in 95% DMF and 5% water with phosphate buffer
dissolved in the water to provide different pH values. Testing was carried out with
5% water on it’s own and phosphate buffers set at pH 5.0, 7.0 and 9.0.
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Figure 5.57. UV spectrum showing the effect of 4-chloro-1-butanol on the absorption
maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate in 95 % DMF and
5% water. Blue = 0 ppm, pink = 50 ppm ad orange = 100 ppm.
Under the conditions described, 4-chloro-1-butanol reduced the absorption maximum
in a fashion similar to that already seen in this study.
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Figure 5.58. UV spectrum showing the effect of 4-chloro-1-butanol on the absorption
maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate in 95 % DMF and
5% phosphate buffer solution at pH 7.0. Blue = 0 ppm, pink = 50 ppm ad orange =
100 ppm
2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate had a smaller absorption
maximum to begin with but the maximum reduced in the presence of 4-chloro-1-
butanol in a fashion similar to that already observed in this study.
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Figure 5.59. UV spectrum showing the effect of 4-chloro-1-butanol on the absorption
maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate in 95 % DMF and
5% phosphate buffer solution at pH 9.0. Blue = 0 ppm, pink = 50 ppm ad orange =
100 ppm
At pH 9.0, 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate had an absorption
maximum similar to that observed for 5% water. The absorption maximum reduced
in the presence of 4-chloro-1-butanol in typical fashion.
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Figure 5.60. The changing absorbance maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-
1-pyridinio) phenolate in the presence of 4-chloro-1-butanol in four different pH
environments.
The addition of buffer at pH 5.0 had a profound effect. The dye bleached completely
and therefore it was not possible to detect alkylation by 4-chloro-1-butanol using UV-
vis spectroscopy. To confirm the reversibility of the bleaching by phosphate buffer at
pH 5.0, a drop of organic base was added and the dye regained its colour.
The addition of 5% water and the addition of phosphate buffer at pH 9.0 produced a
similar response with the dyes’ absorbance decreasing in a fashion similar to that seen
in earlier experiments.
Having shown apparent pH to have an effect on the dyes’ behaviour it was decided to
manipulate the pH conditions in the presence of drug compounds in order to see if dye
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performance could be improved. Previous experiments had shown acetaminophen to
affect the dyes behaviour and a likely explanation was the drugs’ effect on the
apparent pH. Acetaminophen is weakly acidic and at 100 mg/ml especially would
have caused a pH effect on the dye. Ibuprofen was also tested but it was found to
strongly bleach the dye when present at a concentration of 100 mg/ml. The addition
of organic base restored colour and so in the light of these experiments which showed
apparent pH manipulation may benefit the assay, it was decided to investigate the
possibility of pH manipulation in the presence of acetaminophen in an attempt to
improve the robustness of the assay in the presence of drug compounds.
Alkylation and apparent pH effects in the presence of acetaminophen
Due to the high concentrations of drug present in the system (10 mg/ml or 100 mg/ml)
it was not possible to continue this line of enquiry with phosphate buffer. The DMF
to water ratio was 95% to 5% and dissolving the phosphate compounds in water at the
necessary concentrations would not have been possible. It was therefore decided to
use an organic base and triethylamine was selected. Concentrations of 0.662 M and
0.066 M were selected because these gave an equimolar ratio with acetaminophen at
100 mg/ml and 10 mg/ml.
The assay for 4-chloro-1-butanol was tested with acetaminophen present at 10 mg/ml
and 100 mg/ml and with triethylamine present at 0.066 M and 0.662 M concentrations.
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Figure 5.61. UV-vis spectrum showing the effect of 4-chloro-1-butanol on the
absorption maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate with
acetaminophen present at 10 mg/ml and triethylamine present at a concentration of
0.066 M.
This UV spectrum showed that the UV absorption maximum for 2,6-diphenyl-4-
(2,4,6-triphenyl-1-pyridinio) phenolate reduced as the concentration of 4-chloro-1-
butanol increased.
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Figure 5.62. UV-vis spectrum showing the effect of 4-chloro-1-butanol on the
absorption maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate with
acetaminophen present at 100 mg/ml and triethylamine present at a concentration of
0.662 M.
The UV absorption maximum for 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)
phenolate did not reduce as markedly as it had in previous assays and the decreases
were not uniform and concentration dependant as they had been shown to be in other
cases. There was a significant difference between 0 ppm and 100 ppm which implied
alkylation of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate was taking place
but the system was less reliable at measuring the alkylation.
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Figure 5.63. The effect of 4-chloro-1-butanol on the absorption maximum of 2,6-
diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate in the presence of acetaminophen
at 10 mg/ml and triethylamine at 0.066 M.
At 10 mg/ml of acetaminophen the presence of triethylamine produced a plot with an
R2 value of 0.9926 which therefore had good linearity. Earlier experimentation
showed the assay had reasonable linearity and good preservation of concentration
dependant drops in absorbance so the performance of triethylamine at 10 mg/ml of
acetaminophen was not as critical as for 100 mg/ml where drug interference
represents a more profound effect.
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Figure 5.64. The effect of 4-chloro-1-butanol on the absorption maximum of 2,6-
diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate in the presence of acetaminophen
at 100 mg/ml and triethylamine at 0.662 M.
It can be seen that the presence of triethylamine did not improve linearity of the assay
or increase the concentration dependant drops in absorbance. An R2 value of 0.813
represents poor linearity and so it was found that the presence of triethylamine did not
improve the robustness of the assay in the presence of acetaminophen.
A potential problem with 4-chloro-1-butanol and the presence of base is that the
molecule can cyclise to THF and therefore it was decided to test the assay with ethyl
methane sulfonate in order to ensure that we weren’t observing a lessened effect due
to THF formation from 4-chloro-1-butanol. It was also hypothesised that the presence
of water might aid proton exchange and improve the reaction.
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Therefore experiments were carried out with 4-chloro-1-butanol and ethyl methane
sulfonate where 0.662 M triethylamine was ever present and in which some samples
contained 5% water.
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Figure 5.65. UV-vis spectrum showing the effect of 4-chloro-1-butanol on the
absorption maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate in the
presence of 100 mg/ml acetaminophen, 0.662 M triethylamine and 5 % water.
The UV spectrum showed that when 100 mg/ml acetaminophen and 0.662 M
triethylamine were present, 100 µg/ml 4-chloro-1-butanol caused a reduction in the
absorption maximum. The presence of 5% water reduced the overall drop in
absorption maximum.
273
0
0.1
0.2
0.3
0.4
0.5
0.6
400 500 600 700 800
Wavelength (nm)
A
bs
or
ba
nc
e
Base + 0 ppm
Base + 100 ppm
Base + 0 ppm + 5% water
Base + 100 ppm + 5% water
Figure 5.66. UV-vis spectrum showing the effect of ethyl methane sulfonate on the
absorption maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate in the
presence of 0.662 M triethylamine and 5 % water.
The UV spectrum showed that when 100 mg/ml acetaminophen and 0.662 M
triethylamine were present, 100 µg/ml ethyl methane sulfonate caused a reduction in
the absorption maximum. The presence of 5% water reduced the overall drop in
absorption maximum.
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Figure 5.67. Summary of the effect of 4-chloro-1-butanol on the absorption
maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate in the presence of
0.662 M triethylamine and 5% water. Bars represent standard deviation (n = 3).
It can be seen that the presence of water at 5% reduced the size of the drop in
absorption maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate as a
result of alkylation by 4-chloro-1-butanol.
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Figure 5.68. Summary of the effect of ethyl methane sulfonate on the absorption
maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate in the presence of
0.662 M triethylamine and 5% water. Bars represent standard deviation (n = 3).
It can be seen that the presence of water at 5% reduced the size of the drop in
absorption maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate as a
result of alkylation by 4-chloro-1-butanol.
It can be seen that water caused the absorption maximum of 2,6-diphenyl-4-(2,4,6-
triphenyl-1-pyridinio) phenolate to decrease and then reduce in a smaller manner than
usual in the presence of 4-chloro-1-butanol or ethyl methane sulfonate. Therefore it
can be concluded that rather than aiding proton exchange as was originally
hypothesised, in combination with drug and base, water somehow inhibits the reaction
between 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate and 4-chloro-1-
butanol and ethyl methane sulfonate.
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It has been shown that the presence of drug compound at 100 mg/ml has an adverse
effect on the linearity of the assay and the magnitude of the alkylation induced
changes to the absorption maximum of 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)
phenolate.
It was shown that when dye was present alone it was possible to manipulate the assay
by altering the apparent pH with phosphate buffer. However, when it becomes
necessary to buffer in the presence of interfering drug compounds such as
acetaminophen it is no longer possible to buffer with the phosphate system and so it is
necessary to use a base.
Triethylamine was selected as a base and it was found that it did not make a
significant difference to the linearity of the assay in the presence of 100 mg/ml of
acetaminophen.
2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio) phenolate is extremely sensitive to its
local environment and it was found that in the presence of 100 mg/ml acetaminophen
and 0.662 M triethylamine the addition of 5% water adversely effected the reaction so
that only very small changes in the absorption maximum of 2,6-diphenyl-4-(2,4,6-
triphenyl-1-pyridinio) phenolate could be observed. Therefore, the tendency for the
assay to worsen in the presence of acetaminophen could possibly be explained by a
pH effect and also the presence of water as an impurity within the drug especially at a
concentration as high as 100 mg/ml. It should also be remembered that when it was
attempted to test with ibuprofen rather than acetaminophen, 2,6-diphenyl-4-(2,4,6-
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triphenyl-1-pyridinio) phenolate was completely bleached by the acidic nature of
ibuprofen but colour could be restored by the addition of organic base.
Therefore it can be concluded that changes in apparent pH and the aqueous and
solvent environment of the dye have an effect on its performance when used to
measure alkylation by 4-chloro-1-butanol and ethyl methane sulfonate. Further
testing would be required to identify the optimum conditions for the measurement of
alkylation by 4-chloro-1-butanol and ethyl methane sulfonate or should that testing
prove unsuccessful it may be necessary to introduce a preparation step involving a
technique such as solid phase extraction to remove drug compounds.
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5.4 Discussion
Fluorescence spectroscopy and UV-vis spectroscopy were tested for the quantification
of alkylation of the betaine dyes by alkylating agents. Fluorescence spectroscopy
demonstrated small changes in fluorescence in the presence of alkylating agents but
the changes were not shown in as reproducible a fashion as UV-vis spectroscopy.
Dilution of the dyes in an attempt to increase the fluorescence signal did not increase
the magnitude of the changes resulting from alkylation and it did not help to make
fluorescence detection a suitable technique for measurement of alkylation.
Fluorescence is potentially a sensitive technique but is often more suited to measuring
gains in fluorescence. The problem in this case could be self quenching by the dye or
the changes in fluorescence levels of the dye due to alkylation being too small for
accurate detection.
UV-vis spectroscopy performed much better when it came to quantifying alkylation
of the dyes. From UV-vis spectra it was possible to detect loss in absorbance as a
result of alkylation of the dye and using the technique it was possible to investigate
the potential of Reichardt’s dye and the related dyes for the detection of alkylating
agents.
4-Chloro-1-butanol alkylated all the dyes used in the study and changes in the
absorption maximum for the dye were pronounced. 2,6-diphenyl-4-(2,4,6-triphenyl-
1-pyridinio)phenolate showed excellent linearity in the presence of 4-chloro-1-butanol
at different concentrations. The reaction proceeded rapidly at room temperature with
colour changes observable by eye taking place within one or two seconds of mixing
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dye 4-chloro-1-butanol. The reaction proceeded well in acetonitrile and DMF but
showed a greater overall drop in absorbance in DMF.
Fast Red B, the diazonium salt also showed good reactivity with 2,6-diphenyl-4-
(2,4,6-triphenyl-1-pyridinio)phenolate and the presence of the compound at different
concentrations caused the absorption maximum of the dye to change in a linear
fashion. The reaction proceeded within seconds of mixing dye with Fast Red B.
1-Bromobutane is an alkyl halide like 4-chloro-1-butanol but reactivity between the
alkylating agent and the dyes was less pronounced than for 4-chloro-1-butanol. The
reaction did not proceed at all in acetonitrile where as heating at 85oC for four hours
in DMF caused the reaction to proceed. As with 4-chloro-1-butanol and Fast Red B, a
linear plot could be made which showed a decrease in absorption in response to the
presence of 1-bromobutane at different concentrations. Additionally, it was found
that the catalyst tetrabutlyammonium iodide increased the rate of the reaction so that
the changes in absorbance were greater over the equivalent time period.
Ethyl methane sulfonate was also unreactive with the betaine dyes in acetonitrile. As
with 1-bromobutane the, reaction between ethyl methane sulfonate and 2,6-diphenyl-
4-(2,4,6-triphenyl-1-pyridinio)phenolate could be made to proceed by heating the
reaction mixture up to 85oC for a period of four hours. The presence of
tetrabutylammonium iodide did not increase the rate of the reaction. The change in
absorbance could be plotted in a linear fashion as with the other compounds.
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The experiments where alkylating agent and dye were reacted alone in either
acetonitrile and DMF showed that the dye 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate would undergo alkylation. The change in absorbance was
proportional to the concentration of alkylating agent present and so a linear plot could
be produced.
It was established through one of the series of results presented in this chapter that the
compound 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate could be used as a
sensitive assay for the alkylating agents: 4-chloro-1-butanol, 1-bromobutane, ethyl
methane sulfonate and Fast Red B. 4-Chloro-1-butanol and Fast Red B reacted with
2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate instantly and at room
temperature giving visible colour changes that could be quantified
spectrophotometrically. 1-Bromobutane and ethyl methane sulfonate were found to
react less well with 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and to
produce the linear assay seen for 4-chloro-1-butanol and Fast Red B, the reaction
conditions needed to include heating at 85oC for four hours in DMF. 1-
Bromobutane’s reaction was also slightly sped up by the presence of
tetrabutlyammonium iodide. The extra conditions required for 1-bromobutane and
ethyl methane sulfonate prompted the study to look at the azo dyes 4-
phenylazophenol and Fat Brown B. Both dyes performed similarly in that some
changes to the eye could be seen when alkylating agents were present but
spectrophotometrically the changes were much less easy to interpret. The data
presented in this chapter on the azo dyes showed that the changes in response to
presence of alkylating agents were small in comparison to the betaine dyes and those
changes did not always appear in the step wise fashion needed to construct a linear
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assay. After testing with 4-chloro-1-butanol for the purposes of comparison and then
1-bromobutane and ethyl methane sulfonate it was found that 4-phenylazophenol and
Fat Brown B were not as useful as the betaine dyes for the detection and potential
quantification of alkylating agents. These results provided the basis for a sensitive
and quantitative assay for alkylating agents. The next challenge was to determine if
the dyes would undergo the alkylation in the presence of drug sample. The dyes
working in the presence of drug would be very useful to the final assay because
sample preparation would be unnecessary. The drug is often provided to the
analytical scientists within a company in powder form and then analysis will take
place. If the drug can be dissolved straight away and then subjected to the assay for
genotoxins it would represent a significant time saving.
The experiments where acetaminophen was dissolved at 10 mg/ml showed that the
linearity of the assay was maintained in the presence of acetaminophen. The
absorbance values were much smaller and the overall change in absorbance maxima
at 100 mg/ml of acetaminophen. The failure of the assay to work at 100 mg/ml of
acetaminophen resulted in the investigation of apparent pH as a possible means of
stabilising it. Acetaminophen is mildly acidic and at the concentration of 100 mg/ml
was found to be bleaching 2,6-diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate and
when ibuprofen was tried it was found to cause complete bleaching. The bleaching
was reversible with the addition of base and was due to a pH effect. It was therefore
decided to investigate the possibility of buffering so that dye performance could be
maintained in the presence of drug. It was found that the use of phosphate buffer did
affect dye performance. At pH 5.0 the dye bleached meaning that no measurements
could be carried out (addition of organic base restored colour), at pH 7.0 and 9.0 the
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dye’s performance improved indicating that in slightly basic conditions performance
was better. It was not possible to use phosphate buffer when dissolving drug because
of the problem of getting the buffers into solution at such high concentration so it was
decided to try triethylamine as an organic base in a 1:1 ratio with acetaminophen. It
was found that the presence of triethylamine at an equimolar ratio to acetaminophen
at 100 mg/ml did not restore the assay. It was found that whilst absorbances changed
in response to alkylating agent in a concentration dependant fashion the assay
performed very poorly for 100 mg/ml of acetaminophen. It was also found that the
presence of 5% water alongside acetaminophen also worsened the assay which may
suggest that when drug is added the presence of water as an impurity and the effect on
apparent pH may be responsible for the assay not working. The advantage of being
able to dissolve large amounts of drug lies in the fact that it increases the amount of
genotoxic impurity available for measurement.
To set the importance of this work into a context, the European Medicines Agency
released a statement on the 21st of June 2007 in which it was recommended to the
European Commission that the authorisation for the marketing of a drug called
Viracept be suspended due to the presence of a genotoxic impurity at levels deemed
unsafe. The suspension was subsequently lifted on the 20th of September 2007 after
the new production methods and product checks from the manufacturing company
had been reviewed by the agency. Incidents such as this one highlight the importance
of genotoxic impurities and illustrate the idea that a recall or suspension of
authorisation can have a very negative effect on a company. A generic and easy to
operate assay for alkylating agents would be a very useful tool to the pharmaceutical
industry and an extra fail safe for patient welfare.
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In the light of results presented in this chapter, further work that could be done to
enhance the understanding and potential of this system would be to look at the
reaction between dye and alkylating agent in the presence of drug by NMR. Testing
can also be carried out with other drugs to see if a universal assay system for
alkylating agents can be developed. Other refinements to the system could involve
the production of a sensor which may involve the dye covalently attached to a
polymer or present in a sol/gel type sensor.
5.5 Conclusions
In this chapter the idea of genotoxic impurities was introduced. Reichardt’s dye (2,6-
diphenyl-4-(2,4,6-triphenyl-1-pyridinio)phenolate) was identified as a potentially
useful dye molecule for the optical detection of alkylating agents. Testing was carried
out with 4-chloro-1-butanol, 1-bromobutane, ethyl methane sulfonate and Fast Red B
which showed the optimum reaction conditions to detect the presence of the
alkylating agents at different concentrations. 2,6-diphenyl-4-(2,4,6-triphenyl-1-
pyridinio)phenolate was found to be the most suitable dye molecule of the three
investigated. As the two most industrially relevant impurities, NMR was carried out
on the reactions of 4-chloro-1-butanol and ethyl methane sulfonate with Reichardt’s
dye and the alkylated dye product of the reaction was confirmed. Testing of the dye
and alkylating agent in the presence of acetaminophen at 10 mg/ml and 100 mg/ml
was carried out and this showed the linearity of the assay remained to some degree
but the drug was interfering with the assay.
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6 Overall Discussion and Future
Work
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The work of Chapter 3 was been aimed at gaining understanding of particular
elements of the swabbing process. Swab sampling is a critical aspect of the cleaning
verification process. It is of paramount importance that a pharmaceutical company
can accurately estimate the amount of material remaining on its manufacturing
equipment. At present many companies have validated processes for a particular drug
in combination with a particular swab and analytical technique. Understanding does
not go much further beyond a particular swab, drug and solvent combination
producing adequate recoveries. Companies at present do not know what is their
optimum combination of swab, solvent and drug. The results presented in Chapter 3
demonstrate how compound recovery can be affected by the combination of swab,
solvent and drug. It was shown that recoveries varied in some instances from forty
eight percent to eighty eight percent.
The literature in the cleaning verification field often makes fairly general claims about
what type of swabs should be used. This work puts some of those claims into context
because it has produced typical recoveries for different swab, solvent and drug
combinations and also quantified the process of debris generation. We have shown
that the extraction procedure is generally efficient and that the remaining drug is left
behind on the surface of interest rather than remaining unextracted from the swab. It
was found that in line with manufacturers’ claims, debris generation was low. This is
an important confirmation, particularly for swabs that are marketed for applications in
clean room environments.
The section of the study which shed light on the swabbing process and demonstrated
that the critical feature of the swabbing process – recovery, can be affected
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significantly by the swab, solvent and drug combination was also particularly useful
for Chapter 4 and the SERS enquiry.
Another aspect of the swabbing process on which important light was shed was error.
All swab sampling was carried out by one person in order to minimise variation but
the results showed that a certain amount of error is inherent in the swabbing process.
It was also shown that certain combinations of swab, solvent and drug had smaller
errors which again is a very important point because it shows that companies can
reduce the amount of error in their swabbing process by choosing a proven
combination of swab, solvent and drug.
Cleaning verification itself is a growing field because there is currently a more
widespread desire within the pharmaceutical industry to deviate away from an HPLC
driven cleaning verification process. This is because other analytical techniques
which offer faster analysis times and potential portability are starting to emerge as
serious alternatives to HPLC. Companies producing this new generation of analytical
technology are tending to focus on total organic carbon analysis, ion mobility
spectroscopy and UV analysis. In this study, we have provided evidence to support
the idea that surface enhanced Raman spectroscopy is a potentially useful analytical
technique capable of meeting the sensitivity requirement for cleaning verification
work and having the advantages of specificity, portability and rapid analysis times.
The use of commercially available Klarite™ SERS slides to measure swab extracts
proved a successful approach. This section of the project has received commercial
funding to continue. It is hoped that through our work, the SERS approach can be
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optimised further in combination with chemometric analysis to offer a very credible
alternative to HPLC analysis of cleaning verification samples.
In terms of further experiments for SERS and cleaning verification a number of
options exist. In many ways the capability of the technique is limited by the
reproducibility of the SERS effect. By employing the commercially available
Klarite™ SERS substrates it has been shown that analysis of cleaning verification
samples can be carried out. With analysis of cleaning samples being an industrial
process of importance it is essential that the SERS effect is reproducible. As has
already been said the reproducibility comes from he highly ordered nano-architecture
of the Klarite™ slide. Advances in SERS and SERS substrates will only improve the
techniques’ amenability to the problem of cleaning verification. As was discussed in
the literature review, tip-enhanced Raman spectroscopy is a technique of immense
promise, particularly in combination with fibre optic cable that would allow for
portable sampling and direct measurement from contaminated surfaces. Our attempts
to produce a SERS swab were the beginning in a potential line of enquiry that may
yield a sampling device capable of directly detecting contamination of manufacturing
equipment.
As has already been said, genotoxic impurities are a subject of growing importance
within the field of pharmaceutical manufacturing. Until now their analysis has relied
on the traditional techniques of analytical chemistry. In this study, a potential optical
sensor for commonly occurring alkylating impurities has been developed on the basis
of the molecule known as Reichardt’s dye. The assay was developed by dissolving
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the dye in organic solvent and testing the effect of various alkylating agents and
varied conditions.
The findings showed that in ordinary circumstances where Reichardt’s dye and
alkylating agent were present in solvent, the reaction proceeded efficiently and could
be used to form the basis of a linear assay. It then became apparent that the presence
of drug alongside Reichardt’s dye and alkylating agent had an adverse effect on the
linearity on the assay. The absorption maximum of Reichardt’s dye also reduced
significantly in the presence of acetaminophen and the alkylaton induced changes in
absorption maximum reduced in size in the presence of acetaminophen and caused
poorer separation of absorption maxima between different concentrations of
alkylating agent. It was established through experimentation that apparent pH might
have been affecting the performance of Reichardt’s dye. The introduction of
phosphate buffer at pHs 5.0, 7.0 and 9.0 in 5% water showed that the absorption
maximum of Reichardt’s dye was affected by apparent pH. Unfortunately it was not
possible to buffer reactions where drug was present with phosphate buffer and so the
base triethylamine was used. It was found that the presence of triethylamine did not
stabilise the reaction when acetaminophen was present.
The work on Reichardt’s dye and alkylating agents showed clear potential for the
development of an optical sensor for genotoxic impurities. The problem of drug
interference would need further investigation and there are a number of ways by
which this could be done. It was clear that apparent pH and water had an adverse
effect on dye performance so other solvent conditions could be investigated.
Reichardt’s dye could be investigated as a sensor through inclusion of the molecule in
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polymer films or through covalent attachment to polymeric fibres. The dye’s
performance may differ in these conditions and so drug interference may prove less
problematic. Through inclusion in a sensor type device it may prove possible to
increase the overall sensitivity of the assay by having large amounts of dye present in
a relatively small area. Should it not prove possible to circumnavigate the problem of
drug interference then the assay would still work in combination with an appropriately
chosen separation column or through solid phase extraction which is the
predominantly employed technique when cleaning up samples for genotoxic analysis.
In summary this project has addressed issues associated with the production of
pharmaceuticals. Through experimentation the understanding of the swabbing
process has been increased, surface enhanced Raman spectroscopy has been shown as
a technique of promise for the analysis of cleaning verification samples and a simple
and rapid linear assay for alkylating agents has been developed that through further
refinement may turn out to be an industrially implementable system.
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8.1 Appendix 1 – fabrication of SERS nanostructures by Dr Jin-Sung Kim
(University of Michigan)
1. Non Lift off sample
MRI 8020
Spin Coating
On Pyrex Glass
Imprinting
(Heat & Pressure)
Separating
The reversed stamps
Deposition of Au with 20nm
After imprinted, there is
always some residual layer
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2. Lift off sample
MRI 8020
Spin Coating
On Pyrex Glass
Imprinting
(Heat & Pressure)
Separating
Removal of
the residual layer
After imprinted, there is
always some residual layer
Deposition of
Au with 20nm
Removal of
the Polymer layer
using Acetone
